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Abstract 
 
In the eukaryotic genome, DNA and histone modifications regulate chromatin function 
and mediate basic processes such as gene transcription, DNA repair and DNA 
replication. Maintaining chromatin modifications after DNA replication is essential for 
chromatin homeostasis, especially for regions of the genome that need to be kept 
silenced such as repetitive elements. The maintenance DNA methyltransferase, 
DNMT1, is responsible for ensuring that cytosine methylation at CpG dinucleotides, 
and thus proper transcriptional programmes, are propagated to the daughter cells. 
DNMT1 is specifically recruited to newly replicated, hemi-methylated DNA and the E3-
ubiquitin ligase UHRF1 (Ubiquitin-like containing PHD- and RING-finger domains 
protein 1) plays a critical role for this. The mechanisms of the recruitment of DNMT1 
to chromatin via UHRF1 are currently an area of active investigation. 
 
Several studies using modified nucleosomes, histone peptides and DNA 
oligonucleotides have identified UHRF1 to bind to hemi-methylated CpG dinucleotides 
and to histone H3 di- or tri-methylated at Lys-9. Since UHRF1 was also found to 
interact with DNMT1, it was postulated that UHRF1 acts as an adapter that directly 
recruits DNMT1 to newly replicated DNA. Additionally, it has recently been reported 
that the E3-ubiquitin ligase activity of its C-terminal RING-finger is required for the 
recruitment of DNMT1 to replication forks. Ubiquitylation of either K18 or K23 on 
histone H3 that is recognised by a ubiquitin-interacting motif within DNMT1 appears to 
be critical for DNMT1 targeting but the recruitment mechanism has so far not been 
completely elucidated.  
 
This study has investigated the binding and E3-ubiquitin ligase activity of UHRF1 in 
the context of physiologically relevant chromatin substrates. Using a fully reconstituted 
system, the chromatin binding and enzymatic activity of UHRF1 and how this is linked 
to its intra-molecular arrangement have been elucidated. In the context of modified 
nucleosome substrates, we observe an increase in binding of recombinant UHRF1 in 
the presence of hemi-methylated DNA whilst with histone H3K9me2/3, only a small 
increase in binding is detected. We also provide evidence that binding to nucleosome 
core particles is enhanced by a basic region between the SRA-domain and the RING-
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finger. This so called polybasic region or PBR has previously been implicated in the 
regulation of UHRF1 binding to H3K9me2/3 marks. Our findings therefore suggest that 
binding of UHRF1 to physiological chromatin substrates is more complex than 
previously thought. In-solution crosslinking/mass spectrometry experiments using the 
full-length protein confirm that UHRF1 exhibits complex intra-molecular contacts that 
can potentially regulate its interaction with chromatin or other factors. In addition to 
reported contacts between the PBR with the Tandem-Tudor domain and between the 
PHD-finger and the SRA-domain, the UBL-domain also makes extensive contacts to 
other regions within UHRF1. These appear to be weak and dynamic. Crucially, removal 
of the UBL-domain does not affect nucleosome binding but does result in a strong 
reduction in UHRF1 E3-ubiquitin ligase activity. Further experiments suggest that the 
UBL-domain is involved in establishing the enzyme/substrate complex between the 
E2-conjugating enzyme and the chromatin substrate and in stimulating the transfer of 
ubiquitin from the E2~Ub complex to histone H3. 
 
In summary, by combining a crosslinking/mass spectrometry approach to interrogate 
the intra-molecular arrangement of UHRF1 with fully reconstituted enzyme and 
chromatin-binding assays using physiologically relevant substrates, we have identified 
a function for the UBL-domain of UHRF1. Our results suggest that the UBL is highly 
flexible in solution and that it forms transient contacts with other parts of UHRF1 and 
the E2-conjugating enzyme that are required for the formation of the E2/E3/substrate 
complex in allosterically activating ubiquitin transfer from the E2~Ub to the histone 
target substrate. These findings assign, for the first time, a function for the UBL-domain 
and pave the way for further investigation of the involvement of this domain in the 
physiological role of UHRF1. 
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Chapter 1 
1. Introduction 
1.1 Chromatin in the eukaryotic nucleus1 
Epigenetics describes biological events resulting in heritable changes to gene 
expression that occur without alteration to the underlying DNA sequence. Nearly all 
cells within the human body have an identical genotype, but during development they 
acquire an array of phenotypes, resulting from alterations in their gene expression 
profiles. Specific gene expression patterns are shaped by epigenetic mechanisms 
leading to variation in their epigenomes whilst the genome remains unaltered.  
 
 
 
The majority of DNA within eukaryotes resides in the nucleus where it exists as a 
complex assembly called chromatin (Fig 1.1). The primary repetitive unit of chromatin 
is called the nucleosome that consists of approximately 147 bp of DNA wrapped 
around a core octamer of histone proteins made up of 2 copies each of the histones 
H2A, H2B, H3 and H4 with a linker histone H1 bound to DNA between nucleosomes 
(reviewed in (Luger et al, 2012). Chromatin is rarely a static structure and is 
dynamically regulated by many factors and mechanisms within the nucleus. These 
mechanisms include covalent modifications on DNA and histone proteins, regulation 
of nucleosome assembly by histone chaperones, ATP-dependent nucleosome 
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remodelling by chromatin remodellers to control DNA accessibility and exchange of 
canonical histones with histone variants. These processes allow epigenetic information 
to be encoded within chromatin and acts in regulating gene expression, DNA repair 
and DNA replication.  
 
The compaction of genetic material into chromatin generally leads to the repression of 
transcription meaning genes and their regulatory regions need to be made accessible 
for the transcriptional machinery for gene expression to occur (Pazin et al, 1994). The 
central importance of these epigenetic mechanisms in establishing and maintaining 
gene expression patterns also means that pathological states may occur if this 
regulation at the epigenetic level is compromised and the role of epigenetics in a 
variety of diseases is now widely appreciated. The reversible nature of many of these 
underlying processes, however, also provides a basis for possible prevention and 
treatments for diseases associated with epigenetic origins. Therefore, an 
understanding of these basic epigenetic mechanisms at the molecular level is 
paramount to help develop therapeutics to some of these diseases.  
 
1.1.1 Chromatin regulation1 
Activation and repression of regions of the genome (e.g. genes and repetitive regions) 
in addition to the regulation of DNA repair and replication mechanisms tend to be 
orchestrated by the recruitment of transcription factors and chromatin-binding protein 
complexes. These chromatin-associated complexes often combine a variety of 
molecular functions such as specific chromatin modifying or de-modifying activities and 
chromatin remodelling activities. The resulting modifications on chromatin can be 
combined to give a specific readout for the cell depending on the cell type and 
developmental stage. 
 
1.1.2 DNA modifications1 
Whilst the underlying genome tends to remain unchanged and stable, the bases 
themselves are available to be targeted for chemical modifications. The major form of 
DNA modification in higher eukaryotes is methylation at the 5-position of cytosine in 
CpG dinucleotides (Schübeler, 2015). The methyl mark is placed by enzymes known 
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as DNA methyltransferases (DNMTs) that transfer a methyl group from S-adenosyl 
methionine to DNA (Li & Zhang, 2014; Jurkowska & Jeltsch, 2014; Jurkowska et al, 
2011; Jeltsch & Jurkowska, 2014). In mammals, DNMTs can be grouped into de novo 
DNMTs (DNMT3A and DNMT3B) and a maintenance DNMT (DNMT1). De novo 
DNMTs establish DNA methylation patterns during embryonic development and are 
highly expressed in embryonic stem (ES) cells but are downregulated in differentiated 
tissues. The catalytically inactive DNMT3L acts as a general co-factor for DNMT3A 
and DNMT3B. DNMT1, however, has preferential activity on hemi-methylated DNA in 
the cell (Jeltsch & Jurkowska, 2016). It is thought to follow the replication fork via 
interactions with proliferating cell nuclear antigen (PCNA, (Chuang et al, 1997) and 
Ubiquitin-like containing PHD and RING finger domains 1 (UHRF1, (Bostick et al, 
2007; Sharif et al, 2007) in restoring DNA CpG methylation on hemi-methylated DNA 
after synthesis of the daughter strand. The precise mechanism as to how this 
recruitment occurs will be discussed later in more detail.  
 
DNA methylation tends to be associated with repressed regions of the genome (Fig. 
1.1). CpG dinucleotides make up around 1% of the mammalian genome with the 
majority being methylated. CpG islands (regions of highly elevated CpG content) are 
associated with about 60% of human gene promoters and are usually unmethylated in 
normal cells, although around 4% become methylated in a tissue-specific manner 
during early development, which generally leads to silencing of the associated genes 
(Borgel et al, 2010; Shen et al, 2007). Gene body methylation, on the other hand, is 
coupled to transcriptional activation in ubiquitously expressed genes and may correlate 
with elongation efficiency (Laurent et al, 2010; Lister et al, 2009). Repetitive elements 
within the genome are silenced by DNA methylation to prevent aberrant expression 
that could cause chromosomal instabilities, translocations and gene disruption due to 
transposition events. Imprinted genes tend to have a closely associated imprinting 
control region (ICR), the methylation of which dictates whether the paternal or maternal 
allele is expressed (Sanli & Feil, 2015). DNA methylation is further linked to nuclear 
organisation (Pombo & Dillon, 2015), concentrating in dense silenced chromatin 
known as heterochromatin (Grewal & Moazed, 2003).  
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CpG methylation can exert its repressive effects by blocking DNA-binding proteins, 
such as transcription factors, from accessing the underlying DNA or by recruiting 
proteins that contain methyl-CpG binding domains (MBD). One example is MeCP2 that 
also contains a transcriptional-repression domain (TRD) that can recruit other co-
repressors such as Sin3a and histone de-acetylases (HDACs) in addition to chromatin 
remodellers that maintain the silenced chromatin state (Jones et al, 1998; Nan et al, 
1998). Another methyl-CpG binding domain is the SET and RING-associated (SRA) 
domain that binds preferentially to hemi-methylated CpG DNA. This domain has been 
identified in Kryptonite (KRY) histone methyltransferase in Arabidopsis that is required 
for CHG DNA methylation (Du et al, 2014) and UHRF-family proteins that are thought 
to play a role in recruiting DNMT1 to hemi-methylated DNA for maintaining the CpG 
methylation status of DNA after replication.  
 
DNA methylation has traditionally been regarded as a stable modification with few DNA 
de-methylases identified (Li & Zhang, 2014). DNA demethylation can occur in a 
passive process due to the absence of functional UHRF1 or DNMT1 in successive cell 
cycles. Evidence for this process is found in the maternal genome when mouse pre-
implantation development occurs to remove paternal methylation. Recent 
technological advances have identified oxidised forms of 5-methyl cytosine (5mC) in 
hydroxyl-methyl cytosine (5hmC), formyl-methyl cytosine (5fmC) and carboxy-methyl 
cytosine (5camC). The identification of these marks and the enzymes involved in their 
formation, such as the TET (Ten-eleven Translocation) proteins (dioxygenases), 
suggests that these oxidation products may form intermediates in the active removal 
of the repressive 5mC mark whilst they may also have independent roles in directly 
regulating gene expression (Wang et al, 2014b; Tan & Shi, 2012).  
 
Methylated cytosine (or oxidised derivatives) at the 5-position (5mC) has often been 
described as the “5th base” of DNA but other DNA modifications have been identified 
on the back of technologies primarily used to investigate RNA modifications. 
Methylation at the 6-position of adenosine (m6A) has recently been identified at low 
levels in the genome while its role is still being elucidated (Luo et al, 2016; Wu et al, 
2016). 
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1.1.3 Histone modifications1 
Histone proteins are highly basic proteins with a globular core histone fold and flexible 
N- and C-terminal tails that contain a high percentage of lysine and arginine residues 
protruding from the nucleosome core particle. The amino acid residues on histones 
can be post-translationally modified with residues on the flexible tails being particularly 
highly modified compared with the globular core residues. Numerous modifications can 
exist such as lysine or arginine methylation, lysine acetylation and ubiquitylation, serine 
or threonine phosphorylation and ADP-ribosylation to name but a few. Furthermore, 
histone post-translational modifications (PTMs) rarely occur in isolation and it is the 
position, extent and context of the modifications that mediate their regulatory effects 
on chromatin (Bannister & Kouzarides, 2011; Kouzarides, 2007; Allis & Jenuwein, 
2016; Huang et al, 2014; Lawrence et al, 2016). The combination and specific pattern 
of histone modifications that regulate transcription within the genome have become 
known as the “histone code” (Ruthenburg et al, 2007; Strahl & Allis, 2000). 
 
Histone PTMs are deposited by modifying enzymes (known as “writers”) such as 
methyltransferases (MTases) and acetyltransferases whilst demodifying enzymes 
(“erasers”) remove these marks (Fig. 1.2). The opposing activities of these groups of 
enzymes enables a highly dynamic regulation of gene expression as modifications can 
be added or removed depending on whether a particular writer or eraser is recruited 
to a specific location of the genome. Histone PTMs can act as docking sites for 
epigenetic “reader” proteins that contain modification-specific binding domains. These 
binding domains, such as bromodomains that can recognise acetylated lysine, or 
Tudor domains that can bind methylated lysine, are integral in directing epigenetic 
effector proteins to chromatin (Yun et al, 2011). Indeed, many chromatin reader 
proteins tend to have multiple modification-specific domains to bind to a specific 
readout of histone PTMs and this specificity of binding is further enhanced with multiple 
chromatin reader proteins coming together to form much larger chromatin reader 
complexes. With multiple histone PTM patterns, they are thought to form a code that 
enables highly specific recruitment of epigenetic factors that mediate distinct 
downstream events in particular regions of chromatin (Jenuwein & Allis, 2001; Strahl 
& Allis, 2000). Histone modifications can also directly affect chromatin structure. 
Histone acetylation and phosphorylation effectively reduce the positive charge of 
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histones and potentially affect the electrostatic interactions between histones and DNA 
or between neighbouring nucleosomes, which can lead to a decondensation of 
chromatin. This is supported by evidence that histone acetylation is associated with 
active open chromatin that is sensitive to DNase digestion (Hebbes et al, 1994) and 
acetylation of histone H4 at lysine 16 (H4K16Ac) diminishes the compaction of 
chromatin arrays in vitro (Shogren-Knaak et al, 2006). 
 
Many histone PTMs correlate with gene expression patterns within tissues and during 
development. For instance, lysine acetylation is generally associated with actively 
transcribed chromatin (euchromatin), along with methylation of histone H3 lysine 4, 
which marks promoter and enhancer regions, and H3K36 methylation that is found in 
active gene bodies. H3K9 and H3K27 methylation, however, are marks predominantly 
associated with silenced heterochromatic regions of the genome (Fig. 1.2). Other 
marks on histones can occur in response to DNA damage such as ubiquitylation 
(discussed more below) and phosphorylation, and histone proteins are modified in a 
cell cycle-dependent manner, e.g. by H3S10 phosphorylation. The presence or 
absence of these modifications can bring about specific recruitment of factors to 
chromatin at specific genomic loci to enable suitable regulation depending on the cell 
situation and environment (Romanoski et al, 2015). 
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1.1.4 Chromatin remodelling1 
Another mechanism involved in chromatin regulation is the control of nucleosome 
positioning by chromatin remodelling factors. Along with histone chaperones, 
chromatin remodellers shape chromatin architecture by relocating nucleosomes along 
the DNA, creating nucleosome-free regions by the eviction of histones, or by facilitating 
the deposition or exchange of new histones and histone variants. The action of these 
factors allows access of the transcription machinery to normally condensed genomic 
DNA and thereby controls gene expression (Fig. 1.2) and processes such as DNA 
replication and repair. A common feature of these remodellers is the presence of an 
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enzymatic ATPase subunit allowing them to utilise the energy released from ATP 
hydrolysis to reposition nucleosomes. There are four major families of chromatin 
remodellers – SWI/SNF, ISWI, CHD and INO80/SWR1 – based on their subunit 
composition and their modes of nucleosome remodelling (reviewed in (Gurard-Levin 
et al, 2014). 
 
1Extracted and modified from Mirabella AC, Foster, B, Bartke T. Chromatin 
deregulation in disease. Chromosoma 2016. 125(1): 75-93 
 
1.1.5 Crosstalk of DNA and histone modifications 
As already described, modifications on histone proteins rarely occur in isolation and 
these histone PTMs can also cross-talk to DNA CpG methylation. Increasing evidence 
from model organisms support crosstalk between DNA methylation and histone 
modifications. In Neurospora, DNA methylation that is catalysed by DIM-2 is 
dependent on DIM-5, a histone H3 Lys-9 methyltransferase. A HP1 homologue protein 
in Neurospora directly interacts with DIM-2 and is required to recruit DIM-2 to methylate 
DNA (Tamaru & Selker, 2001). In Arabidopsis and other plants, DNA methylation is 
more complicated and more DNA methyltransferases are involved but evidence 
suggests that CMT2-CMT3 DNA methylation requires the interaction of CMT3 with H3 
Lys-9 methylation via its Bromo-adjacent homology- (BAH) and chromo-domains 
(Stroud et al, 2014). Also in Arabidopsis, the histone methyltransferase KRY has been 
shown to bind methylated CHG or CHH via its SRA-domain, so potentially creating a 
feed-forward mechanism for heterochromatin formation (Jackson et al, 2002; Du et al, 
2014). In mammals, DNMT3L and DNMT3A-mediated de novo DNA methylation has 
been linked with unmethylated H3 Lys-4 (Hu et al, 2009). DNMT3B has been reported 
to interact with HP1a to methylate major satellite repeats at pericentromeric 
heterochromatin, dependent on Suv39h-mediated H3 Lys-9 methylation (Fuks et al, 
2003). Furthermore, a recent study has implicated H3K36 methylation in targeting 
DNMT3B for methylation within gene bodies (Morselli et al, 2015). Maintenance 
methylation in somatic cells by DNMT1 has been proposed to require interaction with 
G9a and is linked to H3 Lys-9 methylation (Lehnertz et al, 2003). However, studies 
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have identified UHRF1 as the key player that links DNA CpG maintenance methylation 
and H3 Lys-9 methylation in mammalian cells.  
 
1.1.6 Reading chromatin modifications 
The existence of a wide array of chemical modifications on histones increases the 
functional space for the binding of chromatin-interacting proteins. To further 
understand the function of combinatorial chromatin modifications, it would be useful to 
study them in the context of physiologically relevant chromatin substrates rather than 
individual modifications on histone peptides or short DNA constructs. In addition to this 
complexity at the level of chromatin, not much is known as to how combinatorial 
modification patterns are interpreted by larger multi-domain and multi-subunit 
complexes, nor how these complexes are physically associated. Several attempts 
have been made to identify factors that are able to recognise histone and DNA 
modifications in concert, with the molecular details still being investigated. A study by 
Bartke et al. utilised a SILAC-labelled nucleosome affinity purification (SNAP) 
technique that identified factors that might be regulated in such a way (Bartke et al, 
2010). This study concentrated more on heterochromatin modifications such as 
H3K9me3 and H3K27me3 marks in addition to DNA CpG methylation, using the 
heavy/light labelling of lysine and arginine residues to identify factors that are enriched 
or depleted on such modifications. The lysine demethylase KDM2a was one such 
identified protein that was enriched for binding H3K9me3 marks but depleted if DNA 
CpG methylation was present. It was since found (Borgel et al, 2016) that KDM2a has 
a nucleosome-binding module consisting of a CxxC zinc-finger and a PHD-domain in 
addition to having a close link to HP1 in mammalian cells for recruitment to H3K9me3-
modified chromatin. Other proteins identified in this study include the polycomb 
components enriched for H3K27me3 as well as other possibly novel chromatin binding 
factors with the origin recognition complex (ORC) enriched for binding to DNA CpG 
methylation and other heterochromatin marks, indicating a possible role in 
heterochromatin organisation in addition to its known role in DNA replication. 
 
Identifying the proteins that bind to combinations of chromatin modifications is 
informative. But to elucidate how these specific binding events allow a particular 
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epigenetic state to be communicated to the cell, it will be crucial to know the basic 
stoichiometry, arrangement and architecture of these factors when bound to different 
chromatin states. By using biochemical techniques with nucleosome substrates, it is 
possible to characterise these binding events in molecular detail. Much of the current 
knowledge relies on information about individual protein fragments or domains binding 
to short histone peptides or DNA but using more physiologically relevant chromatin 
substrates will allow extraction of more biologically relevant information that can then 
be tested in a cellular context.  
 
1.2 Ubiquitin-like containing PHD- and RING-finger domains 1 (UHRF1) 
UHRF1 is a multi-domain protein that has been described as a “facilitator” that 
mediates cross-talk between DNA methylation and histone modifications due to its 
ability to recognise hemi-methylated CpG DNA at replication forks in addition to histone 
H3 modified at Lys-9. UHRF1 was a factor identified in the SNAP experiments and 
other studies as being able to bind both H3K9me3 and DNA CpG methylation (Bartke 
et al, 2010; Hashimoto et al, 2009; 2010; Rottach et al, 2010; Bronner et al, 2010). 
Both are hallmarks of pericentromeric heterochromatin where UHRF1 is preferentially 
localised (Papait et al, 2007) but UHRF1 has also been implicated in regulating gene 
expression in euchromatin, especially in silencing tumour suppressor genes possibly 
through affecting chromatin modifications. However, UHRF1 is primarily thought to be 
involved in the maintenance methylation of CpG dinucleotides of newly synthesised 
DNA after semi-conservative replication (Bostick et al, 2007; Sharif et al, 2007). It does 
this by recruiting the maintenance DNA methyltransferase DNMT1 to hemi-methylated 
DNA after the passing of the replication fork. UHRF1 is also thought to allosterically 
act on DNMT1 to enhance its methyltransferase activity (Berkyurek et al, 2014; 
Bashtrykov et al, 2014).  
 
UHRF1 was originally isolated while screening proteins that could bind to the inverted 
CCAAT box (ICB2) in the promoter of Topoisomerase IIa (Hopfner et al, 2000). UHRF1 
is highly expressed in proliferating cells and is required for the G1/S phase transition 
(Mousli et al, 2003) and alterations in UHRF1 expression (normally overexpression) 
have been correlated with the aggressiveness of several human malignancies such as 
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lung cancer (Unoki et al, 2010), colorectal cancer (Kofunato et al, 2012) and 
osteosarcoma (Liu et al, 2015b) plus many others (Wang et al, 2012; Bronner et al, 
2013; Mudbhary et al, 2014; Zhou et al, 2015; Yan et al, 2015; Abu-Alainin et al, 2015). 
Several studies have identified UHRF1 as a potential cancer drug target where the 
knockdown or silencing in cancer cells led to reduced proliferation and increased 
apoptosis (Zhu et al, 2015; Yan et al, 2011; 2015). For instance, UHRF1 silencing 
arrested gall bladder cancer cells at G1/S phase in a p21-dependent pathway (Kim et 
al, 2009) and triggered apoptosis by up-regulating the expression of promyelocytic 
leukaemia (PML) protein (Qin et al, 2014). Deletion of UHRF1 in mice is embryonic 
lethal and UHRF1-/- ES cells show reduced DNA CpG methylation (similar to DNMT1-
/- ES cells), enhanced susceptibility to DNA damage, impaired maintenance of higher-
order chromatin structure and spurious transcription at repetitive DNA elements. 
 
UHRF1 is known to interact with other chromatin-associated factors such as G9a and 
HDAC1 (Cartron et al, 2013; Kim et al, 2009). These factors are predominantly 
involved in the formation of heterochromatin (e.g. G9a lays down H3K9me2/3 marks), 
this might indicate a role for UHRF1 in general heterochromatin organisation or for 
establishing heterochromatin after DNA replication (for a review, see Sidhu & 
Capalash, 2017). Other potentially interesting interaction partners include proteins 
involved in DNA repair pathways for interstrand crosslinks. UHRF1 was identified to 
bind to interstrand crosslinks via its SRA-domain and further proposed to be involved 
in recruiting the repair machinery such as the fanconi anaemia (FA) pathway factors 
or ERCC1/MUS81 (Liang et al, 2015; Tian et al, 2015). 
 
UHRF2 is another member of the UHRF family (Pichler et al, 2011) that has been 
reported to bind more specifically to hydroxymethylated cytosines at the 5-position 
(5hmC, (Zhou et al, 2014; Liu et al, 2017). The biological role of UHRF2 has not been 
fully elucidated however. The expression profile of UHRF2 is different to that of UHRF1 
with UHRF2 upregulated during differentiation and tends not to be cell cycle regulated 
at the protein level. Ectopic expression of UHRF2 in a UHRF1-/- background, however, 
did not restore DNA methylation at major satellites indicating functional differences as 
well. The interaction of UHRF2 with DNMT1 is also not cell cycle-dependent as is the 
case with UHRF1 (Zhang et al, 2011).  
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1.2.1 UHRF1 domain architecture 
There are several functionally described domains that exist within UHRF1 that have 
been shown to bind to particular chromatin modifications, aiding in its localisation to 
heterochromatin within the cell and at replication forks during S-phase. The SRA-
domain can bind preferentially to hemi-methylated DNA through a base-flipping 
mechanism (Arita et al, 2008; Hashimoto et al, 2008; Avvakumov et al, 2008). The 
crystal structure of the SRA-domain bound to hemi-methylated DNA indicated that two 
loops termed the “thumb” and NKR finger mediate the interaction with the DNA duplex 
by penetrating through the minor and major grooves, respectively (Fig. 1.4a). R491 
replaces the 5mC in the DNA helix and pairs with the orphaned guanine. The “flipped-
out” 5mC gets positioned into the binding pocket by P-stacking interactions mediated 
by two conserved aromatic residues in the active site, Y478 and T466. Residue N489 
within the finger loop acts as a selective filter to reduce binding to symmetrically 
methylated CpG dinucleotides by sterically clashing with the methylated cytosine on 
the opposite strand of DNA. Recent reports have also found that the SRA-domain plus 
the proceeding linker region binds hemi-methylated CpG DNA higher than that of the 
SRA-domain without the linker region, indicating that the linker region plays a role in 
hemi-methylated DNA binding (Fang et al, 2016). This basic region between the SRA-
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domain and the RING-finger (discussed more below) may mediate interaction with 
DNA via non-specific salt bridges.  
 
 
 
The SRA-domain in UHRF1 has been reported to bind to DNMT1 in addition to its role 
in DNA recognition. The base-flipping mechanism is thought to be associated with 
coordinating the transfer of the hemi-methyl site from UHRF1 to DNMT1 (Sharif & 
Koseki, 2011). However, DNMT1 is unable to catalyse DNA CpG methylation on 
UHRF1-bound hemi-methylated sites as NKR finger recognition of the unmethylated 
cytosine prevents processive maintenance methylation. It is likely, therefore, that 
UHRF1 dissociates from the hemi-methylated site to allow DNMT1-mediated 
maintenance methylation. Earlier reports suggested that the SRA-domain could 
interact with the replication foci targeting sequence (RFTS) domain of DNMT1 to 
enable direct recruitment of DNMT1 to replication forks but this is still inconclusive. The 
RFTS-domain of DNMT1 was recently observed to require the linker region between 
the SRA-domain and the RING-finger in addition to the SRA-domain of UHRF1 for 
binding but this interaction is impaired in the presence of hemi-methylated DNA (Fang 
et al, 2016). More recent studies have suggested that interaction of UHRF1 with 
histone marks is essential for subsequent DNMT1 recruitment. 
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The Tandem Tudor domain (TTD) and plant homeodomain (PHD) regions of UHRF1 
are required for binding to histone H3 tails (Nady et al, 2011; Arita et al, 2012; Rothbart 
et al, 2012; Xie et al, 2012; Rothbart et al, 2013). An aromatic cage formed by F152, 
Y188 and Y191 within the N-terminal Tudor domain (TTDN) can bind preferentially to 
H3K9me2/3 marks (Fig. 1.4b). The peptide binding groove between the TTD sub-
domains ensure the specificity to H3K9me2/3 by establishing contacts to residues up- 
and downstream of the methylated lysine in histone H3. The PHD-finger determines 
the binding specificity of UHRF1 by binding to unmodified N-terminal H3R2 and H3K4 
residues on histone H3 (Rajakumara et al, 2011; Hu et al, 2011; Lallous et al, 2011; 
Wang et al, 2011). The cooperation in binding to H3R2unK4unK9me2/3 by the 
TTD/PHD region contributes to pericentromeric heterochromatin localisation of 
UHRF1, which was supported by structural studies showing the ability of UHRF1 to 
engage both the unmodified N-terminus of histone H3 and H3K9me2/3 simultaneously. 
In UHRF1-/- mouse ES cells, rescue experiments suggested H3K9me2/3 binding 
promotes but is not essential for DNA maintenance methylation. A recent study used 
a mouse UHRF1 knock-in (KI) model with specific impairment of H3K9me2/3 binding 
(Y187A/P188A TTD mutant). The homozygous KI mice were viable and fertile with 
~10% reduction of DNA methylation in different tissues (Zhao et al, 2016). Also in this 
study, a GST-tagged fusion of the central region of UHRF1 (95-610aa) containing the 
described chromatin-reader domains indicated that binding to reconstituted mono-
nucleosomes was enhanced with hemi-methylated DNA with some increase in binding 
to H3K9me2/3 marks. The study indicated that the nucleosome positioning relative to 
the hemi-methylated CpG seemed to be important (binding was increased with hemi-
methylated DNA present in the linker region more so than in the core nucleosome 
sequence) whilst the role of H3K9me2/3 seemed to be to enhance UHRF1 binding to 
sites where hemi-methylated DNA is already present at replication forks. 
 
Other studies have indicated that both the hemi-methylated DNA and histone H3 
binding activities seem to be required for maintenance methylation. Individual 
mutations in the TTD or the SRA-domain see a partial loss in heterochromatin 
association but a mutation in both the SRA and TTD regions see a greater reduction 
in heterochromatin association of UHRF1 and reduced maintenance methylation 
rescue in complementation assays (Liu et al, 2013). HPLC analysis of global DNA CpG 
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methylation and bisulfite sequencing at repeat regions were used in this case in 
UHRF1-/- ES cells and in the same system, a fusion of PCNA and DNMT1 could also 
bring about the same effect.  
 
Other domains also exist within UHRF1 that are important for its function. A C-terminal 
RING-domain has E3-ubiquitin ligase activity that is thought to ubiquitylate histone 
substrates whilst an N-terminal ubiquitin-like domain (UBL) is also present although 
the function of this conserved domain is, as yet, unknown.  
 
1.3 Histone ubiquitylation and RING-mediated E3 activity 
The original identification of UHRF1 was based on its RING-dependent ubiquitin ligase 
activity on histone substrates and is required for growth regulation of tumour cells 
(Citterio et al, 2004; Karagianni et al, 2008; Jenkins et al, 2005). 
 
Histone lysine ubiquitylation has been reported in processes such as DNA repair and 
DNA replication with additional crosstalk to other histone PTMs such as histone H4 
Lys-20 di-methylation and H3K79 methylation (Holt et al, 2015; Zhou et al, 2016; 
Wilson et al, 2016; Hu et al, 2017). Specific histone ubiquitylation can have effects on 
the overall chromatin architecture (Debelouchina et al, 2016) and the chromatin 
recognition landscape leading to the recruitment of proteins containing ubiquitin-
binding domains. The mechanism of how these bulkier chromatin marks are introduced 
has recently become clearer, particularly in the context of polycomb-induced histone 
H2A ubiquitylation. The general mechanisms involved in protein ubiquitylation are a 
much larger field, however, and have been extensively studied.  
 
1.3.1 Ubiquitylation mechanisms and function 
Ubiquitin ligases or E3s are a large family of enzymes that catalyse the covalent 
modification of ubiquitin to a large range of target proteins in eukaryotic cells, playing 
fundamental roles in nearly all aspects of cellular processes (Buetow & Huang, 2016). 
Ubiquitylation was initially identified through its role in protein degradation but it can 
also alter the activity, localisation or further protein-protein interactions of target 
molecules, thereby eliciting distinct physiological signals. Ubiquitylation is achieved by 
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a cascade of reactions catalysed by a ubiquitin-activating enzyme (E1), a ubiquitin-
conjugating enzyme (E2) and an E3-ubiquitin ligase (Hershko & Ciechanover, 1998; 
Dye & Schulman, 2007; Pickart & Eddins, 2004). An E1 uses a magnesium ion (Mg2+) 
and ATP to form a covalent thioester bond between its catalytic cysteine and the di-
glycine motif at the carboxy terminus of ubiquitin (Fig. 1.5). The E1 then transfers 
ubiquitin to the catalytic cysteine of an E2 to form an E2~ubiquitin thioester complex 
(tilde, ~ indicates a thioester bond). A specific E3 can bind to E2~ubiquitin and the 
substrate to facilitate the formation of an isopeptide bond between the C-terminal 
carboxy-group of ubiquitin and the amino group side chain of a lysine residue or free 
amino terminal group of a polypeptide. Mono-ubiquitylation occurs with just one round 
of modification. Successive rounds of E3-catalysed reactions can also produce 
substrates with multiple mono-ubiquitylated sites or polyubiquitin chains linked by one 
of the seven lysine residues (K6, K11, K27, K29, K33, K48 and K63) or the N-terminal 
methionine of ubiquitin (Komander & Rape, 2012). Recognition of different 
ubiquitylation patterns by cellular effectors harbouring ubiquitin binding domain(s) can 
elicit downstream signals. For instance, Lys48-linked polyubiquitin targets the 
substrate to the 26S proteasome for degradation (Chau et al, 1989; Finley, 2009). 
Lys63-linked polyubiquitin, however, can direct the substrate to the endocytic pathway 
(Haglund & Dikic, 2012). Mono-ubiquitylation can be involved in DNA repair and 
transcriptional regulation depending on the specific site that is modified (Ulrich & 
Walden, 2010; Hoege et al, 2002; Robzyk et al, 2000).  
 
The human genome encodes two E1s, around 38 E2s and more than 600 E3s (Jin et 
al, 2007; Ye & Rape, 2009; Li et al, 2008). It is the E3s that play a vital role in substrate 
specificity and to coordinate particular ubiquitin linkages in conjunction with the E2-
conjugating enzyme. There are currently three classes of E3s: RING (Really interesting 
new gene), HECT (homologous to E6AP C-terminus) and RBR (RING-between-
RING). Each has different mechanisms for specifying the substrate and interacting with 
E2 partners as well as in the transfer of ubiquitin itself. RING E3s catalyse the direct 
transfer of ubiquitin from E2~ubiquitin to the substrate whereas HECT and RBRs 
contain their own catalytic cysteine that is involved in forming an E3~ubiquitin 
intermediate before transfer to the substrate. However, it is becoming clear that other 
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members of protein complexes or domains associated with the E3 enzyme further 
regulate substrate ubiquitylation. 
 
 
 
1.3.2 RING-mediated ubiquitylation 
RING-family E3-ubiquitin ligases constitute the largest group of E3s of those described 
above. The RING-domain in RING E3s is the minimal component required to recruit 
E2~ubiquitin and to stimulate ubiquitin transfer (Deshaies & Joazeiro, 2009). The 
RING-domain consists of two zinc ions coordinated by cysteine and histidine residues 
arranged in a cross-braced configuration. The zinc ions are essential for RING-domain 
folding and mutation of one of these coordinating Cys/His residues impairs activity of 
the RING-domain. Many RING domains are active as monomers such as CNOT4 
(Dominguez et al, 2004) and RNF38 (Buetow et al, 2015) whereas others are active 
as dimers such as RNF4 that is only active when homodimerised via its RING domain 
(Plechanovová et al, 2011). Some RING domains (e.g. BARD1) lack E3 activity but 
are functional upon heterodimerisation with a RING domain-containing partner such 
as BRCA1 for BARD1 (Brzovic et al, 2001) and BMI1 for RING1B in the polycomb 
repressive complex 1 (PRC1) ubiquitylation module (Buchwald et al, 2006; Li et al, 
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2006). Other RING E3s are part of larger multi-protein complexes such as APC/C, 
which is a 1.2 MDa complex consisting of a 14-subunit core complex, including the 
RING E3 APC11, the cullin-like APC2 subunit and a co-activator (CDC20 or CDH1) 
that aids in substrate recruitment (Chang & Barford, 2014).  
 
Studies of the structures of E2-E3 complexes have indicated that the active site 
cysteine of the E2 is distal from the RING-finger, precluding any direct participation of 
the RING-domain in catalysis (Zheng et al, 2000). The RING-finger, however, may be 
involved in allosterically activating the E2~Ub active site for ubiquitin transfer (Ozkan 
et al, 2005; Benirschke et al, 2010). For RING-family E3s, it has been shown that the 
presence of a RING-domain in isolation shifts the equilibrium between an “open” and 
“closed” E2~Ub towards the closed conformation in which ubiquitin is proximal to the 
RING-finger and more reactive for transferring ubiquitin to the substrate (Dou et al, 
2012; Pruneda et al, 2012; 2011; Page et al, 2012). In this relatively conserved 
conformation, the donor ubiquitin contacts the E2 by the hydrophobic patch (Ile44) and 
a salt bridge via R42 and interacts with the E3 via the I36 hydrophobic patch.  
 
In addition to the general mechanism for ubiquitylation by RING E3s, other contacts 
between RING E3s and E2~ubiquitin can serve to further stabilise the primed closed 
conformation to enhance enzymatic activity (Dou et al, 2013). For instance, the 
monomeric RING E3 ARK2C requires the binding of a second molecule of ubiquitin to 
the RING-domain opposite the E2-binding surface (Wright et al, 2015). Modelling data 
indicate that this ubiquitin directly contacts and stabilises the E2-conjugated ubiquitin 
for transfer. These additional components for E3 activity seem to be distinct features 
that require additional structural and biochemical studies to characterise their specific 
role in E3 activity.  
 
Several RING E3s contain additional domains that bind to the “backside” surface of 
the E2 opposite the active site. An example is the R6BD-domain of RAD18 with RAD6 
(E2). These contacts tend to enhance RING E3-E2 affinity. Some E2s (e.g. RAD6 and 
UBE2D family) also establish non-covalent backside interactions with ubiquitin and this 
interaction promotes processive polyubiquitin chain formation. For UBE2D2, this non-
covalent ubiquitin binding induces allosteric changes in the E2 that increase the affinity 
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of RING E3s for E2~ubiquitin leading to enhanced initial ubiquitin transfer. R6BD 
binding to RAD6 in the example above, however, competes with non-covalent ubiquitin 
binding, thereby limiting RAD18-mediated ubiquitylation (Hibbert et al, 2011).  
 
Other domains within RING E3s as well as E2 backside bound ubiquitin can regulate 
and stimulate substrate ubiquitylation. In BMI1 in the PRC1 ubiquitylation module, a 
ubiquitin-like fold (UBL) is predicted to exist within the central domain and is 
responsible for homo-oligomerisation of BMI1 (Gray et al, 2016). This homo-
oligomerisation is thought to be necessary for the H2A ubiquitylation activity of PRC1. 
While this BMI1 UBL homo-oligomerisation is relatively weak in vitro, the UBL-domain 
may act in conjunction with SAM (sterile alpha motif) domains that are well-known 
oligomerisation motifs in the PHC2 (polyhomeotic protein 2) subunit to enable PRC1 
clustering (Isono et al, 2013). Whether this is a general mechanism for RING E3s with 
associated UBL domains is unclear. An alternative system that utilises UBL domains 
is the RBR E3 Parkin (Ham et al, 2016; Kumar et al, 2017). Parkin plays an important 
role in mitochondria quality control. When mitochondria are damaged, PINK1 kinase 
accumulates on the outer mitochondrial membrane and recruits Parkin, which is initially 
inactive. PINK1 phosphorylation at Ser65 on this UBL-domain enhances the ubiquitin 
ligase activity of Parkin and enables the formation of polyubiquitin chains on the 
surface of mitochondrial membranes (Kondapalli et al, 2012; Shiba-Fukushima et al, 
2012). A feed-forward mechanism ensues with PINK1-dependent Ser65-
phosphorylation on ubiquitin further stimulating Parkin activity, eventually resulting in 
mitophagy. The un-phosphorylated UBL-domain contacts the RING1 domain in Parkin 
(Chaugule et al, 2011), resulting in an auto-inhibited state but Ser65-phosphorylation 
displaces the UBL-domain from RING1 enabling E2~ubiquitin binding (Riley et al, 
2013; Wauer & Komander, 2013; Wauer et al, 2015; Trempe et al, 2013; Narendra et 
al, 2008; Kane et al, 2014; Ordureau et al, 2015).  
 
The mechanism by which different E3s successfully transfer ubiquitin from 
E2~ubiquitin to the substrate varies in each specific case. The ability for the target 
lysine to be ubiquitylated seems to be governed by the target protein structure in 
addition to precisely regulated structural constraints of the E3-E2~ubiquitin complex. 
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The role of the target molecule in the reaction mechanism, however, has been poorly 
defined relative to the more non-specific poly-ubiquitylation mechanisms.  
 
1.3.3 Histone Ubiquitylation 
The size of ubiquitin (8.5 kDa) is smaller than that of histones (hH4 is 11.2 kDa) so its 
attachment to chromatin can increase the surface of the nucleosome by as much as 
4,800 A2 (Krissinel & Henrick, 2007). The ubiquitylation of histones, therefore, could 
alter the steric and electrostatic environment in addition to providing a larger surface 
area to recruit other chromatin binding factors thus making it information rich relative 
to the much smaller modifications of methylation or acetylation. Some of the surfaces 
on ubiquitin have been characterised such as on H2AK15-Ub that revealed a 
hydrophobic patch centred on Leu-8/Ile-44 that can act as a canonical binding hotspot 
(Komander & Rape, 2012; Fradet-Turcotte et al, 2013).  Other interaction surfaces 
have also been identified such as the surface hotspot of Leu-71 and Leu-73 that 
interacts with the N-terminus of H2A in the context of H2BK120-Ub (Holt et al, 2015). 
Whether these ubiquitin-related surfaces solely function to recruit chromatin-binding 
factors to specific genomic regions or whether they have an allosteric effect on 
chromatin modifying enzymes is not wholly clear. Histone ubiquitylation has also been 
shown to affect the higher-level structure of chromatin. The regulatory effects of 
histone ubiquitylation, therefore, could be widespread, particularly in DNA repair and 
replication.  
 
The mechanism by which ubiquitin is attached to histone proteins is still being worked 
out as few nucleosome-bound structures are available that indicate how the 
ubiquitylation enzymes bind to chromatin. However, recent work investigating H2A and 
H2B ubiquitylation have shed some light on how this bulky mark is deposited. Mono-
ubiquitylation of Lys119 in histone H2A by the heterodimeric RING E3 RNF2-BMI1 
(Ring1B-Bmi1/PCGF4) complex is important for polycomb-group proteins to mediate 
gene silencing (Wang et al, 2004). Polycomb-group proteins are important multi-
protein epigenetic regulators of chromatin structure and establish control of 
transcription through the addition or removal of various histone PTMs. RNF2-BMI1 
form the ubiquitylation module of PRC1 and the resulting H2A Lys-119 ubiquitylation 
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acts as the signal to recruit the histone methyltransferase complex PRC2 for H3 Lys-
27 methylation. On its own, RNF2 (Ring1a/1b) is a poor E3 but activity is enhanced 
when it hetero-dimerises with polycomb group RING-finger (PCGF) paralogs (PCGF4 
is also known as BMI1). RNF2 and PCGF paralogs both have RING domains but it is 
the RING-domain in RNF2 that interacts with E2~ubiqutiin conjugates to facilitate 
substrate ubiquitylation. The intrinsic E3 activity is not enough, however, for efficient 
histone H2A ubiquitylation in isolation, but needs other contacts within the complete 
nucleosome substrate for proper activity. Using a fused E2-E3 construct, Song Tan’s 
lab (McGinty et al, 2014) solved a crystal structure of the minimal RNF2-BMI1-UBE2D3 
(UbcH5c) complex bound to the nucleosome core particle. This indicated that the 
RING-domain is anchored onto the nucleosome by interactions with all four histones 
(including an interaction between Lys-97 and Arg-98 of RNF2 with an acidic patch on 
histone H2A), whereas UBE2D3 interacts with both the nucleosomal DNA and the C-
terminus of H2A, thereby restricting RING mobility and the orientation of the E2 to 
specify the substrate lysine for ubiquitylation. Normally, substrate lysine modification 
by RING E3s with the UBE2D family is promiscuous, but in this configuration, the 
accessibility of the catalytic cysteine from the E2 is limited to a specific substrate lysine. 
For RING E3s to build polyubiquitin chains, either the RING-E2 module or the 
ubiquitylated segment of substrate must rotate. In the RNF2-BMI1-UBE2D3-
nucleosomes complex, UBE2D3, nucleosomal DNA and histone H3 and H4 surround 
the C-terminus of H2A, thereby restricting movement of the substrate and only allowing 
mono-ubiquitylation. Ring1a/1b (RNF2) can form active E3 complexes with any of the 
different PCGF paralogs. The functional differences between PCGF paralogs could be 
linked to substrate targeting, localisation to different genomic loci or regulation at 
different genes. What is clear from the study, however, is the importance of 
investigating activity with a physiologically relevant substrate, especially when looking 
at chromatin or histone targets for ubiquitylation where the target substrate (the 
nucleosome) seems to play a prominent role in the reaction mechanism. 
 
RNF168 has recently been described to modify the N-terminal residues K13-K15 of 
histone H2A during DNA double-strand break signalling. Other proteins that are 
localised to DNA damage sites with faster kinetics recruit RNF168 via interaction of its 
conserved ubiquitin interaction motifs with ubiquitin chains already present in the 
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region. RNF168 is a monomeric E3 that ubiquitylates K13-K15 on H2A for a functional 
downstream response. The RING-domain is sufficient to confer target specificity with 
the E2 (UbcH5c) on both H2A-H2B dimers and mono-/oligo-nucleosome substrates. 
Further work in vitro identified the acidic patch formed by H2A and H2B as being 
required for this E3 activity by the minimal RING-domain despite not affecting substrate 
binding (Mattiroli et al, 2014), again demonstrating the importance of the nucleosome-
scaffold in the ubiquitylation reaction. 
 
Another histone ubiquitylation that has been studied is on histone H2B at Lys-120. 
H2BK120-Ub is enriched near the 5’-end of highly expressed genes and is also thought 
to be involved in transcriptional elongation and defining chromatin structure. H2BK120-
Ub also directly regulates methylation at H3K4 and H3K79 by Set1 and Dot1 histone 
methyltransferases, respectively. How this crosstalk occurs is poorly understood. 
Recent work from the lab of Tom Muir has elucidated a functional hotspot on ubiquitin 
(Leu-71 and Leu-73) separate from the Leu8/Ile44 hydrophobic patch that is essential 
for the stimulation of the methyltransferase activity of Dot1 on nucleosome substrates 
(Holt et al, 2015). Further work indicated that this functional hotspot on ubiquitin 
interacted with the N-terminus of H2A and it is this interaction that leads to a 
repositioning or “corralling” of Dot1 to place the active site proximal to H3K79 (Zhou et 
al, 2016).  
 
The equivalent modification in yeast (H2BK123-Ub) is catalysed by the RING E3 Bre1 
in conjunction with the E2, Rad6, during transcription. Bre1 (RNF20/40 in humans) 
associates with RNA polymerase II to aid in transcriptional elongation and specifically 
directs Rad6 towards the physiological target on H2B for Dot1-mediated H3K79 
methylation as described above. The Bre1 RING-domain has been shown to interact 
with Rad6 via “backside” binding as well as canonical E2-E3 binding with both contacts 
being necessary to enhance Rad6 activity and specificity (Turco et al, 2014). The 
RING-domain of Bre1 was also found to recognise the acidic patch on H2A and H2B 
in the context of the nucleosome core particle to properly position the active site over 
H2BK123 (Gallego et al, 2016). Overall, histone ubiquitylation mechanisms therefore 
seem to follow a theme for binding to and potential stimulation by the nucleosome 
acidic patch.  
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1.3.4 UHRF1-mediated histone H3 ubiquitylation 
Another histone ubiquitylation event that has been recently described is UHRF1-
mediated H3 ubiquitylation that has been reported to be important for DNA CpG 
maintenance methylation. As mentioned, UHRF1 was initially identified as an E3-
ubiquitn ligase with activity on histone H3 (Citterio et al, 2004). Recent studies have 
shed some light on the function of histone H3 ubiquitylation by UHRF1. Work carried 
out in Xenopus interphase egg extracts saw reduced recruitment of xDnmt1 to 
chromatin upon depletion of xUhrf1 whereas depletion of xDnmt1 resulted in slower-
migrating forms of histone H3, presumably owing to the rapid maintenance methylation 
in mock-treated extract (Nishiyama et al, 2013). The slower-migrating H3 disappeared 
upon xUhrf1-depletion but was partially rescued by add-back of recombinant hUHRF1. 
Mass spectrometry analysis identified H3K23 ubiquitylation and it was found that 
DNMT1 could bind to this ubiquitylated histone H3. Similar results were observed in 
mammalian cells upon hDNMT1 depletion. It is proposed that this H3-Ubiquitylation 
was required for proper DNA CpG maintenance methylation by aiding in the 
recruitment of DNMT1 to replication forks. Another study indicated H3K18-Ub was the 
target for UHRF1-mediated histone ubiquitylation and proposed that this was required 
for binding of DNMT1 via a ubiquitin-interaction motif (UIM) within the replication foci 
targeting sequence (RFTS). This study also speculated that DNMT1 might be able to 
recognise H2AK119-Ub marks leading to DNA methylation outside of replication (Qin 
et al, 2015).  
 
Given the low levels seen in cells, it is plausible that the H3-Ub mark may be very 
transient in vivo. The modification itself may be laid down by UHRF1 to aid in the 
recruitment of DNMT1 to replication forks but can be removed quickly through the 
action of a de-ubiquitylase (DUB). Indeed, a recent study using a Xenopus interphase 
egg extract system saw that immuno-depletion of USP7 results in the build-up of 
UHRF1-dependent H3-Ub and increased DNMT1 bound to chromatin (Yamaguchi et 
al, 2017). In addition, knockdown or knockout of USP7 in HeLa cells resulted in larger 
DNMT1 foci on chromatin. In this case, USP7 was found to bind DNMT1 
mechanistically indicating that a complex of USP7 and DNMT1, once recruited to 
chromatin at replication forks, can remove this transient H3-Ub laid down by UHRF1, 
resulting in processive maintenance methylation. USP7 has also been reported to 
 40 
interact with DNMT1 and UHRF1 to regulate their stability at the protein level by 
antagonising UHRF1-dependent polyubiquitylation resulting in their subsequent 
proteasomal degradation (Felle et al, 2011; Ma et al, 2012; Du et al, 2010). As a result, 
USP7 might also promote DNA maintenance methylation by regulating the amounts of 
DNMT1 and UHRF1. 
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The specificity of UHRF1 E3-ubiquitin ligase activity on histone H3 seems to be in a 
region that is thought to be occluded by the binding of the TTD-PHD region to this N-
terminal tail. Perhaps its activity is on neighbouring H3 tails in the same or adjacent 
nucleosome core particles. To further investigate the reaction mechanisms for UHRF1 
E3 activity, the Rothbart lab developed an in vitro assay for H3 ubiquitylation with 
recombinant human UHRF1 (Harrison et al, 2016). The study proposed that the 
presence of hemi-methylated DNA oligonucleotides in-trans stimulated the activity of 
UHRF1 to modify H3 N-terminal peptides or mono-nucleosomes purified from HeLa 
cells. No or very little activity could be observed in the presence of unmodified 
oligonucleotides or absence of DNA substrate on mono-nucleosome or H3 peptide 
substrates. This potentially indicated an allosteric regulation of UHRF1 RING E3-
ubiquitin ligase activity by hemi-methylated DNA that might change the conformation 
of UHRF1. This was not thought to be due to increased binding of UHRF1 to the 
histone substrate, as unmethylated DNAs also seemed to enhance histone binding in 
the same study. Furthermore, mutations in the spacer between the TTD and PHD-
finger, the PHD-finger and the SRA-domain also abrogated E3 activity against H3 
peptides indicating that substrate binding and dynamic intra-molecular interactions 
within UHRF1 are important for this activity. It was concluded that the novel mechanism 
involved hemi-methylated DNA allosterically directing the TTD-PHD bound H3 
substrate to the E2~Ub active site for transfer. H3K18 ubiquitylation was observed in 
high abundance in addition to others (H3K14, H3K27 and H3K36 ubiquitylation) whilst 
H3K23-Ub was only detected in the presence of H3K18-Ub on the same peptide. A 
single UHRF1 auto-ubiquitylation site could be identified (K303) that is solvent-
exposed in the PHD-finger of UHRF1. With limited structural information for the full-
length, enzymatically active UHRF1 with its substrate or E2 partner, the mechanism 
and regulation of UHRF1 RING E3 activity on chromatin remains relatively unknown. 
 
1.4 The linker regions of UHRF1 and conformational flexibility 
The functionally characterised structural domains within UHRF1 have been studied as 
described. However, the linker regions within UHRF1 have also been shown to be 
important for the proper functioning of UHRF1 both at the molecular and the cellular 
level (Tauber & Fischle, 2015). The unstructured linker between the SRA-domain and 
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the RING-finger has a stretch of amino acids that are enriched in basic lysine and 
arginine residues and has become known as the polybasic region (PBR, Gelato et al, 
2014). This region has been implicated in regulating the specific binding of UHRF1 to 
H3K9me2/3 marks by competing for binding to the peptide-binding groove of the TTD 
that inhibits interaction of the TTD-PHD linker and therefore recognition of H3K9me2/3 
marks. Upon binding of a specific phosphoinositide, PI(5)P, to the PBR, this intra-
molecular interaction within UHRF1 is thought to be released, enabling specific binding 
to H3K9me2/3 marks (Fig. 1.7). 
 
 
 
This region has also been shown to bind to the ubiquitin-specific-processing protease, 
USP7 (a known interaction partner of UHRF1) that is also thought to regulate UHRF1 
at the protein level (Felle et al, 2011). It does this by protecting it from proteasomal 
degradation during G1/S phase but not during M-phase when a CDK1/cyclinB-
dependent phosphorylation of S652 within UHRF1 abrogates the interaction with 
USP7 and UHRF1 levels decrease (Ma et al, 2012). USP7 is also thought to protect 
DNMT1 from proteasomal degradation that is dependent on Tip60-mediated 
acetylation (Du et al, 2010; Qin et al, 2011; Cheng et al, 2015). A phosphomimic 
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mutation at S651 (in mouse UHRF1) also decreased the binding affinity for this linker 
to the TTD suggesting that the phosphorylation at this region may also affect UHRF1 
binding dynamics to chromatin. Other post-translational modification events have been 
identified within UHRF1 such as acetylation of two lysine residues in the SRA-domain 
and S298 phosphorylation by Protein Kinase A (PKA) that interferes with TTD-PHD 
cooperativity and abrogating recognition of H3 by UHRF1 (Trotzier et al, 2004). A 
possible Tip60-mediated acetylation at K659 in UHRF1 (like DNMT1 acetylation by 
Tip60) has been observed to abrogate the UHRF1-USP7 interaction in vitro. It is 
thought that the interaction of UBL2/3 of USP7 with the PBR of UHRF1 also perturbs 
the intra-molecular interaction between TTD and PBR, enabling recognition of 
H3K9me2/3 marks (Zhang et al, 2015). A USP7-interaction-deficient mutant 
(K657E/K659E) significantly reduces the chromatin association of UHRF1. 
Interestingly, VIM1 (Variant in Methylation 1, a UHRF1 homologue in Arabidopsis) also 
has an equivalent spacer region that has been shown to be required for hemi-
methylated DNA recognition by its SRA-domain (Woo et al, 2007). This linker region 
has very low sequence similarity between UHRF1 and UHRF2 despite high sequence 
conservation in the other structural domains, suggesting that the functional differences 
between the two may lie in the behaviour of this linker region. 
 
In addition to the TTD-PBR intra-molecular interaction mentioned, the PHD-finger and 
the SRA-domain are also thought to interact, preventing PHD-dependent recognition 
of the unmodified H3 N-terminus. Upon binding to hemi-methylated DNA, this intra-
molecular interaction is released and the PHD-finger can bind H3-tails (Fang et al, 
2016). From the same study, binding of hemi-methylated DNA was also found to 
release the linker from the TTD to facilitate recognition of H3K9me3.  
 
These studies have led to the idea that UHRF1 exists in equilibrium between an 
“inactive” closed conformation and an “active” open conformation (Fig. 1.7). In the 
absence of particular biological molecules, UHRF1 remains in a “closed” conformation, 
inhibiting interactions with histone marks and preventing interaction with DNMT1. Upon 
physiological cues (e.g. hemi-methylated DNA, PI(5)P or USP7), UHRF1 adopts an 
“open” conformation that can bind to heterochromatin and recruit DNMT1 to replication 
forks. Much of this work has been based on using affinity-tag fusions of individual or 
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combinations of domains within UHRF1 and incubation with other UHRF1 fragments 
+/- DNA or PI(5)P. The identification of inter-domain interactions in this case is possible 
but investigating intra-molecular interactions using an inter-molecular system may not 
be the most suitable method especially if other dynamic conformations exist that are 
important for biological function. Perhaps using other whole molecule methods (e.g. 
FRET, NMR or SAXS) in conjunction with molecular modelling strategies will aid in 
deciphering this complex intra-molecular interplay. 
 
1.5 The structure of nucleosome-bound complexes 
As detailed above, structural studies can provide valuable insight into enzymatic 
mechanisms. Little has so far been reported on the structure of chromatin binding 
proteins bound directly to nucleosomes, although more work is being done in this area. 
The size and structural heterogeneity in addition to the low binding affinities of many 
of these readers to chromatin marks makes it difficult to prepare well-ordered and 
stable complexes for x-ray crystallography and other structural approaches. Several of 
the nucleosome-bound complexes investigated so far, however, have been those 
amenable for x-ray crystallography. Sir3 (Arnaudo et al, 2013) and RCC1 (Makde et 
al, 2010) proteins bound to nucleosome core particles are two examples. In addition 
to this, the structure of the PRC1 ubiquitylation module (McGinty et al, 2014) bound to 
the nucleosome was elucidated using a fusion construct of the E3-E2 minimal proteins. 
A common theme found from these nucleosome-bound structures is the presence of 
an acidic patch on H2A and H2B that seems to be important for the functional binding 
of chromatin readers. These interactions tend to be charge-based using basic lysine 
and/or arginine residues in the chromatin-associated protein with glutamate or 
aspartate residues in this nucleosome region (e.g. H2A E57 and H2B E116). A further 
study that has used electron microscopy (EM) approaches has investigated the binding 
of modified nucleosomes by 53BP1 that binds to RNF168-mediated H2AK15-ub in 
addition to H4K20me2 that act as signalling marks for DNA double-strand breaks 
(Wilson et al, 2016; Hu et al, 2017). Again, this showed important contacts to the acidic 
patch on the nucleosome in addition to specific contacts to H2AK15-ubiquitin and 
H4K20me2 by the ubiquitylation-dependent recruitment motif (UDR) and tandem 
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Tudor domain (TTD) of 53BP1, respectively. It was a first step into using EM for 
nucleosome bound complexes indicating the potential for this technique.  
 
1.5.1 Crosslinking with mass spectrometry 
A potentially complimentary approach to the structural data obtained by x-ray 
crystallography or EM is chemical crosslinking with mass spectrometry (XL-MS). The 
method is theoretically able to identify interacting regions within proteins and protein 
complexes in its more native environment without using artificial baits and protein 
fragments (Holding, 2015; Navare et al, 2015; Shi et al, 2015; Liu et al, 2015a). 
Furthermore, using chemical cross-linkers of known lengths it is possible to gain some 
low-resolution restraint information about which subunits or protein domains are in 
close proximity (Ferber et al, 2016; Kahraman et al, 2013; Merkley et al, 2014). Work 
in this area has focused on complexes with known and available x-ray data to validate 
the approach but more work is also using the method alongside EM, bioinformatics 
and modelling algorithms in an integrative approach to discern the molecular details of 
much larger protein complexes such as the Mediator and SAGA complexes and RNA 
polymerases (Nguyen-Huynh et al, 2015; Luo et al, 2015; Male et al, 2015; Tosi et al, 
2013; Larivière et al, 2013; Han et al, 2014; Chen et al, 2010; Murakami et al, 2013; 
Knutson et al, 2014).  
 
The method relies on the use of chemical cross-linkers with two reactive ends (Chen 
et al, 2013a) and a spacer in between. The most commonly used commercial cross-
linkers are DSS (disuccinimidyl suberate) and the water-soluble BS3 
(bis(sulfosuccinimidy) suberate) that use N-hydroxysuccinimide (NHS) ester chemistry 
to react with primary amines such as at lysine residues or N-termini of polypeptide 
chains (Boeri Erba et al, 2015; Paramelle et al, 2013). Other chemistries are available 
such as the use of maleimides (cysteine-reactive) or photo-reactive groups that can 
react with backbone atoms within the polypeptide chain making them more non-
specific. Other cross-linker chemistries include acid-specific (Leitner et al, 2014a; 
Gutierrez et al, 2016; Winkelman et al, 2015) and arginine-specific reagents. 
Furthermore, different length spacers can be used. DSS and BS3 have a spacer length 
of 11.4 Å which can be extrapolated to a maximum distance restraint of around 25 Å 
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between a-carbons (when considering lysine side-chains) to calculate the potential 
distance between crosslinked residues (Hofmann et al, 2015; Merkley et al, 2014). 
Zero-length cross-linkers (Rivera-Santiago et al, 2015) can also be used in addition to 
longer-chains with variable flexibility (e.g. using long hydrocarbon chains or aromatic 
rings) increasing the range of cross-linker chemistries (Brodie et al, 2014). A major 
caveat of this chemistry, however, is the low crosslinking efficiency between residues. 
Whilst adding a greater molar equivalent of cross-linker may account for this, an 
excess or increased quantity of cross-linker can lead to distortion and aggregation of 
the protein complex potentially resulting in non-physiologically relevant crosslinks 
being formed. Therefore, enrichment strategies for crosslinked proteins or peptides 
have become desirable. Such strategies have utilised the higher charge of crosslinked 
peptides (e.g. using strong cation-exchange chromatography) or the higher relative 
molecular weight of crosslinked peptides to use size-exclusion chromatography (SEC) 
peptide columns. However, the enrichment is not always satisfactory and cross-linkers 
have been synthesised that allow specific enrichment of crosslinked species such as 
using a biotin- or FLAG-tag attached to the linker region. In addition to these off-line 
practical steps to enable enrichment and subsequent downstream identification of 
crosslinked peptides, methods that utilise mass spectrometry methods have also been 
devised. A simple approach is to use isotope-labelled cross-linkers that give a specific 
m/z shift between light and heavy crosslinked species to enable more robust 
identification (Yu et al, 2014; Fischer et al, 2013). This has been useful in purified 
systems.  
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The types of crosslinks that can be formed can vary depending on the position of the 
reactive lysine (for NHS-ester reactive cross-linkers such as BS3). If both reactive ends 
of the cross-linker react with lysine residues, type-II crosslinks are formed. These can 
be inter-molecular (between two different proteins within a complex) or intra-molecular 
(within the same protein) and are likely to be more highly charged and larger in size, 
enabling their enrichment using methods mentioned above. Type-I crosslinks can also 
form if lysine resides are crosslinked within the same tryptic peptide. Surface lysine 
residues may enable the formation of type-0 crosslinks, where only one NHS-ester 
reactive end reacts with the primary amine and the other end is hydrolysed or 
quenched in the XL-MS experiment. These type-0 or “dead-end” crosslinks can be 
useful to identify solvent-exposed regions of proteins or protein complexes. Therefore, 
the resulting peptide mixture from a XL-MS experiment can be quite complex. The 
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peptide fragmentation pattern of type-II crosslinks will also be much more complex as 
b- and y-ions will have fragments of the other crosslinked peptide as well as the mass 
of the cross-linker itself. Furthermore, crosslinked peptides often fragment poorly 
making the spectra much more difficult to analyse than linear peptides as the two 
peptide chains tend to fragment independently with one often dominating. Therefore, 
crosslink identification can be difficult. Algorithms have been created in the form of 
specific software packages such as xQuest/xProphet (Rinner et al, 2008; Walzthoeni 
et al, 2012; Leitner et al, 2014b; Walzthoeni et al, 2015), Stavrox (Götze et al, 2015; 
2012), Kojak (Hoopmann et al, 2015) and Plink (Fan et al, 2015) to de-convolute this 
problem. To do this, an initial library of crosslinked peptides and in silico fragmentation 
patterns are formed from the input fasta file of proteins and the theoretical data is 
compared with the experimental spectra to identify crosslinked peptides within the 
sample. This is straightforward for relatively simple protein mixtures but for much more 
complex mixtures, such as cell extracts, the library of potentially crosslinked species 
increases in size exponentially. Therefore, there have been efforts to manipulate 
current commonly used software and to develop more powerful software to probe for 
crosslinked species (Chen et al, 2016; Yu et al, 2016; Wang et al, 2014a; Riffle et al, 
2016; Li et al, 2012; Du et al, 2011; Schweppe et al, 2016; Zheng et al, 2013; Kosinski 
et al, 2015) to analyse XL-MS experiments.  
 
The XL-MS method has primarily been used in conjunction with structural methods to 
validate the proximity of protein subunits within a stable complex or to identify 
interacting regions between proteins from more complex mixtures. However, given the 
structural flexibility and heterogeneity of many proteins and complexes, it might also 
be possible to catch dynamic interactions between possibly unstructured regions of 
proteins (Kukacka et al, 2015; Schmidt & Robinson, 2014). These interactions may be 
missed in affinity-based approaches (such as using a bait protein or domain) or 
structural approaches where the dynamic properties of the protein or domain of interest 
may not make it amenable for identifying stable electron density in a crystal structure 
or EM. This “fuzziness” that can be missed by static structural and biochemical 
approaches can be important for the biological function of the protein or complex of 
interest. Using XL-MS, therefore, may indicate novel protein interactions that are 
important for protein function despite being quite weak or transient. Further 
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biochemical and cell biological approaches could then be utilised to further probe the 
importance and function of these transient interactions. One relevant study looked at 
the yeast Rad6-Bre1 E2-E3 pair (Gallego et al, 2016) in complex with a nucleosome 
core particle using XL-MS. This was to probe the critical binding surfaces required for 
a fusion construct of the minimally active complex with a nucleosome core particle as 
no stable structure was elucidated. This indicated a precise molecular mechanism in 
which the Bre1 RING homodimer uses an arginine motif to interact with the 
nucleosome acidic patch. This specifically positioned Rad6 directly above the 
ubiquitylation site, enabling exclusive H2B K123 modification. Other studies have 
looked at larger complexes such as Mediator and INO80 that have used the method in 
conjunction with structural data in integrative approaches (Saravanan et al, 2012; 
Robinson et al, 2015; 2016; Larivière et al, 2013).  
 
1.6 Summary and Project aims 
To maintain the DNA CpG methylation status at specific genomic regions, DNMT1 
needs to be accurately recruited to newly replicated hemi-methylated DNA. UHRF1-
mediated ubiquitylation of histone H3 is reported to play a role in this recruitment step. 
The reaction mechanisms involved in the UHRF1 E3-ubiquitin ligase activity have not 
been fully elucidated. The aim of this PhD was to investigate the binding of full-length 
UHRF1 to relevant chromatin modifications in the context of nucleosomal substrates 
in addition to its E3-ubiquitin ligase activity. In parallel, the intra-molecular contacts 
within UHRF1 were investigated with respect to its chromatin-binding and E3 activity. 
 
To investigate the binding of UHRF1 to nucleosome substrates, we used in vitro 
reconstituted modified nucleosome core particles with relevant H3K9me2/3 marks and 
CpG (hemi-) methylated DNA in the presence of full length UHRF1. Published studies 
have indicated some discrepancies in the binding to histone peptides (e.g. similar 
binding to H3un and H3K9me3) so using physiologically relevant nucleosome 
substrates and full-length protein might help answer some of these outstanding 
questions in a recombinant system. Furthermore, intra-molecular contacts between 
regions within UHRF1 have been reported to regulate the binding to histone peptides. 
To determine whether these contacts exist in solution in the context of the full-length 
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UHRF1 with or without chromatin substrate, a chemical crosslinking and mass 
spectrometry approach was used. This method would also allow to test if so far 
undetected dynamic contacts might regulate the E3 activity or binding characteristics 
of UHRF1. Finally, to investigate the E3-ubiquitin ligase activity of UHRF1, an in vitro 
assay was developed to test what types of chromatin substrates were suitable for 
UHRF1-mediated histone ubiquitylation. Using this assay, we could further probe for 
mechanistic details involved in UHRF1 E3 activity. 
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Chapter 2 
2. Materials and Methods 
2.1 Protein expression and purification  
The expression and purification of histone protein in Dr Bartke’s lab is a shared task 
between the members of the laboratory as they are a common reagent for all the 
different projects. Recombinant histone proteins were expressed from pET21b(+) 
(Novagen) vectors and purified by denaturing gel filtration and ion exchange 
chromatography as described (Bartke et al, 2010; Dyer et al, 2004). The purification 
for hH4 was altered. Recombinant hH4 was purified in 1 M NaCl for the size-exclusion 
chromatography (SEC) step and utilised a linear gradient from SAU-200 (20 mM 
NaAcetate pH 5.2, 200 mM NaCl, 7 M urea, 1 mM EDTA, 5 mM 2-mercaptoethanol) 
to TU-1000 (20 mM Tris HCl pH 7.5, 1 M NaCl, 7 M urea, 1 mM EDTA, 5 mM 2-
mercaptoethanol) for the denaturing ion-exchange chromatography (IEX) step after 
diluting the NaCl of the SEC fractions to 200 mM. Truncated hH3.1 D1-31 T32C protein 
was generated in vivo by expressing a hH3.1 D1-31 T32C precursor in the presence 
of TEV-protease. For this, E. coli cells harbouring the pET28a(+)-AraC-pBAD-
His6TEV/pro-hH3.1 D1-31 T32C plasmid were grown in LB medium supplemented 
with 0.25% L-arabinose to keep TEV-protease induced. At OD600 of 0.6 the 
expression of pro-hH3.1 D1-31 T32C was induced for 3 hr at 37°C with 50 µM IPTG. 
TEV-protease processes the precursor hH3.1 into tail-less hH3.1 D1-31 T32C. The 
insoluble protein was extracted from inclusion bodies with solubilisation buffer (20 mM 
Tris HCl pH 7.5, 7 M guanidine HCl and 100 mM DTT) for 1 hr at RT and passed over 
a Sephacryl S-200 gel filtration column (GE Healthcare) in SAU-200 (20 mM 
NaAcetate pH 5.2, 7 M urea, 200 mM NaCl and 1 mM EDTA) without any reducing 
agents. Positive fractions were directly loaded onto a reversed-phase Resource RPC 
column (GE Healthcare) and eluted with a gradient of 0%-65% B (A: 0.1% TFA in 
water; B: 90% acetonitrile, 0.1% TFA) over 20 column volumes. Fractions containing 
pure hH3.1 D1-31 T32C were pooled and lyophilised. All histone proteins were stored 
lyophilised at -80°C. Truncated hH4 D1-28 I29C was expressed from a pET24b(+) 
vector with a methionine preceding isoleucine-29. The E. coli methionyl-
aminopeptidase removes the N-terminal methionine to expose the N-terminal cysteine 
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for downstream native chemical ligation. Truncated hH4 was expressed by growing E. 
coli to OD600 of 0.6 and inducing hH4 D1-28 I29C expression with 0.2 mM IPTG for 3 
hr at 37°C. The insoluble protein was extracted from inclusion bodies and purified 
exactly as above for truncated hH3.1 D1-31 T32C.  
 
Recombinant mouse UHRF1 protein was expressed from a pCA528-His6-SUMO 
vector (pET24 backbone, Novagen). BL21-CodonPlus(DE3)-RIL E. coli cells 
containing the plasmid were grown to an OD600 of 0.7 at 37°C and expression was 
induced with 0.1 mM IPTG overnight (approximately 16 hr) at 20°C. The cells were 
harvested by centrifugation and re-suspended in lysis buffer (20 mM HEPES-KOH pH 
7.5, 300 mM NaCl, 10 % glycerol (v/v), 1x EDTA-free complete protease inhibitors 
(Roche), 0.5 mM PMSF supplemented with 20 mM imidazole) before flash freezing in 
liquid nitrogen and storage at -80°C until required. Cell pellets were thawed and were 
lysed with lysozyme (1 mg added per ml of re-suspended cells) with sonication and 
benzonase treatment (Sigma) and clarified by centrifugation at 20,000 g for 45 min at 
4°C. The lysate was syringe-filtered with 0.45 µm filters and incubated for 2 hr with Ni-
sepharose beads (GE Healthcare) equilibrated in UHRF1 wash buffer (as lysis buffer 
without protease inhibitors or PMSF). The beads were washed with ten column 
volumes UHRF1 wash buffer before elution with five column volumes of UHRF1 wash 
buffer supplemented with 500 mM imidazole. Imidazole was removed by overnight 
dialysis into UHRF1 SEC buffer (20 mM HEPES-KOH pH 7.5, 300 mM NaCl, 10% 
glycerol (v/v) and 1 mM DTT). The His6-SUMO tag was removed by incubation with 
His6-Ulp1 SUMO-specific protease (made in-house) for 5 hr at RT (23°C). The cleaved 
product was further purified by gel filtration on a Superdex 200 16/60 column (GE 
Healthcare) in 20 mM HEPES-KOH pH 7.5, 300 mM NaCl, 10% glycerol (v/v), 5 mM 
2-mercaptoethanol. An optional ion-exchange step (HiTrap SP HP, GE Healthcare) 
was used before His6-Ulp1 cleavage of the tag but this step seemed to result in loss of 
more protein without enhancing the purity so was removed. Pure protein (>90% as 
analysed by Coomassie Brilliant Blue-stained 10% SDS-PAGE) was pooled, quantified 
by measuring the absorbance at 280 nm, flash frozen in liquid nitrogen and stored at -
80°C. All point mutants and truncated UHRF1 fragments were purified in the same 
way. The His6-UBL domain was expressed from a pET28a(+) vector in an identical 
way to the full-length UHRF1 as above and was purified in a similar manner with Ni-
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sepharose beads and size-exclusion chromatography but the tag was not cleaved off 
in this case. 
 
His6-UBE1, UBE2D1 (both untagged and GST-tagged versions), ubiquitin (HA-tagged, 
untagged and K>R mutant) and His6-USP7 (human full-length protein) were purchased 
from Boston Biochem (Biotechne group).  
 
2.2 Preparation of modified histone and nucleosomal DNAs 
For the native chemical ligations, 1 mg lyophilised modified hH3.1 1-31 thioester 
peptide (Cambridge Peptide) was incubated with 7 mg truncated hH3.1 D1-31 T32C 
protein in ligation buffer (6 M guanidine HCl, 200 mM KPO4 pH 7.9) with thiophenol at 
2% (v/v). The mixture was incubated whilst shaking vigorously at RT for 24 hr. The 
reaction was quenched by adding DTT to a final concentration of 100 mM, dialysed 3 
times against SAU-200 buffer containing 5 mM 2-mercaptoethanol and then loaded on 
to a HiTrap SP HP column (GE Healthcare). The ligated hH3.1 was eluted with a linear 
gradient over 25 column volumes from SAU-200 to SAU-600 buffer (as SAU-200 but 
with 600 mM NaCl). Positive fractions based on analysis by 17.5% SDS-PAGE were 
pooled, diluted 3-fold in SAU-0 buffer (as SAU-200 but with no NaCl) to reduce the salt 
concentration and reloaded onto the column. Two rounds of purification were needed 
to yield sufficiently pure ligated histone away from truncated H3 and excess unligated 
peptide. Following ion exchange purification, the ligated histone was dialysed 
extensively against water containing 1 mM DTT, lyophilised and stored at -80°C.   
 
Optimised native chemical ligation 
20 mg TCEP (Tris(2-carboxyethyl)phosphine hydrochloride, Sigma) was dissolved in 
1 ml chemical ligation buffer (200 mM KHPO4 pH 7.9, 2 mM EDTA pH 8.0, 6 M 
guanidine HCL) and the pH adjusted to pH 7.9 using KOH. 25 mg MPAA (4-
mercaptophenylacetic acid, Sigma) was added and the pH adjusted to ~pH 7.5 using 
KOH. The solution was degassed and 500 µl was used to dissolve 1 mg modified H3 
or H4 peptides (Cambridge peptide) before adding 4 mg hH3.1 D1-31 T32C or 4 mg 
hH4 D1-28 I29C. The reaction was incubated overnight at 40°C. The ligation reaction 
was quenched with 60 µl 1 M DTT and 700 µl 0.5% acetic acid was added. The 
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quenched reaction was centrifuged at maximum speed (approx. 21,000g) in a bench 
top centrifuge to remove any precipitate and loaded onto a C-8 Perkin Elmer Aquapore 
RP-300 250 x 4.6 HPLC column pre-washed and equilibrated in buffer A (0.1% TFA in 
water) and buffer B (90% acetonitrile, 0.1% TFA). Ligated hH3.1 was eluted with a 
gradient 45%-55% B over 10 column volumes. Positive fractions were pooled, 
lyophilised and stored at -80°C. Ligated hH4 was eluted with a similar gradient (35%-
45% B over 10 column volumes) before pooling, lyophilising and storage at -80°C.  
 
Nucleosomal DNA was amplified in E. coli and prepared by Carol Wooding in Dr 
Bartke’s laboratory. Nucleosomal 601 DNA (Lowary & Widom, 1998; Thastrom et al, 
1999; Segal et al, 2006) was excised from the purified plasmid DNAs (Plasmid Giga 
kit, Qiagen) by digestion with EcoRV and separated from the vector by PEG 
precipitation as described (Dyer et al, 2004). For end biotinylation, the DNA was further 
digested with EcoRI and the overhangs were filled in with biotin-11-dUTP (Yorkshire 
Bioscience) using Klenow (3’-5’ exo-) polymerase (NEB). Biotinylated nucleosomal 
DNA was then separated by PEG precipitation. Di- (2x601) and tetra- (4x601) 
nucleosomal DNAs were prepared by a similar method with optimisation of the PEG-
amount to best separate the nucleosomal DNA from the plasmid backbone. For the 
larger array DNA (12x187bp), purified plasmid DNAs prepared as above were digested 
with EcoRV with the plasmid backbone containing multiple EcoRV sites, enabling 
purification of the larger array DNA by PEG precipitation as above. Methylated 
nucleosomal DNA was made by incubation with M. SssI CpG methylatransferase 
(made in-house) at 37°C for 5 hours and then purified by phenol/chloroform extraction 
and ethanol precipitation. Hemi-methylated nucleosomal 601 DNA was made by large-
scale PCR using the pUC19-601 DNA as a template and oligonucleotide pairs with 
CpG methylated bases, with or without biotin at one end (Table 4). The PCR product 
was purified by ion exchange chromatography (HiTrap Q column, GE Healthcare) and 
concentrated by phenol/chloroform extraction and subsequent ethanol precipitation. 
All DNA was stored at -20°C. 
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2.3 Reconstitution of octamers and nucleosomes 
Histone octamers were refolded from purified histone proteins. Individual histones 
were re-suspended in unfolding buffer (7 M GuHCl, 20 mM Tris-HCl pH 7.5, 10 mM 
DTT) for 1 hr at RT before mixing in approximately stoichiometric amounts (for hH3.1 
and hH4 but a slight excess of hH2A and hH2B) and dialysis against refolding buffer 
(2 M NaCl, 10 mM Tris-HCl pH 7.5, 1 mM EDTA, 5 mM 2-mercaptoethanol). The first 
dialysis was carried out for >6 hr with two further changes into fresh refolding buffer. 
Histone octamers were purified away from (H3-H4)2 tetramers and H2A-H2B dimers 
by gel filtration over a Superdex 200 column (GE Healthcare). Nucleosomes were 
assembled by mixing refolded octamers with nucleosomal DNAs into high salt buffer 
(10 mM Tris-HCl pH 7.5, 1 mM EDTA, 2 M NaCl, 1 mM DTT) and salt deposition 
dialysis from 2 M NaCl to 100 mM NaCl. The molar ratio of octamer:DNA used was 
checked empirically for each batch of purified octamer and each batch of nucleosomal 
DNA. For larger arrays of nucleosome core particles (di-nucleosomes, tetra-
nucleosomes, 12x187bp and 25x197bp chromatin arrays), MMTVA DNA was using as 
a competitor/buffer DNA and octamer was added in molar excess to ensure saturation 
of the nucleosomal positioning sequences on the arrays. Mono- and di-nucleosomes 
were analysed and checked for formation on 5% native PAGE gels in 0.2x TBE. Tetra-
nucleosomes and larger chromatin arrays were checked on 0.7% agarose gel in 0.2x 
TB. 12x187bp chromatin arrays were purified away from free DNA and competitor 
MMTVA DNA/nucleosomes by incubation with MgCl2 (5 mM final concentration) on ice 
for 30 min and centrifugation at 16,100 g for 30 min at 4°C. Chromatin arrays were re-
suspended in MgCl2-free buffer and stored at 4°C. 25x197bp chromatin arrays were 
similarly purified away from free DNA and competitor DNA/nucleosomes by incubation 
with 3.4 mM MgCl2 (final concentration). MgCl2 concentration was determined by 
titration of MgCl2 to check for complete separation.  
 
2.4 Bead-based binding assays 
2.4.1 Nucleosome pull-downs  
Nucleosomes corresponding to 2.5 µg of octamer were immobilised on 15 µl 
Dynabeads Streptavidin MyOne T1 (Invitrogen) in the final nucleosome reconstitution 
buffer (10 mM Tris-HCl pH 7.5, 100 mM NaCl, 1 mM EDTA, 1 mM DTT) supplemented 
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with 0.1% NP40 (v/v). The beads were washed with binding buffer (20 mM HEPES-
KOH pH 7.9, 150 mM NaCl, 0.2 mM EDTA, 10% glycerol (v/v), 0.1% NP40, 1 mM DTT) 
and incubated with 2 molar equivalents of the protein(s) of interest for 4 hr at 4°C. After 
3 washes in binding buffer, bound proteins were eluted in SDS-sample buffer, boiled 
at 95°C for 5 min and analysed by 15% SDS-PAGE followed by protein staining with 
Coomassie Brilliant Blue or Western blot probed with the indicated antibodies. For 
experiments with HeLa S3 nuclear extract, streptavidin-coated sepharose beads (GE 
Healthcare) were used with 100 µg extract used per 2.5 µg octamer in the assay and 
fresh 1x EDTA-free complete protease inhibitors (Roche) were added before 
incubation of nuclear extract with immobilised nucleosomes. Pull-downs using 
phosphoinositide included a pre-incubation of UHRF1 with a 10-molar excess of PI(5)P 
(di-C8, Echelon Biosciences) before incubating with bound-nucleosomes.  
 
2.4.2 GST-UBE2D1 pull-downs  
10 µM ubiquitin, 1 µM UHRF1, 2.5 µg octamer-containing chromatin and 1 µM GST-
UBE2D1 (Boston Biochem) or GST (made in-house) were incubated for 1 hour at 25°C 
in 20 mM Tris-HCl pH 7.5, 100 mM NaCl, 5 mM MgCl2, 5 mM ATP. 5 µl equilibrated 
glutathione sepharose 4B beads (GE Healthcare) were added and rotated for 2 hr at 
RT in 20 mM Tris-HCl pH 7.5, 100 mM NaCl, 0.1% NP40, 1 mM DTT. Beads were 
washed 3 times and bound proteins were eluted in SDS-sample buffer, boiled at 95°C 
for 5 min and analysed by 15% SDS-PAGE followed by silver staining. Bands 
corresponding to UHRF1 and histone proteins were quantified using ImageJ and 
normalised to the band intensity of GST-UBE2D1 in each assay. The binding of each 
UHRF1 fragment was quantified in this way in >3 independent experiments and 
normalised to the binding of WT full length UHRF1. Bar charts were made using 
GraphPad Prism and the error bars represent the standard error of the mean (SEM). 
 
2.4.3 TALON pull-downs  
For His6-USP7 (Boston Biochem) and His6-UBL pull-downs, 1 µg protein was bound 
to TALON superflow beads (Clontech) in TALON binding buffer (20 mM Tris-HCl pH 
7.5, 100 mM NaCl, 20 mM imidazole supplemented with 0.1% NP40). Beads were 
washed in TALON binding buffer and equimolar amounts of UHRF1 were added and 
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rotated for 4 hr at 4°C. Beads were washed 3 times in TALON binding buffer and bound 
protein was eluted with SDS-sample buffer and boiling at 95°C for 5 min. Bound protein 
was analysed by SDS-PAGE (4-15% gradient SDS-PAGE (Biorad)) followed by silver 
staining. 
 
2.5 Electrophoretic mobility shift assays (EMSA) 
2.5.1 DNA EMSA  
18-base pair DNA oligonucleotides (Table 4, Integrated DNA Technologies, IDT) were 
re-suspended in DNase-free water to 100 µM and were annealed by mixing primers 
1:1 to a final concentration of 20 µM in annealing buffer (10 mM Tris-HCl pH 7.5, 50 
mM NaCl, 1 mM EDTA). They were incubated at 95°C for 5 min then allowed to cool 
at RT for 60 min. They were subsequently cooled to 4°C and stored at -20°C. 20 pmol 
of UHRF1 was incubated with 20 pmol of each DNA for 30 min at 4°C in binding buffer 
(10 mM HEPES pH 7.0, 150 mM NaCl, 1 mM DTT, 1 mM EDTA, 10% glycerol (v/v)) 
and analysed on a native 8% polyacrylamide gel in 0.5x TBE buffer (50 mM Tris-HCl 
pH 7.0, 45 mM boric acid, 0.5 mM EDTA) at 150 V for 45 min at 4°C. DNA bands were 
detected with ethidium bromide and protein bands by staining with Coomassie Brilliant 
Blue. 120 ng double-stranded co-polymer poly(dI.dC) (Sigma) was used as a non-
specific DNA competitor.  
 
2.5.2 Nucleosome EMSA  
0.1 µM mono-nucleosomes (kept constant) were incubated with increasing 
concentrations of UHRF1 in 10 µl 20 mM Tris-HCl pH 7.5, 1 mM EDTA, 100 mM NaCl, 
1 mM DTT for 5 min at 4°C. Samples were analysed by 5% native PAGE in 0.2x TBE 
at 4°C and nucleosome bands were visualised with ethidium bromide. The apparent 
binding of UHRF1 to mono-nucleosomes was determined by measurement of the 
disappearance of the band corresponding to the unbound nucleosome by integration 
of the band intensity of this band using ImageJ (http://imagej.nih/gov/ij/). The ratio of 
the intensity of free nucleosome in each lane over the intensity in the nucleosome-only 
sample was calculated and used for the normalisation of the percentage of unbound 
mono-nucleosome in each lane. Binding analysis was repeated in triplicate and mean 
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measurements were plotted using GraphPad Prism. Binding at 50% substrate 
saturation gives a level of quantification with respect to nucleosome binding.  
 
2.5.3 Chromatin EMSA  
0.1 µM chromatin 12x187bp arrays (kept constant) were incubated with increasing 
concentrations of UHRF1 in 10 µl 20 mM Tris-HCl pH 7.5, 1 mM EDTA, 100 mM NaCl, 
1 mM DTT for 5 min at 4°C. Samples were analysed by 0.7% agarose in 0.2x TB and 
chromatin was visualised by ethidium bromide stain. The subsequent image analysis 
was similar to the nucleosome EMSAs except using the unbound chromatin band as 
an in-gel control with experiments carried out in triplicate. 
 
2.6 Size-exclusion chromatography and sample preparation for negative-stain 
EM 
Analytical and preparative size-exclusion chromatography experiments were carried 
out on an AKTA micro (GE Healthcare). The Superose-6 3.2/300 column (GE 
Healthcare) was calibrated using molecular weight markers (GE Healthcare). The 
indicated amounts of proteins were incubated at 4°C for 10 minutes before 
centrifugation at maximum speed in a bench top centrifuge at 4°C, before loading onto 
the column. Proteins were eluted in 20 mM HEPES-KOH pH 7.5, 100 mM NaCl, 1 mM 
EDTA, 5 mM 2-mercaptoethanol and 50 µl fractions were collected and analysed by 
15% SDS-PAGE and by 5% native PAGE in 0.2x TBE followed by Coomassie Brilliant 
Blue staining. 
 
Nucleosome core particles were reconstituted as described above and dialysed into a 
final storage buffer of 20 mM HEPES-KOH pH 7.5, 100 mM NaCl, 1 mM EDTA, 1 mM 
DTT and concentrated to ~0.75 mg/ml. The nucleosome sample was fixed on ice with 
0.2% glutaraldehyde (v/v, final concentration) for 15 min before diluting 1 in 20 in 
storage buffer. 2 µl of sample was loaded onto glow-discharged carbon-coated copper 
grids and stained for 1 min with 2% uranyl acetate before blotting off excess stain and 
dried in air. For UHRF1-nucleosome complex samples, 20 µg UHRF1 (WT) was mixed 
with 10 µg mono-nucleosome and incubated for 10 min at 4°C, centrifuged for 10 min 
at max speed in a benchtop centrifuge before loading onto a Superose-6 3.2/300 
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column (GE Healthcare) as described above. Fractions C3 and C4 were mixed (after 
checking fractions by absorbance at 280 nm and Coomassie Brilliant Blue-stained gels 
as above) and fixed with 0.2% glutaraldehyde (v/v, final concentration) on ice before 
diluting in storage buffer (1 in 10) and preparing grids as described above. For 
12x187bp arrays, chromatin was reconstituted and purified by MgCl2 precipitation and 
fixed with 0.2% glutaraldehyde (v/v, final concentration) for 30 min at 4°C at a 
chromatin concentration of 0.625 mg/ml. The sample was diluted 1 in 20 in storage 
buffer and grids were prepared as above. The electron microscopy was carried out on 
a Jeol Electron Microscope at 100 kV. 
 
2.7 In-gel crosslinking with glutaraldehyde 
20 µM of protein (UHRF1, HP1a and Chicken egg-white albumin) was incubated at 
room temperature for 5 min at RT. A dilution series of glutaraldehyde (0%, 0.005%, 
0.01%, 0.02% and 0.05% final concentration (v/v)) was added and incubated at RT for 
5 min in 10 µl volume. 5x SDS-sample loading buffer was added, samples were boiled 
at 95°C for 5 min and loaded onto a 10% SDS-PAGE gel in Tris-Glycine buffer and 
stained with Coomassie Brilliant Blue.  
 
2.8 Crosslinking with mass spectrometry (XL-MS) 
Samples were incubated for 15 min at RT in 10 mM HEPES-KOH pH 7.5, 100 mM 
NaCl, 1 mM EDTA, 1 mM DTT. A 1 mg aliquot of BS3 d0/d12 (Creative Molecules) was 
reconstituted to 25 mM in water and immediately added to the mixture in equimolar 
amounts to the number of moles of lysine residues present in the sample. The 
crosslinking reaction was incubated for 30 min at 25°C with mild agitation and the 
reaction was quenched with 50 mM NH4HCO3 for 20 min at 25°C. The samples were 
reduced in volume in a speedvac and re-suspended in 50 µl 7.2 M urea, 100 mM 
NH4HCO3 and incubated for 15 min at 25°C. Cysteines were reduced with 5 mM DTT 
for 1 hr at 51°C and protected with 15 mM iodoacetamide (Sigma) for 45 min in the 
dark at 25°C. The reaction was quenched with DTT and urea was diluted to < 1 M with 
50 mM NH4HCO3 before adding MS-grade trypsin (Promega) in a ratio of 1:25 
(trypsin:protein) and incubated for 16 hr at 37°C. The reaction was stopped by the 
addition of acetic acid (2.5% final concentration, v/v) and peptides were purified using 
 60 
C18 stage tips (Glygen). Peptides were eluted in 60% acetonitrile, 0.1% formic acid 
and dried and stored at -20°C.  
 
2.8.1 LTQ Orbitrap XL mass spectrometry 
Dried digested peptides were solubilised in 15 µl 0.1% trifluoroacetic acid (TFA) and 
clarified solution was transferred to auto sampler vials for LC-MS analysis. Peptides 
were separated using an Ultimate 3000 RSLC nano liquid chromatography system 
(Thermo Scientific) coupled to a LTQ Orbitrap XL mass spectrometer (Thermo 
Scientific) via a Proxeon nano-spray source. 5 µl sample in technical duplicate was 
loaded onto a trap column (Acclaim PepMap 100 C18, 100 µm x 2 cm) at 8 µl/min in 
2% acetonitrile, 0.1% TFA. Peptides were eluted on-line to an analytical column 
(EASY-Spray PepMap C18, 75 µm x 50 cm). Peptides were separated using a stepped 
90 min gradient, 4-25% buffer B for 60 min, 25-45% buffer B for 30 min (buffer B is 
80% acetonitrile, 0.1% formic acid). Eluted peptides were analysed by the LTQ 
Orbitrap XL operating in positive polarity using a data-dependent acquisition mode. 
Ions for fragmentation were determined from an initial MS1 survey scan at 30,000 
resolution (at m/z 200), followed by ion trap CID (collisional induced dissociation) of 
the top 6 most abundant ions. MS1 and MS2 scan AGC targets set to 1e6 and 1e4 for 
a maximum injection time of 500 ms and 100 ms, respectively. A survey scan m/z 
range 350 – 1800 was used, with a normalised collision energy set to 35%, charge 
state rejection enabled for +1 ions and a minimum threshold for triggering 
fragmentation of 500 counts.  
 
2.8.2 LTQ Orbitrap Velos mass spectrometry 
Sample preparation, peptide loading and chromatography were performed as stated 
above but analysed using an Orbitrap Velos mass spectrometer with the following scan 
settings. Eluted peptides were analysed by the LTQ Orbitrap Velos operating in 
positive polarity using a data-dependent acquisition mode. Ions for fragmentation were 
determined from an initial MS1 survery scan at 30,000 resolution (at m/z 200), followed 
by ion trap CID (collisional induced dissociation) of the top 10 most abundant ions. 
MS1 and MS2 scan AGC targets set to 1e6 and 1e4 for a maximum injection time of 
500 ms and 100 ms, respectively. A survey scan m/z range 350 – 1800 was used, with 
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a normalised collision energy set to 35%, charge state rejection enabled for +1 ions 
and a minimum threshold for triggering fragmentation of 500 counts.  
 
Raw files from experiments run on the Orbitrap XL instruments were converted to 
mzXML files using MSConvert on proteowizard and analysed using xQuest/xProphet. 
The default settings and parameters were used for xQuest/xProphet (Leitner et al, 
2014b). Raw files from experiments on the Orbitrap Velos instrument were converted 
to mgf files using MSConvert on proteowizard and crosslinked peptides were identified 
using Stavrox. Light/heavy-labelled BS3 was used as a cross-linker. A FDR of < 5% 
was used to filter out low-confidence crosslinks and subsequent higher-confidence 
crosslinks were visualised using xiNET (Combe et al, 2015) or xVis (Grimm et al, 
2015). 
 
2.9 E3-ubiquitin ligase assay 
200 nM His-UBE1 (Boston Biochem), 1 µM UbcH5a (UBE2D1, Boston Biochem), 10 
µM ubiquitin (HA-tagged, untagged or K>R mutant, Boston Biochem), 1 µM UHRF1 
with or without 2.5 µg octamer-containing chromatin substrate was incubated for 90 
min at 25°C in 20 mM Tris-HCl pH 7.5, 100 mM NaCl, 5 mM MgCl2, 5 mM ATP in 50 
µl volume. The reaction was stopped by adding 5x SDS-sample buffer and boiling at 
95°C for 5 min. Reaction products were analysed by Western blot probed with 
antibodies to histone H3 and ubiquitin (anti-HA or anti-ubiquitin). Any necessary 
alterations are as described in the figure legends.  
 
For identification of ubiquitylated substrates three different experiments were carried 
out. In the first experiment (see Fig. 6.4, b015p026), two E3 assays were set up using 
wild type, unmodified chromatin substrate (25x197bp) and ~1/5 of the quenched 
reaction was run on a 15% SDS-PAGE gel. Coomassie-stained bands at 25 kDa and 
~35 kDa were cut out, destained and treated with two consecutive rounds of 
propionylation with propionic anhydride (Sigma) followed by in-gel trypsin digestion 
overnight at 37°C. Peptides were extracted with acid and analysed by LC/MS-MS. A 
second follow-up experiment used unmodified and H3K9me3-ligated hH3.1-containing 
12x187bp chromatin substrate +/- CpG methylated DNA (b015p030) and the samples 
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were treated as above. A third experiment (b015p047) cut out bands at ~100 kDa and 
25 kDa but did not protect lysine residues with propionic anhydride although cysteine 
residues were reduced with DTT and capped with iodoacetamide prior to in-gel trypsin 
digestion as described.  
 
2.9.1 B015p026 (experiment 1) mass spectrometry 
Dried digested peptides were solubilised in 15 µl 0.1% trifluoroacetic acid (TFA) and 
clarified solution was transferred to auto sampler vials for LC-MS analysis. Peptides 
were separated using an Ultimate 3000 RSLC nano liquid chromatography system 
(Thermo Scientific) coupled to a Q-Exactive mass spectrometer (Thermo Scientific) via 
an EASY-Spray source. 5 µl sample in technical duplicate was loaded onto a trap 
column (Acclaim PepMap 100 C18, 100 µm x 2 cm) at 8 µl/min in 2% acetonitrile, 0.1% 
TFA. Peptides were eluted on-line to an analytical column (EASY-Spray PepMap C18, 
75 µm x 25 cm). Peptides were separated using a ramped 80 min gradient from 4-70% 
buffer B (buffer B is 80% acetonitrile, 0.1% formic acid). Eluted peptides were analysed 
by the Q-Exactive operating in positive polarity using a data-dependent acquisition 
mode. Ions for fragmentation were determined from an initial MS1 survey scan at 
70,000 resolution (at m/z 200) followed by HCD (Higher-energy collisional dissociation) 
of the top 12 most abundant ions at a resolution of 17,500. MS1 and MS2 scan AGC 
targets set to 1e6 and 1e5 for a maximum injection time of 50 ms and 110 ms, 
respectively. A survey scan m/z range of 350 – 1800 m/z was used, with a normalised 
collision energy set to 27%, underfill ratio – 1%, charge state exclusion enabled for 
unassigned, +1, +8 and >+8 ions.  
 
Data was processed using MaxQuant software platform (v1.5.8.3) with database 
searches carried out by the in-built Andromeda search engine against the Swissprot 
Mus musculus database. A reverse decoy database was used at a 1% false-discovery 
rate (FDR) for peptide spectrum matches and protein identification. Search parameters 
included: two missed cleavages, a fixed modification of cysteine carbamidomethylation 
and variable modification of methionine oxidation, GlyGly, LRGG and propionylation of 
lysine. Label-free quantification was enabled with an LFQ minimum ratio count of 2. 
‘Match between runs’ function was used with match and alignment time limits of 1 and 
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20 min, respectively. Protein and peptide identification and relative quantification 
outputs from MaxQuant were further processed in Microsoft Excel, with hits to the 
‘reverse database’, ‘potential contaminants’ (peptide list only) and ‘Only identified by 
site’ fields removed.  
 
2.9.2 B015p030/p047 (experiments 2 and 3) mass spectrometry 
Dried digested peptides were solubilised in 15 µl 0.1% trifluoroacetic acid (TFA) and 
clarified solution was transferred to auto sampler vials for LC-MS analysis. Peptides 
were separated using an Ultimate 3000 RSLC nano liquid chromatography system 
(Thermo Scientific) coupled to a LTQ Orbitrap XL mass spectrometer (Thermo 
Scientific) via a Proxeon nano-spray source. 5 µl sample in technical duplicate was 
loaded onto a trap column (Acclaim PepMap 100 C18, 100 µm x 2 cm) at 8 µl/min in 
2% acetonitrile, 0.1% TFA. Peptides were eluted on-line to an analytical column 
(EASY-Spray PepMap C18, 75 µm x 50 cm). Peptides were separated using a stepped 
90 min gradient, 4-25% buffer B for 60 min, 25-65% buffer B for 30 min (buffer B is 
80% acetonitrile, 0.1% formic acid). For experiment 3, a stepped 60 min gradient was 
used, 4-25% buffer B for 45 min, 25-45% buffer B for 15 min. Eluted peptides were 
analysed by the LTQ Orbitrap XL operating in positive polarity using a data-dependent 
acquisition mode. Ions for fragmentation were determined from an initial MS1 survery 
scan at 30,000 resolution (at m/z 200), followed by ion Trap CID (collisional induced 
dissociation) of the top 6 most abundant ions. MS1 and MS2 scan AGC targets set to 
1e6 and 1e4 for a maximum injection time of 500 ms and 100 ms, respectively. A 
survey scan m/z range 350 – 1800 was used, with a normalised collision energy set to 
35%, charge state rejection enabled for +1 ions and a minimum threshold for triggering 
fragmentation of 500 counts.  
 
Data was processed using MaxQuant software platform (v1.5.8.3) with database 
searches carried out by the in-built Andromeda search engine against the Swissprot 
Mus musculus database. A reverse decoy database was used at a 1% false-discovery 
rate (FDR) for peptide spectrum matches and protein identification. Search parameters 
included: two missed cleavages, a fixed modification of cysteine carbamidomethylation 
(experiment 3) and variable modification of methionine oxidation, protein N-terminal 
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acetylation, GlyGly, LRGG, tri-methylation (for experiment 2) and propionylation of 
lysine (experiment 2). Label-free quantification was enabled with an LFQ minimum 
ratio count of 2. ‘Match between runs’ function was used with match and alignment 
time limits of 1 and 20 min, respectively. Protein and peptide identification and relative 
quantification outputs from MaxQuant were further processed in Microsoft Excel, with 
hits to the ‘reverse database’, ‘potential contaminants’ (peptide list only) and ‘Only 
identified by site’ fields removed.  
 
2.10 SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
SDS-PAGE was used to separate proteins according to their molecular weight. Sample 
were boiled and denatured for 5-10 min at 95°C in sample buffer (62.5 mM Tris-HCl 
pH 6.8, 10% glycerol, 2% SDS, 0.01% bromophenol blue and 5% 2-mercaptoethanol) 
before loading onto an appropriate percentage polyacrylamide gel (from 8% up to 
17.5%, homemade) and running at 200 V at RT in Tris-Glycine buffer (3% (w/v) Tris, 
14% glycine, 1% SDS). 
 
2.11 Protein staining of polyacrylamide gels 
Protein samples were separated by SDS-PAGE and proteins were visualised by 
Coomassie Brilliant Blue or silver staining depending on the amount of protein loaded. 
Gels were immersed in Coomassie Brilliant Blue solution (Expedeon) for 1 hr at RT 
and de-stained with at least 3 changes of water. For gels with lower amounts of protein 
loaded, silver staining was carried out. The gel was fixed by incubating in fixing solution 
(30% ethanol, 15% acetic acid) for 1 hr at RT before immersing in incubation solution 
(0.5 M sodium acetate, 25% ethanol, 0.1% glutaraldehyde, 0.2% sodium thiosulphate) 
for 1 hr at RT. The gel is washed three times with water before staining in 0.1% silver 
nitrate. Protein bands are revealed with a solution containing 2% sodium carbonate, 
0.05% formaldehyde and the reaction stopped with EDTA when required.  
 
2.12 Western blotting 
For protein immunodetection, samples were first separated by SDS-PAGE and then 
transferred from the gel to pre-activated (in 100% methanol) PVDF membrane (0.45 
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µm; Millipore, IPVH00010) using a wet transfer blotting system (Bio-rad) at a constant 
current (400 mA) for 90 minutes at 4°C in transfer buffer in transfer buffer (10X in 2 L: 
151.5 g Tris, 721 g glycine and 50 g SDS supplemented with 20% methanol). After 
transfer, the PVDF membrane was blocked in 5% milk in TBS-T (150 mM Tris-HCl pH 
7.5, 50 mM NaCl supplemented with 0.1% Tween-20) whilst shaking for 1 hr at RT. 
The membrane was then probed with the primary antibody diluted in 5% milk in 1x 
TBS-T and incubated for 2 hr at RT or at 4°C overnight on a rotating wheel. The 
membrane was subsequently washed four times for 5 min at RT in 1x TBS-T followed 
by incubation with HRP-conjugated secondary antibody diluted in 5% milk in TBS-T for 
1 hr at RT. The PVDF membrane was washed four times in 1x TBS-T and incubated 
for 5 min with ECL Western Blotting Substrate (Thermo Scientific, 34080) and exposed 
and developed on x-ray films (Fujifilm Super RX, 4741019236).  
 
2.13 Plasmid DNA purification 
Plasmid DNA was extracted and purified from 5 or 250 ml bacterial culture using 
Miniprep or Maxiprep kits (Qiagen), following the manufacturer’s instructions. The DNA 
concentration was measured using the Nanodrop ND-1000 spectrophotometer and 
checked by restriction digest and sequencing as performed by the genomics core 
facility on site at the MRC London Institute of Medical Sciences.  
 
2.14 Cloning 
Newly recombined DNA constructs were generated by either directly sub-cloning a 
target vector into a donor vector by restriction enzyme digests (NEB or Roche 
restriction enzymes) or by PCR amplification strategy. Digestion was carried out at 
37°C for 2 hr and the vector was dephosphorylated with 5 U of Calf intestine 
phosphatase (CIP) at 37°C for 1 hr to prevent re-ligation. DNA fragments were run on 
a 1% agarose gel and gel-purified using a kit (Qiagen) as the manufacturer’s 
instructions and ligated with NEB Quick Ligation Kit. Ligation reactions were 
transformed directly into XL-10 Gold cells. 
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2.15 Bacterial transformation and culture 
Chemically competent XL-10 Gold cells were thawed on ice, mixed with DNA in 
polyproplylene round bottom tubes, incubated for 30 min on ice followed by heat shock 
for 90 sec at 42°C in a water bath. Cells were then placed on ice for 90 sec and then 
diluted in SOC medium (20 g/L typtone, 5 g/L yeast extract, 10 mM NaCl, 2.5 mM KCl, 
10 mM MgCl2, 10 mM MgSO4, 20 mM glucose pH adjusted to 7 and sterilised by 
autoclaving) and allowed to recover for 45 min at 37°C while shaking (220 rpm). Cells 
were plated onto LB/agar plates with suitable antibiotic selection and left to grow for 
approximately 12-16 hr at 37°C. Single colonies were isolated and grown in antibiotic 
selective media. Chemically competent BL21 CodonPlus(DE3)-RIL cells were used to 
transform, grow and express recombinant protein. 
 
2.16 Agarose gel electrophoresis 
DNA samples were diluted with Orange G sample buffer (0.1% (w/v) Orange G dye, 
25% (v/v) glycerol, 25 mM EDTA, 0.5% (w/v) SDS) and analysed on a suitable 
percentage agarose gel according to size by electrophoresis at 120 V until the dye 
neared the end of the gel. The gel was stained with ethidium bromide and visualised 
by UV exposure on a Bio-rad Gel Doc system.  
 
2.17 Native polyacrylamide gel electrophoresis 
Nucleosome samples were diluted in native PAGE buffer (10% sucrose (w/v), 0.1% 
bromophenol blue) and analysed by 5% native-PAGE in 0.2x TBE. The gel was 
allowed to polymerise for >4 hr and pre-ran at 200 V for 2 hr at 4°C before changing 
the running buffer and flushing the wells. To run the samples, the gel was run at 150 
V for 50 min at 4°C and stained retrospectively with ethidium bromide. 
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Table 1: Antibodies 
Name/species Antigen Source Application 
H3 
Rabbit 
H3.1 Abcam 
Ab1791 
WB 
H3K9me2 
Mouse 
H3 Lys-9me2 Abcam 
Ab1220 
WB 
H3K9me3 
Rabbit 
H3 Lys-9me3 Abcam 
Ab8898 
WB 
HA 
Mouse 
HA-tag Santa Cruz 
SC-7192 
WB 
Ubiquitin 
Mouse 
Ubiquitin Santa Cruz 
SC-8017 
WB 
UHRF1 
Mouse 
UHRF1 Abcam 
Ab57083 
WB 
HP1a 
Rabbit 
HP1a Abcam 
Ab109028 
WB 
Rabbit secondary ab 
Goat polyclonal HRP-
conjugated 
IgG Thermo Scientific 
31462 
WB 
Mouse secondary ab 
Goat polyclonal HRP-
conjugated 
IgG Santa Cruz 
SC-2005 
WB 
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Table 2: Plasmids and constructs 
Gene Plasmid Reference Application 
hH3.1D1-31 T32C pET28a Bartke et al., 2010 Protein expression 
hH4D1-28 I29C pET24b Till Bartke Protein expression 
hH2A pET21 Bartke et al., 2010 Protein expression 
hH2B pET21 Bartke et al., 2010 Protein expression 
hH3 pET21 Bartke et al., 2010 Protein expression 
hH4 pET21 Bartke et al., 2010 Protein expression 
mUHRF1 (3-782; WT, 
F46A, H730A, 
PBRmut) 
pCA528 This study Protein expression 
mUHRF1 short 
fragment (118-621) 
pCA528 This study Protein expression 
mUHRF1 
DRING/linker (3-621) 
pCA528 This study Protein expression 
mUHRF1 DRING (3-
712) 
pCA528 This study Protein expression 
mUHRF1 DUBL (118-
782) 
pCA528 This study Protein expression 
mUHRF1 (UBL-
domain, 1-117) 
pET28a This study Protein expression 
 
 
 
 
Table 3: Nucleosome DNA 
Nucleosomal/Chromatin 
DNA 
Number and length of 
repeats with 601-
positioning sequence 
Biotinylated 
Bio-601 (mono) 1, 185 bp Yes 
601 (EcoRV, mono) 1, 185 bp No 
601 (hemi-methylated, mono) 1, 185 bp  Yes (by PCR) 
Bio-601 (di) 2, 185 bp Yes 
Bio-601 (tetra) 4, 185 bp Yes 
12x187bp 12, 187 bp No 
25x197bp 25, 197 bp No 
MMTVA 1, 147 bp No 
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Table 4: Oligonucleotides 
Oligo name Sequence (5’-3’) Modification(s) Application 
TB618 ATCGGATCTTACATGCACAGG 5-methyl 
cytosine (in 
bold and 
underlined) 
Primer for 
PCR 
amplification 
of 601 
(mono) 
nucleosomal 
DNA 
TB619 AATTCAGTACTACGCGGCCGCCCTGG 5’-biotin 
 
Primer for 
PCR 
amplification 
of 601 
(mono) 
nucleosomal 
DNA 
TB701 GGATCTTACATCGACAGG n/a Primer for 
annealing 
18-mer DNA 
TB702 GGATCTTACATCGACAGG 5-methyl 
cytosine (in 
bold and 
underlined) 
Primer for 
annealing 
18-mer DNA 
TB703 CCTGTCGATGTAAGATCC n/a Primer for 
annealing 
18-mer DNA 
TB704 CCTGTCGATGTAAGATCC 5-methyl 
cytosine (in 
bold and 
underlined) 
Primer for 
annealing 
18-mer DNA 
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Chapter 3 
3. Making reconstituted modified nucleosomes and recombinant UHRF1 
protein 
UHRF1 has been shown to bind to heterochromatic marks such as H3K9me2/3 and 
DNA CpG methylation, with increased specificity for hemi-methylated DNA that is 
present immediately following DNA replication. Many of the previous studies on 
UHRF1 binding to chromatin have utilised histone peptides or short DNA 
oligonucleotides but there has been little investigation of UHRF1 binding these 
chromatin modifications in the context of more physiologically relevant nucleosome 
substrates. In the SILAC nucleosome affinity purifications (SNAP) study (Bartke et al, 
2010) that used modified nucleosome substrates, UHRF1 in HeLa nuclear extract was 
found to preferentially associate with H3K9me3 and DNA CpG methylation.  
 
In order to further investigate the binding of full-length UHRF1 to nucleosome core 
particles, mouse recombinant UHRF1 was expressed and purified from E. coli and 
subsequently used for in vitro binding assays with reconstituted nucleosomes. The aim 
of this project was to test previously observed results that used histone peptides or 
short DNA oligonucleotides with full-length protein and to test and verify the SNAP 
data. Furthermore, other studies (Gelato et al, 2014) that were published in the process 
of this project indicated other regions of UHRF1 were important for regulating the 
binding to histone marks (e.g. H3K9me2/3) so these additional results could also be 
queried. 
 
The expression and purification of histones, octamers and modified nucleosomes are 
established methods in the laboratory of Dr Bartke (with some optimisation, see below 
and Materials and Methods) and are used by all lab members. The purification of 
different histones and the making of ligated modified histones is shared among lab 
members and these are then stored as communal reagents. Dr Nhuong Nhguyen and 
myself produced the modified histones used in the experiments reported here.  
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3.1 Making recombinant nucleosome core particles 
To investigate the binding of biological molecules to nucleosome substrates with 
specific modifications, the constituent canonical histones were made recombinantly 
and semi-synthetic chemistry was used to add modifications on to histone H3 and H4 
N-terminal tails (see Materials and Methods). A biotin moiety added on to nucleosomal 
DNA enables nucleosomes with differently modified histones to be immobilised on 
streptavidin-coated beads to study the binding of protein mixtures or purified 
recombinant proteins to these chromatin modifications.  
 
The human histones were prepared as described (for hH2A, hH2B and hH3.1) with 
some modifications to the original protocols for hH4 (Fig. 3.1a, Dyer et al, 2004; Bartke 
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et al, 2010). To enhance the yield of histone hH4, the concentration of sodium chloride 
was increased to 1 M for the denaturing size-exclusion chromatography (SEC) step. 
The resulting pooled fractions were diluted to around 200 mM NaCl with no salt urea 
buffer before a further purification by denaturing ion-exchange chromatography (IEX), 
again with slight modifications. A continuous gradient from SAU-200 to TU-1000 was 
used rather than a discontinuous gradient from SAU-200 to SAU-600 used for the other 
histones. The gradient to a higher salt concentration as well as a pH gradient from pH 
5.2 (sodium acetate) to pH 7.5 with Tris-HCl enabled a greater yield for histone H4. 
Purification of the other full-length and truncated histone proteins was as described 
(Fig. 3.1b, c and see Materials and Methods). 
 
Producing enough modified histone with a sufficient yield for use was initially a 
problem. The method uses truncated histone proteins (hH3.1 D1-31 T32C and hH4 
D1-28 I29C, Fig. 3.2a, b) with an N-terminal cysteine that can be chemically ligated to 
histone thioester peptides corresponding to the N-terminal region with specific 
modifications (Muir, 2003). The original method used for native chemical ligation in the 
Bartke lab to semi-synthetically prepare modified histone tended to produce low-yield 
and low-quality full-length histone (Fig. 3.2c). Although the truncated histone could be 
removed from the desired full-length variant, excess peptide from the reaction was 
difficult to remove using two consecutive ion-exchange chromatography steps. This 
contributed to a much poorer yield of refolded histone octamers downstream. It was 
theorised that this was due to a poor rate of conversion of truncated histone to the full-
length histone and a reduced ability to remove any excess peptide from the reaction 
mix. 
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Work carried out in the Bartke lab (predominantly by Dr Nhuong Nhguyen and Dr 
Marek Tyl) contributed to improving the yield and quality of full-length modified histone, 
still using the native chemical ligation strategy to enable continued use of expensive 
thioester peptides. The previous method used an unfolding buffer with 6 M GuHCl with 
2% thiophenol (v/v) as a thiol catalyst. Thiophenol is not water-soluble and is highly 
toxic and its removal required extensive dialysis that produced a large amount of 
chemical waste. This is in addition to the poor resulting yield of modified histone. To 
enhance the yield and reduce the quantity of toxic waste, the chemistry was altered 
(Fig. 3.2d). A water-soluble derivative of thiophenol, MPAA (4-mercaptophenylacetic 
acid, see Materials and Methods) was used in addition to the use of TCEP (tris(2-
carboxyethyl) phosphine) as a reducing agent in the reaction. Upon the addition of both 
TCEP and MPAA to the ligation buffer, the pH needed to be altered to ~pH 7.5 and the 
solution was de-gassed. These changes to the initial reaction mix increased the 
conversion of truncated histone H3 or H4 to the full-length modified variant. The 
reaction could be incubated overnight at 40°C, quenched with DTT and acidified with 
acetic acid before direct loading on to a reversed-phase chromatography column (see 
Materials and Methods). The molecular properties of the histone (both truncated and 
full-length) compared with any excess peptide from the reaction enabled complete 
removal of the peptide. In addition, a suitable gradient of organic solvent successfully 
separated the truncated and the full-length histone for H3 and H4, respectively. The 
overall yield and purity of full-length, modified histone was increased using the 
reversed-phase chromatography rather than normal-phase ion-exchange 
chromatography. As a result, downstream applications of modified histone were 
enhanced for reconstituting nucleosome core particles for biochemical assays. 
Furthermore, ligated histones purified by reversed-phase chromatography were 
chemically pure whereas histone produced by the old protocol via ion-exchange 
chromatography contained carbamyl-modifications introduced by the prolonged 
incubation in urea, as indicated by mass spectrometry. 
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Octamers of histone proteins were formed as described (see Materials and Methods 
and Fig. 3.3a) and then reconstituted into nucleosome core particles by salt deposition 
dialysis once mixed with suitable nucleosomal DNA (Fig. 3.4). The DNA used was the 
601-nucleosome positioning sequence (Table 3 and (Lowary & Widom, 1998) with 
around 15-20 base pairs of linker DNA either side of the core positioning sequence. 
By investigating the ability for UHRF1 to bind chromatin modifications, the underlying 
DNA sequence was kept similar throughout. There are slight differences in some of 
the linker DNA sequences between the mono-, di- and tetra-nucleosome constructs 
and the 12x187bp and 25x197bp array DNAs used but the CpG content and length of 
such nucleosomal DNA repeats was kept as similar as possible. The DNA was 
prepared as described (Bartke et al, 2010). The constructs for the tetra-nucleosomal 
DNA (4x601) were based on the length and linker of the di-nucleosomal DNA (2x601) 
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and were prepared in a similar manner. Methylation of the cytosines at CpG di-
nucleotides was carried out enzymatically as described using M. SssI DNA 
methyltransferase that mimics the methylation pattern found at CpG dinucleotides in 
eukaryotic DNA (Fig. 3.3b). To prepare hemi-methylated mono-nucleosomal DNA, 
primers were designed to include a specifically methylated CpG in the linker region of 
the DNA only on a single strand. Combining this with a primer with biotin at the 5’-end 
enabled the formation of biotinylated nucleosomal DNA for immobilising onto 
streptavidin beads (Fig. 3.3c and Table 4).  
 
3.2 UHRF1 from HeLa S3 nuclear extract specifically binds to H3K9me2/3 histone 
marks 
To verify the SNAP experiments carried out previously in the Bartke laboratory, HeLa 
S3 nuclear extract was prepared as described (Bartke et al, 2010) and incubated with 
recombinant nucleosome core particles (Fig. 3.5). This also provided a quality-control 
for the modified nucleosomes used in this study. Using nucleosomes with DNA 
containing a biotin-tag that can be used to immobilise the core nucleosomes to 
streptavidin-coated sepharose beads, the binding of components in the extract can be 
analysed by washing in SNAP buffer and boiling the beads in SDS-sample loading 
buffer and subsequently probing for binding of proteins of interest by Western blot. 
Biotinylated histone peptides were also used as a comparison to mono- and di-
nucleosomes. HP1a and UHRF1 both show increased binding to H3K9me2/3 marks 
whether in the form of peptides, mono- or di-nucleosomes thus reinforcing previous 
work carried out in other studies. No or very little UHRF1 was observed to bind to 
peptide or nucleosome substrate with unmodified histone H3.  
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3.3 Recombinant mouse UHRF1 
To investigate the binding of UHRF1 protein in greater detail, recombinant mouse 
UHRF1 was expressed and purified from E. coli. Human and mouse UHRF1 have high 
sequence identity (73.6%) and are a similar length with identical domain architecture. 
Using purified protein without the presence of nuclear extract will potentially enable the 
precise binding details to be investigated with reduced background. 
 
Mouse cDNA for UHRF1 (a kind gift from E. Laue, University of Cambridge) was used 
to express recombinant UHRF1 protein from E. coli. A version of the pET24 vector 
(see Materials and methods) that contained an N-terminal His6-SUMO tag (a kind gift 
from Bernd Bukau/ZMBH, University of Heidelberg) was used to boost expression, 
solubility and ease of purification as well as tag-removal. In-house purified Ulp1 
(SUMO-specific protease) was used to remove the tag after Ni-sepharose affinity 
purification (GE Healthcare) and the protein was finally purified by size-exclusion 
chromatography with an optional cation exchange chromatography step (Fig. 3.6a, b). 
A modest amount of the full-length protein could be made this way (approximately 2 
mg per 1 L E. coli culture) but a greater yield could be achieved with the smaller UHRF1 
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fragments that were also expressed and purified (>5 mg per 1 L E. coli culture). The 
presence of the basic stretch in the linker between the SRA-domain and the RING-
finger of UHRF1 seemed to reduce the yield of purified recombinant protein. A His6-
tagged version of the UBL-domain of UHRF1 was expressed and purified using a 
pET28a(+) vector (Fig. 3.6c and see Materials and Methods).  
 
 
 
3.4 UHRF1 binds preferentially to (hemi-) methylated CpG DNA 
It has been reported that UHRF1 binds to hemi-methylated CpG-containing DNA more 
so than symmetrically CpG methylated DNA and unmethylated DNA via the SRA-
domain. To initially test recombinant mouse UHRF1 for binding to DNA, a DNA 
oligonucleotide binding electrophoretic mobility shift assay (EMSA) was set up (Fig. 
3.7). Four sets of primers (see Table 4) were used that contained a single CpG di-
nucleotide with or without cytosine methylation to form four double-stranded DNA 
templates (no meth, hemi-meth 1, hemi-meth 2 and CpG meth). The full-length UHRF1 
and the short fragment (118-621) consisting of the TTD, PHD and SRA-domains (see 
Fig. 1.3) were both tested and showed preferential binding to hemi-methylated and 
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fully methylated DNA. This indicated that the SRA-domain in the recombinant protein 
was functional in binding to its preferred substrate. 
 
 
3.5 Discussion 
To investigate the binding of UHRF1 to physiologically-relevant chromatin substrate, 
modified histone proteins were made and refolded into histone octamers. Nucleosome 
core particles were then reconstituted using nucleosomal DNA that can be 
enzymatically CpG-methylated or have a single hemi-methylated CpG site inserted. 
The quality control steps used here form an important preliminary step to ensure that 
the reagents are reliably and reproducibly formed. Findings from the SILAC 
nucleosome affinity purification (SNAP) study by Bartke et al. could be verified using 
mammalian nuclear extract from HeLa S3 cells, indicating the increased binding of 
UHRF1 to H3K9me2/3 marks on histone peptides, mono- and di-nucleosomes. A 
method to express and purify recombinant mammalian UHRF1 from E. coli was 
developed that enabled the production of purified recombinant protein that was shown 
to be functional with respect to hemi-methyl CpG binding. This enables specific 
mutations and truncations to be made to probe for the binding contributions of 
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particular regions of UHRF1 to in vitro reconstituted nucleosomes that will be 
presented in this thesis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 82 
Chapter 4 
4. Binding of recombinant UHRF1 to nucleosome core particles 
To investigate the chromatin-binding characteristics of recombinant UHRF1, 
reconstituted nucleosomes were used (as prepared in Chapter 3, Fig. 3.4) with either 
unmodified- or H3K9me2/3-ligated histone H3 and un-methylated, CpG-methylated or 
hemi-methylated nucleosomal DNA. The aim was to test previously studied binding 
preferences of UHRF1 for hemi-methylated DNA and/or H3K9me2/3 using 
physiologically-relevant nucleosome core particles and investigate the chromatin-
binding properties of the full-length protein.  
 
4.1 UHRF1 binds preferentially to hemi-methylated CpG DNA in the context of 
the nucleosome 
To assess the binding of mouse recombinant UHRF1 to chromatin modifications, 
nucleosome core particles were used as bait by immobilising nucleosomes to 
streptavidin-coated beads before incubation with UHRF1. Whilst quantitative 
information is difficult to acquire by this method, it can provide informative qualitative 
data about the binding preferences of UHRF1 for particular chromatin modifications. 
 
As with the DNA EMSAs described in Chapter 3, both the full-length UHRF1 and a 
fragment containing the TTD, PHD and SRA-domains (118-621) were tested for 
binding to nucleosome core particles (Fig. 4.1). Unexpectedly, the two variants showed 
different binding characteristics. The full-length protein seemed to bind to the 
unmodified nucleosome without H3K9me3 or CpG methylated DNA more so than the 
shorter fragment. The binding, however, does not seem to be completely non-specific 
as binding to nucleosomes containing H3K4me3 was reduced for the full-length 
protein, as expected from previous studies that showed the H3K4me3 mark prevented 
PHD-dependent binding of UHRF1 to H3 N-terminal peptides (Rajakumara et al, 
2011). As expected, increased binding was observed for both full-length UHRF1 and 
short fragment in the presence of fully CpG methylated DNA and a further increase in 
binding could be detected in the presence of hemi-methylated DNA. However, there is 
only a small detectable increase in binding to H3K9me3 compared with unmodified 
H3-containing nucleosomes. This has been reported when looking at the binding of 
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recombinant full-length UHRF1 with histone peptides, with the linker region between 
the SRA-domain and the RING-finger being reported to regulate the ability of the TTDN 
to bind to H3K9me3 marks (Gelato et al, 2014). A small increase was detected in the 
case of the shorter fragment but this result implies that the PHD-finger binding to H3 
is more dominant than TTD binding to H3K9me2/3. Removal of the basic linker region 
between the SRA- and RING-domains in the shorter fragment did not seem to increase 
the binding specificity for H3K9me3 to a substantial degree. The differences in binding 
between the full-length protein and the shorter fragment indicate that there is likely to 
be additional nucleosome binding contributions outside of the reported chromatin 
reader domains of UHRF1. 
 
 
 
In addition, less detectable binding is observed with so-called “601 no linker DNA” that 
does not contain linker DNA either side of the nucleosome positioning sequence (Fig. 
4.1). The relevance of this was not investigated further here but it has been reported 
that UHRF1 is able to bind more strongly to hemi-methylated DNA in the linker DNA 
rather than in the core positioning sequence (Zhao et al, 2016). This might suggest 
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that the presence of linker DNA is necessary for stable binding of UHRF1 to 
nucleosome core particles, especially in the presence of hemi-methylated CpG DNA.  
 
 
 
4.2 The basic region between the SRA-domain and RING-finger contributes to 
nucleosome binding 
The reproducible difference in binding of full-length UHRF1 compared to the short 
fragment was investigated further (Fig. 4.2). The short fragment ranges from amino 
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acids 118 to 621 in the protein, therefore both the N-terminal and the C-terminal 
regions were individually added back to the UHRF1 fragment (Fig. 4.2a). An N-
terminally truncated variant (DUBL, amino acids 118-782) showed identical binding 
characteristics as the full-length protein as binding was detected with unmodified 
nucleosomes. A small increase in binding was detected in the presence of H3K9me3-
containing nucleosomes but a more substantial increase in binding was observed with 
nucleosomes containing hemi-methylated DNA, as observed for wildtype UHRF1. A 
fragment that had the C-terminal region removed (DRING/linker, amino acids 3-621) 
behaved like the short fragment that contained only the canonical chromatin reader 
domains (118-621), with no detectable binding to unmodified nucleosomes. This 
suggested that a region within the C-terminus of UHRF1 contributed some background 
binding characteristics to unmodified nucleosome core particles. Work carried out by 
Gelato et al. found that a polybasic region (PBR) within the linker between the SRA-
domain and the RING-domain played a role in regulating the interaction of UHRF1 with 
histone H3 peptides in conjunction with PI(5)P (Gelato et al, 2014). Adding back this 
linker region appeared to rescue the binding of a C-terminally truncated variant of 
UHRF1 to unmodified nucleosomes indicating that this basic linker region perhaps 
contributes some binding affinity to unmodified nucleosome core particles rather than 
directly regulating its chromatin mark specificity (Fig 4.2b, see DRING).  
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To investigate the contribution of the basic region in this linker, three lysine residues 
were mutated to glutamine (PBRmut, K644Q/K646Q/K648Q) and used to probe for 
binding to mono-nucleosomes (Fig 4.2b). In this case, reduced binding was detected 
with unmodified nucleosomes although not to the level of the DRING/linker or the 118-
621 fragments. Given the number of basic residues present in this region, it might not 
be surprising that this background binding is not completely lost. However, the idea of 
basic regions in chromatin binding proteins contributing to nucleosome binding is not 
new. At the structural level, several proteins have been found to have basic regions 
that might be involved in nucleosome binding via an acidic patch on histones H2A and 
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H2B (McGinty et al, 2014; Wilson et al, 2016). It is unclear whether this is the case for 
UHRF1. Another possibility is that the PBR can bind non-specifically to DNA as 
previous studies have observed increased DNA binding of the SRA-domain plus this 
linker region (Berkyurek et al, 2014). However, in the DNA EMSA assays (see Chapter 
3, Fig. 3.7), there was no clear difference detected between the full length and short 
fragment of UHRF1. Other studies investigating UHRF1 binding to histone peptides 
have indicated that this region might be involved in binding to other biological 
molecules that help regulate the preferential binding to the H3K9me3 mark. Gelato et 
al. found that a specific phosphoinositide, PI(5)P, was able to bind to the PBR and this 
shifted UHRF1 to the open conformation to enable preferential binding to H3K9me3 
by the TTD. These studies were carried out with histone peptides. To test if this was 
the case for UHRF1 binding to nucleosome core particles, binding assays were carried 
out with mono-nucleosomes with unmodified and H3K9me3-modified octamers with 
and without a molar excess of PI(5)P. No detectable difference in the specificity of 
binding was detected for UHRF1 between the histone modifications in the context of 
nucleosomes in the presence of PI(5)P (Fig 4.3).  
 
Alongside testing the binding of UHRF1 to mono-nucleosomes, streptavidin pull-downs 
were also carried out using biotinylated di- and tetra-nucleosomes containing either 
unmodified or K9me3-containing octamers with and without CpG methylated DNA (Fig. 
4.4). These experiments indicated a very similar outcome as with the binding of UHRF1 
to mono-nucleosomes. The full-length protein was detected to bind to both unmodified 
and H3K9me3-containing octamers with similar affinity whilst the presence of CpG-
methylated DNA increased binding. However, the absence of the linker region between 
the SRA-domain and the RING-finger in UHRF1 reduced the background binding to 
unmodified nucleosomes, similar to the results with mono-nucleosomes.  
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4.3 Determination of in-solution binding characteristics of UHRF1 
Using immobilised nucleosomes to investigate the binding of UHRF1 to chromatin 
modifications gives useful qualitative data about what modifications are preferentially 
bound but provides little quantitative information. Similar to the DNA EMSA described 
in Chapter 3, a nucleosome electrophoretic mobility shift assay was developed to try 
to extract more precise binding information. Furthermore, the method is solution-based 
and may remove any possible bias using a bead-based binding assay. UHRF1 
(wildtype and mutants) were incubated with nucleosomes and the reaction mixture was 
separated by native PAGE. The amount of nucleosome core particles was kept 
constant whilst the concentration of UHRF1 was titrated from equimolar amounts up 
to 10 or 20 molar equivalents. The amount of unbound nucleosome could be quantified 
for each sample relative to the nucleosome-only in-gel control to get semi-quantitative 
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information about the approximate binding affinity of different UHRF1 fragments to 
mono-nucleosomes containing specific chromatin modifications (Fig. 4.5). The 
resulting apparent binding affinities can then be compared. 
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The mobility shift assays for full-length UHRF1 indicate very similar binding affinities 
for both unmodified nucleosomes and H3K9me3 modified nucleosomes with no 
increase in binding in the presence of hemi-methylated nucleosomal DNA. Removal of 
the UBL-domain seemed to generally increase the binding affinity to nucleosomes 
compared with the wildtype. For the DRING/linker fragment without the basic linker 
region, binding is reduced to unmodified/H3K9me3-containing nucleosomes without 
hemi-methylated DNA but is not completely lost as observed for the nucleosome pull-
downs. For the short fragment containing the TTD, PHD and SRA-domains (118-621), 
there was a substantial difference in binding between nucleosomes +/- hemi-
methylated DNA, with much-reduced binding to nucleosomes without hemi-methylated 
DNA. An increase in binding was detected with H3K9me3-containing mono-
nucleosomes, irrespective of the DNA methylation status, as well. The control EMSA 
using the His6-UBL-domain of UHRF1 showed no binding even at higher molar 
equivalents (Fig. 4.5a). Therefore, whilst the UBL-domain itself has no direct 
chromatin-binding contributions, it seems to interfere with general nucleosome binding 
by other domains within UHRF1 without affecting specificities to DNA- or H3K9-
methylation. 
 
4.4 Discussion 
UHRF1 was found to bind preferentially to nucleosome core particles containing hemi-
methylated CpG DNA with only a small increase in binding to the H3K9me3 mark. 
Using bead-based binding assays, the presence of the polybasic region (PBR) was 
observed to increase binding to nucleosomes irrespective of any modifications 
present. The UBL-domain, however, did not seem to have any direct nucleosome-
binding contribution. In-solution binding assays however indicate that the UBL-domain 
may have other indirect effects on UHRF1-binding to chromatin. 
 
The binding of UHRF1 to histone H3 Lys-9 di-/tri-methylation and DNA CpG 
methylation have predominantly been based on using short histone peptides and short 
hemi-methylated DNA oligonucleotides with only few studies investigating the binding 
to more relevant nucleosome substrate. Furthermore, most of these studies used 
shorter fragments of UHRF1 that only contained selections of domains rather than the 
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full-length protein.  One study identified that UHRF1 from HeLa nuclear extract can 
bind both H3K9me3 and DNA CpG methylation individually and there is an additive 
increase when both modifications are present in the context of nucleosome core 
particles (Bartke et al, 2010). In the current study, recombinant mouse UHRF1 was 
expressed and purified to further probe the binding determinants to nucleosome core 
particles. The aim of this was to understand how UHRF1 recognises chromatin by 
setting up a fully reconstituted system using chromatin substrate with the protein in 
isolation. Using this system, it might be possible to identify the major binding 
contributions of individual domains of UHRF1 in the context of full-length protein to 
modified chromatin. From this, the biological mechanism for specific recruitment of 
UHRF1 to replication forks and its role in general heterochromatin formation might be 
eluded to further.  
 
Full-length wildtype mouse UHRF1 associates more strongly with nucleosomes 
containing hemi-methylated DNA in the linker sequence and this seems to be the 
primary determining factor for enhanced recruitment of UHRF1 to chromatin. There 
was a slight detectable increase in binding to H3K9me2/3 marks as observed 
previously with recombinant protein but there was already substantial binding detected 
for the full-length UHRF1 to unmodified nucleosomes. This has been seen for 
recombinant UHRF1 on histone H3 peptides but not in the context of nuclear or cellular 
extract (Gelato et al, 2014). This finding has previously resulted in the identification of 
factors that might regulate this interaction such as phosphoinositides (Gelato et al, 
2014), hemi-methylated DNA oligonucleotides (Fang et al, 2016) and potentially USP7 
(Zhang et al, 2015). It is thought that the presence of these factors might induce an 
“open” conformation in UHRF1 to enable specific binding to the H3K9me2/3 mark. The 
polybasic region (PBR) of UHRF1 was identified as being the instigator of this 
regulation in previous studies and was found to be an important determinant for binding 
to H3K9me2/3-modified nucleosomes. However, in this work, removing or mutating the 
PBR seemed to bring about a general reduction in nucleosome binding rather than 
increased specificity for the H3K9me2/3 mark (Fig. 4.2). Furthermore, in this system, 
PI(5)P seemed to have no effect on the binding of UHRF1 to mono-nucleosomes (Fig. 
4.3). These results suggest that binding of UHRF1 to nucleosomes is much more 
complex than previously observed using histone peptides, with potentially more 
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interaction or allosterically regulated sites. Work using the SRA-domain of UHRF1 saw 
a general, non-specific increase in DNA-binding affinity when this basic linker was 
added to the SRA-domain, implicating it in having some DNA binding capacity 
(Berkyurek et al, 2014). Furthermore, increasing structural evidence from nucleosome-
bound reader complexes have elucidated that the acidic patch formed by H2A and 
H2B on the nucleosome surface, might form a platform for electrostatic interactions to 
a basic Arg/Lys patches on chromatin readers (McGinty et al, 2014; Wilson et al, 2016). 
It is unclear from this study so far if this is also a mechanism for UHRF1 binding to 
nucleosome or chromatin substrate but this basic linker does seem to form 
nucleosome contacts to enhance binding. Another study identified that a CDK-
dependent phosphorylation in this region (S652) is involved in regulating the 
degradation of UHRF1 (Ma et al, 2012) but a phosphomimic at this site (Zhang et al, 
2015) might also affect chromatin binding by UHRF1. Therefore, PTMs on UHRF1 may 
have a regulatory role for binding to chromatin. 
 
The timing of UHRF1 recruitment to hemi-methylated DNA after the passing of the 
replication fork is not well known. Given that DNMT1 is also thought to bind the 
proliferating cell nuclear antigen (PCNA) via a region close to the RFTS-domain 
(Schermelleh et al, 2007), it might be assumed that UHRF1 binds soon after the 
passing of the replication machinery. The number of CpG hemi-methylated sites and 
their position in the genome might influence the timing and strength of UHRF1 binding. 
A recent study using a short fragment of UHRF1 indicated that hemi-methylated CpG 
sites in the linker region (i.e. outside of the nucleosome core sequence) were more 
strongly bound by UHRF1 than those within the nucleosome positioning sequence 
(Zhao et al, 2016). In the current study, hemi-methylated CpG sites were also placed 
outside of the nucleosome positioning sequence in the linker region of mono-
nucleosomes. Only a single hemi-methylated CpG was necessary to increase binding 
to nucleosomes and preliminary work where more hemi-methylated CpG sites were 
included gave increased binding still (data not shown). Furthermore, it was observed 
in some cases that nucleosomes containing hemi-methylated CpG DNA were bound 
more strongly than those containing enzymatically CpG methylated DNA (i.e. on both 
strands). This agrees with previous studies that the SRA-domain binds hemi-
methylated CpG DNA greater than symmetrically methylated DNA. As an aside to this, 
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using nucleosomes with no linker DNA resulted in reduced general binding to mono-
nucleosomes independent from DNA CpG methylation. Therefore, it might be plausible 
that UHRF1 requires a suitable length of linker DNA or chromatin substrate to 
efficiently recognise hemi-methylated DNA after DNA replication. This might provide 
an inherent level of regulation/timing for the recruitment of DNMT1 after the passing of 
the replication fork at hemi-methylated CpG sites.  
 
The in-solution EMSAs (Fig. 4.5) highlight no major differences in binding preference 
between chromatin modifications for wildtype UHRF1. This suggests that PBR-
mediated binding to nucleosomes is dominant in these particular assays. However, 
there is a general increase in affinity for the DUBL fragment. This suggests that the 
UBL-domain is somewhat inhibitory for chromatin-binding. Upon removal of the C-
terminal RING and basic linker region, there is a reduction in binding to nucleosomes 
not containing hemi-methylated DNA. For the short fragment (118-621), the 
specificities in binding are as expected with a strong preference for binding hemi-
methylated CpG-containing nucleosomes. Whilst it is difficult to conclude any concrete 
information from this, our results suggest that the UBL-domain, whilst not having any 
direct binding contributions to nucleosomes itself, may affect the binding of other 
domains of UHRF1 to nucleosome core particles. 
 
To conclude, using recombinant components, it is possible to recapitulate some of the 
binding characteristics of UHRF1 to nucleosome substrates with increased binding to 
hemi-methylated CpG DNA and a small increase in binding to H3K9me2/3. However, 
other regions within the full-length protein seem to directly or indirectly contribute to 
nucleosome-binding. The UBL-domain does not directly bind to nucleosomes but 
might indirectly affect the binding of other domains within UHRF1 to nucleosomes as 
its removal resulted in a general increase in chromatin-binding (Fig. 4.5). The PBR in 
the linker between the SRA- and RING-domains generally increases the binding to 
nucleosomes irrespective of chromatin modifications. Therefore, whilst recombinant 
UHRF1 can bind more strongly to hemi-methylated CpG sites in the context of 
nucleosomes as shown in this study, it already has some affinity for unmodified 
nucleosomes. The mechanisms behind these binding contributions would be 
interesting to investigate in the context of full-length UHRF1. 
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Chapter 5 
5. Crosslinking with mass spectrometry (XL-MS) 
5.1 A method for identifying interacting regions within and between proteins 
UHRF1 is a large, multi-domain protein and it has been reported that domains within 
the protein interact. These intra-molecular interactions have been reported to regulate 
its biochemical function to bind chromatin (e.g. at H3K9me2/3 marks and DNA CpG 
hemi-methylated sites, (Gelato et al, 2014; Fang et al, 2016). Many of these studies 
have utilised individual protein domain fragments of UHRF1 that were immobilised on 
beads and incubated with other isolated domains of UHRF1. This has identified 
interactions between the different domains within UHRF1 but might miss interactions 
that, in an inter-molecular environment, are quite weak or dynamic. Furthermore, the 
conformation of UHRF1 might be altered in the presence of other binding partners such 
as nucleosomes, larger chromatin arrays or other proteins. 
 
Several techniques could be used for this such as FRET (Förster resonance energy 
transfer), SAXS (small-angle x-ray scattering) or NMR (nuclear magnetic resonance). 
These methods require the introduction of fluorophores or are limited by the size and 
amino acid composition of the respective proteins involved. The size of UHRF1 (~90 
kDa) and the potential difficulties of interpreting complex FRET or SAXS data from a 
likely flexible protein makes it potentially difficult to analyse using these techniques. A 
method that utilises the native protein in the presence of interacting partners is 
crosslinking with mass spectrometry (XL-MS, see Chapter 1). Here a chemical cross-
linker is used to crosslink parts of the protein that are in close proximity. The detection 
of crosslinked peptides would enable identification of interacting regions within UHRF1 
as well as between UHRF1 and histones in the context of chromatin. Differences in 
the crosslinking pattern might also give an indication towards conformational changes 
within the protein in the context of different chromatin substrates (e.g. with different 
histone or DNA modifications or different length chromatin substrates) or with other 
interaction partners. 
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5.2 Stoichiometry of UHRF1 in solution 
Before investigating some of the molecular details of UHRF1 with respect to its overall 
architecture, the stoichiometry was examined. Previous studies have indicated that 
UHRF1 in isolation forms a monomer in solution (Harrison et al, 2016). In the current 
study, size-exclusion chromatography (SEC) experiments also indicate that UHRF1 
does not form a dimer or higher order oligomers but is monomeric in solution. This is 
apparent both at small, analytical scale experiments (see Chapter 7, Fig. 7.1) but also 
in larger scales such as during the purification process (Fig. 5.1). The full-length protein 
seems to elute at approximately 150 kDa when compared to marker proteins (Fig. 5.1, 
dotted blue line), which is larger than the theoretical mass of 90 kDa but is not large 
enough for a dimer. This may be due to the full-length protein not being completely 
globular thus migrating at a slightly larger molecular weight than to be expected. SEC 
with multiple-angle light scattering (MALS) will be a useful method to help answer this 
question. Analytical ultra-centrifugation (AUC) is another method that might help verify 
this. Other fragments of UHRF1 such as the truncated DUBL and DRING/linker also 
seemed to approximately migrate in the SEC as monomers (Fig. 5.1). 
 
To further probe for potential higher-order forms of UHRF1 forming in solution, 
crosslinking experiments with glutaraldehyde were carried out with UHRF1. Chicken 
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egg-white albumin was used as a negative control and HP1a was used as a positive 
control as it is known to dimerise and to form tetramers and higher-order oligomers 
(Fig. 5.2). HP1a and albumin behave as expected but analysis of the stoichiometry of 
UHRF1 when analysed by 10% SDS-PAGE and Coomassie Brilliant Blue staining is 
quite interesting. A band for the monomer is present at ~90 kDa and the smear near 
the top of the gel indicates over-crosslinked UHRF1 that forms aggregates. The fuzzy 
band at ~130-140 kDa is similar to the SEC experiments that indicated UHRF1 
migrating at ~150 kDa. The cross-linker may be able to fix UHRF1 in an alternative 
conformation with a greater hydrodynamic radius resulting in reduced migration in the 
SDS-PAGE gel. No band is present at ~180-200 kDa (i.e. just below the 250 kDa 
marker) that would indicate a dimer. Therefore, UHRF1 does not form a dimer but both 
the SEC and glutaraldehyde crosslinking experiments indicate that monomeric UHRF1 
is not perfectly globular and may form a range of different conformations.  
 
 
 
5.3 A basic XL-MS workflow designed to investigate intra-molecular contacts 
within UHRF1 
The in-gel crosslinking and the SEC experiments suggest that UHRF1 exists in a range 
of conformations in solution. A method that uses a mass spectrometry approach with 
chemical crosslinking of proteins in solution was therefore developed to try and identify 
interacting regions between UHRF1 and chromatin substrates whilst potentially 
indicating alterations in the intra-molecular conformation of UHRF1 (Fig. 5.3). This 
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method has previously been used in conjunction with static structural approaches to 
identify and validate interacting domains between proteins within larger protein 
complexes. For UHRF1, no full-length protein structural information is known, as 
opposed to the individual domains and the TTD-PHD module with H3 peptides for 
instance (Rothbart et al, 2012; Arita et al, 2012). Therefore, the XL-MS approach was 
utilised to test if previously identified intra-molecular interactions could be verified with 
this method and if novel intra-domain interactions could be identified (Gelato et al, 
2014; Fang et al, 2016). Furthermore, inter-molecular interactions between UHRF1 
and nucleosome substrates might also be identified to investigate what regions of 
UHRF1 are in close proximity to histone proteins in the context of a chromatin 
substrate. 
 
 
 
Initial tests were based on work from the lab of Ruedi Aebersold (Leitner et al, 2014b) 
that used commercially available cross-linkers and followed identification of 
crosslinked peptides using the xQuest/xProphet software. A general workflow (Fig. 
5.3) and a more detailed description of the method, sample processing and mass 
spectrometry methods are described. The amount of cross-linker used in each sample 
was based on the number of moles of lysine residues present in the sample. An 
equimolar amount of BS3 (d0/d12, 1:1) compared with the number of lysine residues 
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was used. The amount added, therefore, is not in excess thus preventing aggregation 
or distortion of the proteins and formation of non-specific or non-physiological 
crosslinks. This metric was used for all the XL-MS experiments described here. The 
total amount of protein used was approximately 50 µg for each experiment at ~1 mg/ml 
of protein in 10 or 20 mM HEPES-KOH pH 7.5, 100 mM NaCl, 1 mM DTT. The amount 
of protein was tested in preliminary experiments so not to overload the LC-column 
whilst still identifying crosslinks in the samples. There was no enrichment step (e.g. 
peptide size-exclusion chromatography) used as crosslinked peptides could be 
detected without. 
 
The raw mass spectrometry files from the LTQ Orbitrap XL instrument were converted 
to mzXML file formats using proteowizard MSConvert using 32-bit binary encoding and 
no zlib compression. The files were prepared using the workflow as described (Leitner 
et al, 2014b) and searched against a fasta database containing uniprot sequences of 
mouse UHRF1 with human histone proteins and a decoy database of the reversed 
sequences. Three missed trypsin cleavages were allowed for with cysteine 
iodoacetamide-capping as a stable modification and methionine oxidation as a variable 
modification. Isotope-labelled BS3 (d0/d12) was used as the cross-linker. Other 
parameters were left unaltered from the default settings. 
 
The output from the xQuest/xProphet search engine provided a list of possible 
crosslinked peptides identified against the input fasta database with false-discovery 
rates (FDRs) and scores indicating the likelihood that the crosslink was present. An 
FDR of less than 5% is often used as a cut-off for whether a crosslink is likely to be 
“real” or not. The FDR cut-off was determined by the xProphet in-built algorithm 
(Walzthoeni et al, 2012). Example spectra (Fig. 5.4) indicate the crosslinked peptide 
and the b- and y-ions that were used to identify the species given the theoretical and 
actual spectral output. Alpha(a)- and beta(b)-ions are used to indicate the first and 
second peptides that are crosslinked together. A table of the highest scoring 
crosslinked peptides for each of these experiments could be used and visualised using 
xiNET (Combe et al, 2015). A ld-score (linear-determinant score) of 30 or more for 
each crosslinked peptide hit was deemed as being of a reasonable likelihood that a 
crosslink was present and was therefore visualised. This webserver uses input fasta 
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files (equivalent to those used in the data analysis described above) and input protein 
annotations (e.g. domain names and architecture) as a .csv file. The table of 
crosslinked species could be exported from the virtual machine used for the 
xQuest/xProphet analysis and the .csv file of this was used to visualise the crosslinks. 
Dead-end crosslinks were indicated by flagged lines, intra-protein crosslinks as purple 
lines and inter-protein crosslinks as green lines. 
 
xQuest result
AKMASATSSSR-DWGKGMACVGR-a2-b4
mz min. 200  mz max. 2000
MS2 tolerance for common-ions [Da] 0.2  MS2 tolerance for xlink-ions [Da] 0.3
logscale labels hide peptide structure
water-loss NH3-loss allow matching of 2nd isotopic peak show table with matching
ions show comparison of original spectra
a x
b y
c z
reload
xQuest ionseries http://localhost/cgi-bin/V2_1_1/xions2.cgi?id=///TT...
1 of 3 05/10/2016 11:03 AM
alpha-chain
alpha_common_b_standard_plus1 72.04 - - - - - - - - - -
alpha_common_b_standard_plus2 36.53 - - - - - - - - - -
alpha_common_b_standard_plus3 24.69 - - - - - - - - - -
alpha_xlink_b_standard_plus2 - 787.38 852.91 888.42 931.94 967.46 1017.98 1061.50 1105.01 1148.53 1226.58
alpha_xlink_b_standard_plus3 - 525.26 568.94 592.62 621.63 645.31 678.99 708.00 737.01 766.02 818.06
alpha_xlink_b_standard_plus4 - 394.20 426.96 444.72 466.47 484.23 509.49 531.25 553.01 574.77 613.79
AA A K M A S A T S S S R
alpha_common_y_standard_plus1 - - 897.41 766.37 695.33 608.30 537.26 436.22 349.18 262.15 175.12
alpha_common_y_standard_plus2 - - 449.21 383.69 348.17 304.65 269.14 218.61 175.10 131.58 88.06
alpha_common_y_standard_plus3 - - 299.81 256.13 232.45 203.44 179.76 146.08 117.07 88.06 59.05
alpha_xlink_y_standard_plus2 1235.59 1200.07 - - - - - - - - -
alpha_xlink_y_standard_plus3 824.06 800.38 - - - - - - - - -
alpha_xlink_y_standard_plus4 618.30 600.54 - - - - - - - - -
beta-chain
beta_common_b_standard_plus1 116.03 302.11 359.14 - - - - - - - -
xQuest ionseries http://localhost/cgi-bin/V2_1_1/xions2.cgi?id=///TT...
2 of 3 05/10/2016 11:03 AM
xQuest results
GKSGFLVWR-VVKYWPER-a2-b3
mz min. 200  mz max. 2000
MS2 tolerance for common-ions [Da] 0.2  MS2 tolerance for xlink-ions [Da] 0.3
logscale labels hide peptide structure
water-loss NH3-loss allow matching of 2nd isotopic peak show table with matching
ions show comparison of original spectra
a x
b y
c z
reload
xQuest ionseries http://localhost/cgi-bin/V2_1_1/xions2.cgi?id=///TT...
1 of 3 05/10/2016 11:01 AM
alpha-chain
alpha_common_b_standard_plus1 58.03 - - - - - - - -
alpha_common_b_standard_plus2 29.52 - - - - - - - -
alpha_common_b_standard_plus3 20.01 - - - - - - - -
alpha_xlink_b_standard_plus2 - 700.39 743.91 772.42 845.95 902.49 952.03 1045.07 1123.12
alpha_xlink_b_standard_plus3 - 467.26 496.27 515.28 564.30 602.00 635.02 697.05 749.08
alpha_xlink_b_standard_plus4 - 350.70 372.46 386.71 423.48 451.75 476.52 523.04 562.06
AA G K S G F L V W R
alpha_common_y_standard_plus1 - - 864.47 777.44 720.42 573.35 460.27 361.20 175.12
alpha_common_y_standard_plus2 - - 432.74 389.22 360.71 287.18 230.64 181.10 88.06
alpha_common_y_standard_plus3 - - 288.83 259.82 240.81 191.79 154.09 121.07 59.05
alpha_xlink_y_standard_plus2 1132.12 1103.61 - - - - - - -
alpha_xlink_y_standard_plus3 755.08 736.08 - - - - - - -
alpha_xlink_y_standard_plus4 566.57 552.31 - - - - - - -
beta-chain
beta_common_b_standard_plus1 100.08 199.14 - - - - - -
xQuest ionseries http://localhost/cgi-bin/V2_1_1/xions2.cgi?id=///TT...
2 of 3 05/10/2016 11:01 AM
A
B
Figure 5.4 xQuest/xProphet spectral output and nalysis. The spectral output of the
xQuest/xProphet data analysis pipeline. (A) The crosslinked peptides indicated give the
respective b- and y-ions for crosslinked peptides (red) a common ions (green, i.e. no isotopic
shift with light-/heavy-BS3) in the left panel and the MS2 peaks of the alpha-(top) and beta-
(bottom) peptides for the identified crosslink. (B) Identical arrangement as above for a different
crosslinked species. Both crosslinks were identified in the UHRF1 (118-621) protein with (A)
without mono-nucleosomes (Fig. 5.5b) and (B) with mono-nucleosomes (Fig. 5.6b).
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5.4 XL-MS experiments with UHRF1 indicate intra-molecular contacts that are 
altered in the presence of nucleosome substrate  
UHRF1 (the full-length protein and shorter fragment, 118-621) were treated with 
isotope-labelled BS3 and analysed for crosslinked peptides using xQuest/xProphet as 
described above. UHRF1 has been shown to be monomeric in solution both in this 
study (Fig. 5.1 and 5.2) and reported elsewhere so any identified crosslinks were 
deemed as being intra-molecular at the protein concentration used. Crosslinks were 
detected between the PHD-finger and the SRA-domain as well as between the PHD-
finger and the linker between the PHD and the SRA-domain in the shorter fragment 
(Fig. 5.5b) and the full-length UHRF1 (Fig. 5.5a). In addition to these crosslinks, the 
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UBL-domain present only in the full-length protein (Fig. 5.5a) exhibited crosslinks to 
both the PHD-finger and the SRA-domain, putting it in close proximity with the SRA-
linker region. Other dead-end crosslinks are also identified that might indicate solvent-
exposed regions of UHRF1 in solution such as in the UBL-domain, PHD-finger and the 
SRA-domain. The dead-end crosslinks were observed to be common between both 
fragments.  
 
When mono-nucleosomes were added into the crosslinking reaction with UHRF1, the 
full-length and the shorter fragment exhibited differing crosslinking profiles (Fig. 5.6). 
For the shorter fragment (Fig. 5.6b), similar intra-molecular crosslinks were identified 
both with and without mono-nucleosome substrate, with crosslinks detected between 
the SRA-domain and the PHD-finger within UHRF1. Inter-molecular crosslinks were 
detected between the PHD-finger and the N-terminus of histone hH3.1, confirming 
previous reports of an interaction between the very N-terminus of histone H3 and the 
PHD-finger of UHRF1 (Rajakumara et al, 2011). No other crosslinks could be identified 
between other domains of UHRF1 and other histone proteins, independent of the 
modification present (e.g. H3K9me3 and DNA CpG methylation). When H3K9me3 was 
present in the nucleosome substrate (data not shown), lysine tri-methylation was 
included as a variable modification in the xQuest/xProphet analysis parameters but no 
further crosslinks could be identified between UHRF1 and histone protein using this 
method to detect potential binding of the TTDN to H3K9me3. This is in line with the 
nucleosome binding experiments that indicate only a minor contribution by H3K9me3 
to binding of full-length recombinant UHRF1. This shows that the PHD-finger binding 
of the N-terminus of histone H3 may be the primary binding interaction for UHRF1 to 
histone proteins in the context of nucleosome substrates. 
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For full-length UHRF1, although many of the dead-end crosslinks identified previously 
were present, many of the intra-molecular crosslinks between the PHD-finger and the 
SRA-domain were not detected, despite being detected for the shorter fragment 
(compare Fig. 5.6a and 5.6b). A single crosslink was observed between the SRA-
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domain and the UBL-domain, however. Furthermore, several crosslinks can be 
identified between the PHD-finger and the N-terminus of histone H3 as for the shorter 
fragment. This indicates that with the addition of the N-terminal UBL-domain and the 
C-terminal linker and RING-domain, the intra-molecular conformation of UHRF1 was 
altered in the presence of nucleosome binding partners. Another possibility is that due 
to the increased binding of full-length UHRF1 to nucleosomes relative to the shorter 
fragment, more surface of UHRF1 is, on average, not available for the cross-linker to 
react with in the full-length protein. However, UHRF1 (118-621) binding to hemi-
methylated DNA-containing nucleosomes is detected to be quite strong (Chapter 4, 
Fig. 4.1) so this is not likely. As the method is solution-based, the crosslinked peptides 
are a result of a mixture of different conformations of UHRF1 and/or histones both 
bound and unbound and the output is an average of that equilibrium. Therefore, the 
different crosslinking profiles are likely to be due to the differences in the conformation 
of UHRF1 bound to nucleosomes with and without the UBL-domain and C-terminal 
RING/linker.  
 
Similar experiments were carried out with full-length UHRF1 in the presence of longer 
chromatin arrays (Fig. 5.6c and d). The resulting crosslinking profiles for full-length 
UHRF1 were almost identical as that seen for mono-nucleosome substrate with 
crosslinks identified between the SRA-domain and the UBL-domain within UHRF1 and 
inter-molecular crosslinks between the PHD-finger and the N-terminus of hH3.1. 
Again, this seemed to be independent of H3K9me3 marks and/or DNA CpG 
methylation present on the chromatin substrate. The dead-end crosslinks observed 
were also similar for UHRF1 with mono-nucleosomes or 12x187bp chromatin arrays. 
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5.5 An optimised XL-MS workflow increases the number of observed crosslinks 
within UHRF1 
In the process of developing the XL-MS protocol, some samples were run on a more 
sensitive mass spectrometry instrument (LTQ Orbitrap Velos, see Materials and 
Methods). The difference to the Orbitrap XL instrument is that more MS1 spectral 
peaks are taken for peptide fragmentation (top10 for the Orbitrap Velos vs top6 for the 
Orbitrap XL instrument, see Materials and Methods). This increases the number of 
peptide species detected and identified, thereby potentially increasing the coverage of 
Figure 5.7 Stavrox spectral output and analysis. Screenshots from the Stavrox data
analysis software (Gotze et al., 2012) for two intra-molecular crosslinks within wildtype
UHRF1.
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crosslinked peptides in each experiment. As a result, the size of the raw files and 
resulting mzXML files were increased and it was not possible to process the data on 
the virtual machine that was used for the xQuest/xProphet data analysis. As an 
alternative, Stavrox (Götze et al, 2012) was used to analyse and identify crosslinked 
peptides. In this case, raw files were converted to mgf files using MSConvert on 
proteowizard and analysed using similar parameters as used for the xQuest/xProphet 
analysis pipeline described above. In this case, an FDR of 0.05 was used as the cut-
off for the presence of crosslinked species. The isotope-labelled BS3 d0/d12 was 
manually entered as the cross-linker used with other parameters kept as described by 
default. The output was different (Fig. 5.7) to that for xQuest/xProphet but used the 
same principle. Alpha and beta ions are shown with the identified crosslinked species 
detected and annotated spectra with tables of the output crosslinks as well. 
 
An increase in the number of searched peptides for each experiment led to an increase 
in the number of crosslinked species from within UHRF1 (Fig. 5.8). The raw data files 
from the Orbitrap XL instrument experiments (see above) were also processed using 
Stavrox but did not see an increase in the number of crosslinks identified (data not 
shown). Therefore, the increased crosslinking information is due to the increased 
sensitivity of the Orbitrap Velos instrument rather than using a different algorithm. The 
identified crosslinks between peptides were visualised with xVis (Grimm et al, 2015). 
This webserver used the same XL-MS data and domain information as xiNET but gave 
circular diagrams to visualise the crosslinks within and between proteins. Dead-end 
crosslinks were not shown. For the full-length protein in isolation (Fig. 5.8a), a similar 
crosslinking profile to that seen above (Fig.5.5a) was evident with crosslinks from the 
SRA-domain to the PHD-finger and the UBL-domain in addition to the linker between 
the PHD-finger and SRA-domain. The difference in this case is the increase in detected 
crosslinks between regions of UHRF1. Further crosslinks were identified between the 
TTD and the basic linker region (PBR) between the SRA-domain and the RING-finger. 
In general, a greater number of crosslinks were observed around the TTD and PBR. 
This may verify information from previous studies that identified some intra-molecular 
interactions between this basic region and the TTD (Gelato et al, 2014) that is thought 
to regulate the binding of UHRF1 to H3K9me2/3 marks. Further crosslinking 
experiments were carried out on the shorter fragment (118-621) is addition to other 
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truncated variants using the full-length protein as the protein sequence to search 
against (Fig. 5.8b, c, d). These experiments indicated identical crosslinking patterns 
when compared to the full-length wildtype protein. The crosslinks identified within the 
truncated fragments did not contain contacts with regions not present within the 
protein, despite using the full-length UHRF1 amino acid sequence as a template (for 
the analysis by Stavrox), which suggests that the identified crosslinks are valid and 
that the technique and analysis was reliable with few false-positives. 
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5.6 The UBL-domain cannot form stable contacts to UHRF1 in-trans 
The XL-MS experiments described here verify previously identified intra-molecular 
contacts within UHRF1, such as the TTD-PHD (Gelato et al, 2014) and the PHD-SRA 
(Fang et al, 2016). In addition, these experiments provide the first evidence that the 
UBL-domain makes intra-molecular contacts to other regions within UHRF1. To test if 
these contacts are stable or transient, a His6-tagged UBL-domain (see Chapter 3) was 
expressed and purified from E. coli, immobilised on TALON superflow beads (see 
Materials and Methods) and used in pull-down experiments to detect interactions with 
the full-length UHRF1 or various deletion mutants. His6-USP7 (a known interaction 
partner of UHRF1), was used as a positive control (Fig. 5.9). UHRF1 was detected to 
bind to USP7 but neither the wildtype nor the other truncated mutants of UHRF1 were 
observed to bind to the UBL-domain in-trans. This indicates that whilst the UBL-domain 
appears to make contacts to other regions of UHRF1, these are likely to be weak and 
transient in nature and do not result in stable trans-interactions. Therefore, the UBL-
domain of UHRF1 in-solution is possibly quite flexible and is able to contact other 
solvent-exposed regions within UHRF1 transiently.  
 
5.7 UHRF1 can form inter-molecular crosslinks to USP7 
The stable interaction observed between UHRF1 and USP7 (Fig. 5.9a) enabled the 
XL-MS described here to be tested on UHRF1 in the context of an alternative 
interaction partner. USP7 has been identified to interact with UHRF1 and regulate its 
abundance at the protein level by removing polyubiquitin chains from UHRF1 thereby 
preventing proteasomal-mediated degradation (Ma et al, 2012) as well as regulating 
its binding to chromatin (Zhang et al, 2015). In the Zhang et al. study, it was proposed 
that the PBR within UHRF1 can bind to UBL2-UBL3 of the tandem UBL-domain (TUD) 
of USP7. This was detected using fragments of each protein. The UHRF1-USP7 
complex was used as a test substrate for the XL-MS workflow (Fig. 5.9b).  
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The intra-molecular contacts within UHRF1 do not seem to be altered (compare with 
Fig. 5.8) with additional inter-molecular contacts between UHRF1 and USP7. 
Crosslinks are detected between the UBL-domain and the PBR predominantly to 
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UBL3-UBL4 of the USP7 TUD. The UBL-domain also forms crosslinks to the catalytic-
domain of USP7. The PHD-finger forms crosslinks to UBL1 and contacts are detected 
between the SRA-domain and UBL1 and UBL3-UBL4 of USP7. From the binding 
experiments, there is a suggestion that removal of the C-terminal RING/linker region 
reduced binding of UHRF1 to USP7. The crosslinks formed between the PBR and the 
TUD of USP7 may be necessary for the interaction, with other contacts from the SRA-
and UBL-domains also contributing. The crosslinks from the UBL-domain to the same 
region may be linked to the intra-molecular contacts within UHRF1, positioning the N-
terminal UBL in close proximity to the PBR/TUD interaction. Intra-molecular crosslinks 
within USP7 were observed between the catalytic-domain and the TUD and also 
between the catalytic-domain the C-terminus that have been reported previously to be 
linked to its activity (Rougé et al, 2016). Previously identified contacts within and 
between UHRF1 and USP7 were verified with the XL-MS workflow, suggesting that it 
is a reliable technique for detecting intra- and inter-molecular interactions. In addition, 
it is able to detect weak and transient contacts that might be important for the 
physiological function of the protein and protein complex. These might be missed with 
other techniques. 
 
5.8 The optimised XL-MS workflow detects increased inter-molecular contacts 
between UHRF1 and histones in the context of chromatin 
To improve the results presented in Fig. 5.6, XL-MS using the LTQ Orbitrap Velos with 
Stavrox data analysis was carried out for UHRF1 with chromatin substrates. 
Crosslinking experiments of full-length UHRF1 with nucleosomes indicated similar 
results as described above using the xQuest/xProphet analysis with many additional 
detected crosslinks to histone proteins (Fig. 5.10).  Crosslinks were still observed 
between the UBL-domain and the SRA/PBR region in the presence of mono-
nucleosomes as well as longer 12x187bp chromatin arrays. Crosslinks are also 
detected between the UBL-domain and both the PHD-finger and the SRA-domain as 
well as between the linker of the PHD-finger and SRA-domain and the SRA/PBR 
region whilst crosslinks between the PBR and the TTD are generally not detected or 
reduced within UHRF1 in the presence of nucleosome substrate. Despite histone 
proteins having a relatively high percentage of lysine and arginine residues, crosslinks 
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could also be detected both within and between histone proteins and between histones 
and UHRF1. The high number of Lys/Arg residues usually results in the production of 
short peptides after trypsin digestion that are not easily detected by LC-MS/MS. Using 
a lysine reactive cross linker, the lysine residues are protected from trypsin digestion 
(so increasing the number of missed cleavages) and lengthening peptides from histone 
proteins that otherwise would not be observed.  
 
As with the xQuest/xProphet analysis described above, crosslinks were observed 
between the PHD-finger and the N-terminus of H3 (Fig. 5.10). In addition, crosslinks 
were also detected between histone H3 and the SRA-domain and PBR as well as the 
UBL-domain. Crosslinks were also found between the N-terminus of histone H4 to near 
the PHD-finger, the SRA-domain and PBR and between H2A/H2B and the SRA/PBR 
and near the PHD-finger. Some of these were common for mono-nucleosomes and 
12x187bp chromatin arrays with differences in coverage between samples. 
 
Both experimental methods, despite using different mass spectrometry instruments 
and data analysis software, gave overlapping outputs with regard to the intra-molecular 
interactions within UHRF1 and inter-molecular contacts between the PHD-finger and 
histone H3. With the stark increase in the overall proteomic information using the 
Orbitrap Velos instrument and Stavrox analysis, however, this method was taken 
forward for use in further XL-MS experiments with UHRF1 (see Chapter 6). 
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5.9 Discussion 
During the course of this project, several publications have indicated that the regulation 
and function of UHRF1 is closely linked to intra-molecular contacts within the protein 
(Gelato et al, 2014; Fang et al, 2016; Zhang et al, 2015). The basic region between 
the SRA-domain and the RING-finger known as the polybasic region (PBR) is reported 
to regulate TTD-binding to histone H3K9me2/3 by binding in the same peptide binding 
groove thus inhibiting the interaction with the histone (Gelato et al, 2014). The binding 
of a specific phosphoinositide, PI(5)P, to the PBR is reported to compete for TTD-PBR 
contacts thus releasing the TTD and enabling specific H3K9me2/3 binding. USP7 
binding to UHRF1 is also thought to have a similar effect on UHRF1-binding to 
chromatin (Zhang et al, 2015). The PHD-finger and the SRA-domain are also reported 
to interact. The binding of hemi-methylated DNA to the SRA-domain releases this intra-
molecular interaction, enabling the PHD-finger to bind the very N-terminus of H3 (Fang 
et al, 2016). Taken together, these studies suggest that UHRF1 exists in a range of 
conformational states that can be regulated by other biological molecules. The inter-
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domain contacts within the full-length protein are thought to regulate its function (e.g. 
binding to chromatin and DNMT1). However, many of these studies investigating intra-
molecular contacts within UHRF1 have used inter-molecular binding methods using 
fragments of the full-length protein to test how they bind. Stable inter-molecular 
contacts can be determined using these methods but it would be more useful and 
physiologically relevant to study these intra-molecular interactions within the full-length 
protein in-solution. 
 
In this study, XL-MS techniques were developed to identify intra-molecular interactions 
within UHRF1 in addition to contacts to interaction partners. The protein was found to 
be monomeric and bound to chromatin-based substrate as expected and observed in 
previously published studies (see Chapter 4). XL-MS has emerged as a versatile 
method to investigate interacting regions between proteins within larger, multi-subunit 
complexes (Rappsilber, 2011). The method was validated using complexes with 
known 3-D structures to verify the distance restraints of the crosslinks formed between 
components and was further used in reverse, to constrain subunits within more flexible 
and unknown protein complex structures (Walzthoeni et al, 2013). Other uses involve 
identifying relatively weak or dynamic protein-protein interactions within nuclear or 
cellular extract (Shi et al, 2015). For our purposes, there is some pre-existing 
information regarding the structures of individual domains within UHRF1 (Arita et al, 
2008; Rothbart et al, 2013) but how the full-length protein is arranged is unknown. The 
recombinant protein is relatively easy to express and purify from E. coli but attempted 
crystallisation trials failed, which indicates that the protein might be flexible. 
 
Information from XL-MS experiments indicate what regions of the protein are in close 
proximity to each other in the absence or presence of chromatin. Previous interactions 
such as the ones between the TTD and the PBR, and between the TTD, the PHD-
finger and the SRA-domains were detected within UHRF1 (Fig. 5.8). Another 
previously reported interaction that was identified using this technique is between the 
PHD-finger and SRA-domain (Fang et al, 2016). Further experiments with UHRF1 in 
the presence of nucleosome substrate indicated that many of the crosslinked contacts 
between the TTD and PBR were generally absent (Fig. 5.6 and 5.10). It was reported 
by Gelato et al. that PI(5)P was involved in abrogating this interaction within UHRF1 to 
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open up the protein for increased specificity. Other reports have identified USP7 as 
aiding in this “opening up” regulation for UHRF1 binding to chromatin (Zhang et al, 
2015). What the current study implies, is that upon binding to chromatin through the 
TTD-PHD region and the PBR, these domains lose contacts with each other to instead 
make contacts to the nucleosome core particle, rather than having a specific regulatory 
effect. This was the case for mono-nucleosomes and other chromatin substrates. This 
was not, however, observed with other binding partners such as USP7 (Fig. 5.9) or 
UbcH5a (see Chapter 6) despite this basic region (PBR) potentially being involved in 
the interaction. Whether this is relevant for the regulatory mechanisms for binding to 
specific chromatin is unclear as this was mostly with unmodified histone H3 and un-
methylated CpG DNA. It is possible that the background binding to unmodified 
nucleosomes via the PHD-finger and PBR out-competes some of the more subtle and 
specific interactions between the TTD and H3 when H3K9me2/3 is present for 
instance. 
 
A caveat of using the XL-MS in this way is that in solution, UHRF1 +/- chromatin is 
possibly quite flexible and dynamic with respect to the intra- and inter-molecular 
interactions. The binding assays suggest that UHRF1 binds quite strongly to chromatin 
but it is likely to be an on/off equilibrium. Therefore, the XL-MS output is likely to be an 
average of the different conformations of UHRF1 with chromatin. Although on average 
the most abundant conformation will be observed, other minor conformations will also 
be present so conclusions need to be taken with caution. However, some suggestions 
(as discussed above) can be drawn to provide a hypothesis for future studies. 
 
One example of these dynamic conformations can be observed when looking at the 
crosslinks between the UBL-domain and other regions of UHRF1. The function of the 
UBL-domain within UHRF1 has not been completely elucidated despite it being quite 
conserved across species and present in UHRF2. From the binding studies (see 
Chapter 4), the UBL-domain does not seem to directly contribute to regulating 
nucleosome binding specificities. However, there are extensive crosslinks detected 
between the UBL-domain and several other regions within UHRF1, including the TTD, 
PHD-finger, the SRA-domain and the PBR. Therefore, in the absence of chromatin, 
UHRF1, and in particularly the UBL-domain, appears to be folding back onto the 
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“chromatin-binding” module in solution, forming a variety of contacts. Since many 
dead-end contacts are detected for the exact same lysine residues, this indicates that 
these contact sites are also likely solvent-exposed regions. These contacts are 
therefore probably quite weak and dynamic as the isolated UBL-domain in-trans (Fig. 
5.9a) is unable to stably bind to UHRF1. In the context of nucleosome substrate, some 
of these crosslinks are not detected indicating some reduced flexibility once bound but 
not completely due to the presumed on/off equilibrium. This might be a reason for the 
lack of a known full-length structure of UHRF1 neither with nor without chromatin as 
crystals would be quite difficult to form and homogeneous EM particles might be 
difficult to produce. It is likely that these intra-molecular contacts are quite transient 
and dynamic rather than being stable entities and may not have a direct role in the 
binding of UHRF1 to chromatin. There have been PTMs reported near the N-terminus 
such as S108 phosphorylation (Chen et al, 2013b) but none directly within the UBL-
domain that might influence the function of UHRF1. Whether other PTMs within 
UHRF1 (e.g. S652 phosphorylation) restrains some of these dynamic contacts could 
be investigated using this technique however. 
 
Investigating the inter-molecular contacts of UHRF1 in the presence of other factors 
like chromatin is possible using XL-MS. For nucleosome-bound complexes, crosslinks 
between histones and neighbouring partners can also be determined. Despite being 
Lys-/Arg-rich, the lysine-reactive cross linker used in this study enables a form of 
protection against trypsin digestion (similar to propionic anhydride) for those histone 
peptides that are crosslinked. This enables the detection of the contact sites on 
histones, which are usually difficult to study by mass spectrometry. In this study, 
crosslinks were detected primarily between the PHD-finger and SRA/PBR-region and 
histone H3 N-terminus with additional crosslinks formed to H2A (primarily C-terminus), 
H2B and H4 (N-terminus) from UHRF1. From this, it seems clear that the PHD-H3 
interaction previously reported is dominant with respect to histone binding. Further 
contacts to the PBR indicate that this basic region also contacts histones in the context 
of nucleosome substrates. When these crosslinked sites are mapped onto the 
structure of the nucleosome (Fig. 5.11), many of the contacts are close to the DNA 
entry-/exit-site. The crosslinks from the PBR to H2A/H2B are nearer the C-/N-termini, 
respectively, which suggests that these contacts are unlikely to be related to binding 
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to the acidic patch (e.g. H2A E57 and H2B E116) on H2A/H2B in the context of the 
nucleosome. Although conclusions can be made regarding interacting regions in 
histone proteins, identifying structural information might be difficult using XL-MS with 
chromatin-bound complexes. Nucleosomes are made up of an octamer of two of each 
of H2A, H2B, H3 and H4. Therefore, caution needs to be taken interpreting crosslinks 
between UHRF1 and histone peptides as they could be from the same or sister 
histones within the same nucleosome core. Furthermore, if more than one nucleosome 
core exists (e.g. in 12x187bp arrays), it is plausible that contacts exist between UHRF1 
and adjacent nucleosomes so forming crosslinks to histones in different core particles. 
Therefore, it would be difficult with the current knowledge to apply this crosslinking 
data to gleam reliable and physiologically relevant structural information for UHRF1 
bound to nucleosome core particles. With other structural or biophysical data in 
addition to detailed modelling approaches, this might prove useful and this is 
something that is being undertaken (see Chapter 7 regarding the preliminary EM work). 
The data analysis in this study was carried out using an FDR of 5% with little manual 
validation of the detected crosslinks due to the volume of contacts observed. For 
downstream structural analysis, it would be necessary to more stringently assess the 
crosslinks formed with respect to the identification. 
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In addition to primarily investigating UHRF1 in the presence of chromatin substrate, 
another UHRF1 interacting partner that was tested was the de-ubiquitylase, USP7. 
The interaction has been reported to regulate UHRF1 at the protein level (Felle et al, 
2011; Ma et al, 2012) whilst also regulating UHRF1 binding to chromatin (Zhang et al, 
2015). The binding of USP7 to UHRF1 was observed in this study (Fig. 5.9a) and XL-
MS experiments were performed. The interaction was previously observed to occur 
between the PBR of UHRF1 and UBL2-UBL3 of the TUD (tandem UBL-domain) within 
USP7 and this was shown using tagged fragments of each protein before solving a 
crystal structure of UBL2-UBL3 of USP7 with a short PBR peptide from human UHRF1 
(Zhang et al, 2015). From the current study, UHRF1 bound to USP7 produced 
crosslinks between the SRA/PBR region and the UBL-domain of UHRF1 and UBL3-
UBL4 of the TUD-domain. The latter interaction is almost in agreement with previous 
reports indicating an interaction between the basic region in the PBR and UBL2-UBL3 
in the TUD-domain. The crosslinks from the UBL-domain could be as a result of the 
intra-molecular architecture of UHRF1, putting the UBL-domain in close proximity to 
the PBR. Other intra-molecular contacts within UHRF1 were not affected. This included 
crosslinks between the TTD and the PBR that were reduced or not detected within 
UHRF1 in the presence of chromatin. This suggests that the molecular architecture of 
UHRF1 in the context of different interaction partners (e.g. chromatin or USP7) is 
altered. Within USP7, intra-molecular crosslinks are observed such as between the 
catalytic domain with UBL3/4/5 and the C-terminus. C-terminal activation of USP7 has 
been reported (Rougé et al, 2016) that regulates its activity and explains why it is more 
active as a full-length protein than the catalytic domain in isolation. The molecular 
details for USP7 DUB activity were not investigated in detail in this study. USP7 has 
been reported to bind to other heterochromatin-related proteins such as MBD4 (Meng 
et al, 2015) that might be connected to UHRF1 and DNMT1-mediated maintenance 
methylation. These interactions are likely to be involved in recruiting the DUB activity 
to specific regions of chromatin for regulating factors at the protein level.  
 
In summary, the XL-MS experiments described indicate that the intra-molecular 
conformation of UHRF1 is complex and is altered in the presence of chromatin. 
Contacts identified between UHRF1 and histones in the context of nucleosomes 
include the PHD-finger binding to unmodified histone H3 and between the SRA/PBR 
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and histones. No substantial differences were observed with pre-existing histone or 
DNA modifications but these subtle differences might be difficult to detect in bulk 
assays. However, the crosslinks formed between the PBR and histones do implicate 
this basic region in contacting nucleosomes, correlating with binding data from Chapter 
4. The reduction in detected crosslinks between the TTD and the PBR suggest an 
“opening up” of UHRF1 upon binding to chromatin that has been hinted at in previous 
studies. The XL-MS techniques may also detect weak or transient contacts within and 
between proteins. This has allowed us to detect multiple contacts involving the UBL-
domain. The UBL-domain does not directly affect chromatin binding (see Chapter 4), 
nor can it form stable contacts to UHRF1 in-trans (Fig. 5.9a). In the presence of 
chromatin and USP7, the UBL-domain forms crosslinks to these binding partners as 
well. Despite robust detection of interactions involving the UBL-domain by XL-MS, the 
function of these dynamic contacts is not clear and requires further investigation. 
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Chapter 6 
6. UHRF1 E3-ubiquitin ligase activity 
The presence of a conserved RING E3-ubiquitin ligase domain towards the C-terminus 
of UHRF1 indicates a key functional role for this domain and several studies have 
reported RING-dependent E3 activity of UHRF1, particularly targeting histone 
substrate. The crosslinking/mass spectrometry and binding experiments highlight a 
complex interplay between the annotated domains within UHRF1 and one hypothesis 
is that this intra-molecular architecture might play a role in the E3 activity, the 
mechanisms of which are still relatively unknown. 
 
Two recent studies have identified UHRF1-dependent histone H3 ubiquitylation that is 
thought to occur at DNA replication forks to recruit DNMT1 for processive maintenance 
methylation (Nishiyama et al, 2013; Qin et al, 2015). This work has concentrated on 
the site of ubiquitylation in Xenopus interphase egg extracts and mammalian cells 
(H3K18 and/or H3K23) in addition to its subsequent binding to DNMT1. Another recent 
investigation (Harrison et al, 2016) attempted to further probe the E3 reaction 
mechanism of UHRF1 on histone H3 peptides. In this case, it was found that the 
presence of a molar excess of hemi-methylated DNA oligonucleotides increased E3-
ubiquitin ligase activity on H3 peptides and mono-nucleosomes purified from HeLa 
cells. This allosteric activation may be important with respect to UHRF1 but whether 
this situation occurs within the cell is unclear. It would be more informative if a more 
physiologically relevant chromatin substrate in-cis were able to stimulate the E3 
activity. As a result, there is currently little information on the enzyme mechanism of 
the RING-domain of UHRF1. Information such as the target substrate and functional 
role of this activity have only been alluded to recently, much less the natural E2-
conjugating enzyme or the precise mechanistic details for ubiquitin transfer. 
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6.1 Development of an in vitro UHRF1-dependent E3-ubiquitin ligase assay 
To answer some of the outstanding questions regarding the inherent E3 activity of 
UHRF1, an in vitro assay was set up using purified constituents (see Materials and 
Methods for more details). Recombinant mouse UHRF1 was used as the E3 enzyme 
with His6-UBE1 as the E1-activating enzyme. Previous work using PRC1 components 
and the recent Harrison et al. study used UBE2D3 (UbcH5c) as the E2 enzyme. To 
investigate the activity of UHRF1, an E2 enzyme starter kit (Boston Biochem) 
containing ten different E2-conjugating enzymes was used (Fig. 6.1). Without 
knowledge of the suitable chromatin substrate for UHRF1 activity, an auto-
ubiquitylation assay was set up and UHRF1 auto-ubiquitylation used as a readout for 
E3 activity. The resulting reaction products were probed for ubiquitylation adducts by 
Western blot and two E2 enzymes produced UHRF1 auto-ubiquitylated product as 
indicated by a strong formation of high-molecular weight conjugates. These were both 
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UbcH5 family members that are known to be quite promiscuous E2-conjugating 
enzymes. UbcH5a and UbcH5b (UBE2D1 and UBE2D2) both produced a smear at 
higher molecular weights of auto-ubiquitylated UHRF1. The disappearance of the full-
length, unmodified UHRF1, as indicated in the Coomassie Brilliant Blue-stained gel, 
shows that these high-molecular weight conjugates are poly-auto-ubiquitylated UHRF1 
species rather than polyubiquitin chains formed in the reaction. UbcH5a was chosen 
out of the two after repeats of these experiments with a smaller sub-selection of active 
and inactive E2 conjugating enzymes (data not shown). UbcH5c produced a band of 
what could be mono-ubiquitylated UHRF1. Whether this was due to reduced activity 
or just reduced poly auto-ubiquitylation was not investigated further.  
 
6.2 UHRF1 E3-ubiquitin ligase activity is stimulated on longer arrays of 
chromatin 
Following on from identifying an active E2-E3 pair for UHRF1 E3 activity, reconstituted 
chromatin substrates were used to see if histones could be ubiquitylated in this assay. 
Given previous information about H3K18 and H3K23 ubiquitylation, slower migrating 
species of histone H3 due to H3 ubiquitylation were probed for by Western blot. The 
E3 assay was tested on nucleosome core particles using nucleosomal DNA with one, 
two, four or up to 12 repeats of the 601-nucleosome positioning sequence with 
approximately 50 bp linker lengths. No activity was seen on mono-, di or tetra-
nucleosomes but surprisingly, the E3-ubiquitin ligase activity of UHRF1 was stimulated 
in the presence of longer chromatin arrays (Fig. 6.2a). Auto-ubiquitylation was 
increased in the presence of the longer chromatin substrate (12x187bp arrays) and a 
slower-migrating band of H3 was detected by Western blot probed for the presence of 
histone H3. This band was present at a molecular weight of approximately 25 kDa, 
which indicates potential mono-ubiquitylation on histone H3, whilst a weaker band 
migrating at approximately 35 kDa might be di-ubiquitylated H3. Whether this was a 
second ubiquitin on a different lysine on H3 or a di-ubiquitin chain is unclear but later 
experiments (Fig. 6.6a) indicate that it is likely to be two ubiquitin moieties on two 
different lysine residues as both bands form when using a no K-ubiquitin mutant. 
Activity was dependent on a functional RING-finger, as the catalytically-dead mutant 
H730A (causing a disruption in coordinating Zn2+ ions for correct domain folding) 
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remained inactive in these assays. Further assays and repeats indicated ATP-
dependent activity (Fig 6.2b). There is, however, not complete conversion of the 
histone to ubiquitylated histone and stoichiometric amounts of UHRF1 are added to 
the reaction. However, over a time-course, more H3 is converted to H3-ub (Fig. 6.2d) 
and the activity is UHRF1 concentration-dependent (Fig. 6.2c).  
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The increased activity on longer chromatin arrays may imply that the RING-finger has 
quite low basal E3 activity but in the presence of multiple nucleosome cores, a 
conformational change in the E2~Ub/UHRF1/chromatin complex may enhance 
ubiquitin transfer from the E2 to the target substrate. Whether this is due to an 
increased local concentration of histone target or because of an allosteric regulatory 
mechanism for UHRF1 E3 activity is unclear. 
 
6.3 Effect of magnesium chloride concentration on UHRF1 E3 activity 
As part of the ubiquitin ligase assay, magnesium chloride is added in combination with 
ATP to activate the E1 enzyme for ubiquitylation to occur. Preparation of the 12x187bp 
arrays for these assays utilises a magnesium chloride precipitation step to purify them 
away from free DNA and competitor mono-nucleosomes. To check that activity is not 
dependent on having high or excess levels of magnesium present in the reaction, 
leading to precipitation of arrays and alteration of the substrate, reduced magnesium 
chloride concentrations were used whilst keeping the amount of ATP the same (Fig. 
6.3a). Low levels of Mg2+ ions (1 mM) result in reduced E3 activity but this could be as 
a result of reduced activation of ubiquitin by the E1-activating enzyme due to Mg-ATP 
not being available for the reaction. At higher or intermediate Mg2+ concentrations (2.5 
or 5 mM), E3 activity is observed with the suggestion that at higher Mg2+ levels, 
UHRF1-mediated ubiquitylation was reduced. Furthermore, to check how the 
ubiquitylated arrays respond in solution to magnesium and E3 activity, the assay was 
centrifuged, similar to the arrays post-dialysis during the chromatin preparation, to test 
if the ubiquitylated histone substrate precipitates or stays in solution (Fig. 6.3b). 
Whereas the chromatin array appears to predominantly stay in solution, the auto-
ubiquitylated UHRF1 almost completely precipitates in the reaction. Whether this is 
relevant for the biological activity of the protein or an artefact of the in vitro assay design 
is unclear. The precipitated fraction of 12x187bp chromatin arrays observed could 
potentially co-precipitate with UHRF1 (wildtype and H730A). 
 
 123 
 
 
6.4 Identifying the sites of UHRF1-dependent histone ubiquitylation 
To further validate that it was histone H3 ubiquitylation and to check if other histones 
were also modified by UHRF1, the reaction products were identified by a mass 
spectrometry approach (Fig. 6.4a). E3 assays were performed in the presence of 
25x197bp arrays and instead of probing for activity by Western blot, the reactions were 
run on a 15%SDS-PAGE gel and the band(s) at 25 kDa and ~35 kDa were excised 
and processed for identification of ubiquitylation by mass spectrometry (Exp 1, 
b016p026). Given the high propensity of lysine residues within histones, the gel pieces 
were treated with two consecutive rounds of propionylation to protect the lysine 
residues before in-gel trypsin digestion and acid extraction of peptides. Using trypsin 
as the protease enabled identification of modified sites by searching against peptides 
with a di-glycine (GG) motif at lysine residues. A derivative of this GG motif is the LRGG 
motif that could arise from a missed cleavage within the ubiquitin modification and was 
also used to search for possible ubiquitylated species. 
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The resulting modified peptides were predominantly from the N-terminal tail of histone 
H3, including Lys-9, Lys-18, Lys-23, Lys-27 and Lys-56 (Fig. 6.4b, c and Appendix 2). 
Ubiquitylation at Lys-9, Lys-18, Lys-23 and Lys-27 were more abundant than the 
modification event at Lys-56. Despite some of the modified lysine residues being 
present on the same peptide (e.g. K9 and K14, K18 and K23), no doubly modified 
peptides indicating multiple ubiquitylation events on these lysine residues in the same 
histone could be detected in either of the bands at ~35 kDa. Modifications on ubiquitin 
were identified in the bands excised at ~35 kDa (Lys-48 and Lys-63) but it was 
inconclusive if these were di-ubiquitin marks resulting from a modified histone or 
polyubiquitin chains formed in the reaction. These target residues match with some of 
those identified in other studies, particularly K18 and K23 ubiquitylation. Other lysine 
ubiquitylation events such as K27 were also identified in the study by Harrison et al. 
indicating that the E3 assay with mouse recombinant UHRF1 has a broad specificity 
for the N-terminus of histone H3 but it is unclear if some of these sites could be an 
artefact of the in vitro assay design.  
 
Further experiments were performed that used modified chromatin substrate in the 
assay (such as H3K9me3 and/or DNA CpG methylation in the context of chromatin 
12x187bp arrays) to see if the presence of specific chromatin marks induced a change 
in the target ubiquitylation (Fig. 6.4a, Exp 2, b015p030). Results from this indicated no 
change in the sites of modification (with the exception that H3K9me3 prevented 
ubiquitylation at this residue). Whether there was a change in the relative amounts (i.e. 
increased propensity to modify a particular residue) in the reaction is unclear although 
H3K18 and H3K23 ubiquitylation events seem to be the most abundant in all samples 
tested based on the MaxQuant analysis of the abundance of modified peptides (see 
Materials and Methods). Furthermore, there was no clear increase in activity in the 
presence of either H3K9me3 or DNA CpG methylation. Using a more robust method 
for analysing the reaction kinetics might reveal some differences but using the current 
mass spectrometry or Western blot output, no discernible differences could be 
observed.  
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Another product of the E3 assay was UHRF1 auto-ubiquitylation. This reaction product 
also seemed to increase in the presence of chromatin arrays indicating a general 
enhancement of RING-mediated ubiquitin transfer from UbcH5a to the substrate, 
whether that be H3 or UHRF1. UHRF1 has been observed to be regulated in a cell-
cycle dependent manner with M-phase regulated proteasomal degradation of UHRF1 
at the protein level. CDK-dependent phosphorylation of S652 in UHRF1 is thought to 
abrogate binding to the de-ubiquitylase (DUB) USP7 at M-phase, resulting in 
polyubiquitylation and subsequent degradation (Ma et al, 2012). It is yet unknown 
whether UHRF1 auto-ubiquitylates itself or whether another E3 enzyme carries out this 
ubiquitylation to target UHRF1 for degradation.  
 
In addition to identifying the sites of H3 ubiquitylation therefore, a similar protocol was 
used to identify UHRF1 auto-ubiquitylated residues (Fig. 6.4a, Exp 3, b015p047). In 
this case, lysine residues were not propionylated but cysteine residues were capped 
with iodoacetimide prior to trypsin digestion. Ranges of ubiquitylated residues within 
UHRF1 were identified in this case with increased relative amounts in the presence of 
chromatin substrate, similar to what was seen by Western blot analysis. The sites 
seem to be concentrated around three regions of UHRF1 – the UBL-domain, the linker 
between the PHD-finger and the SRA-domain and the PBR (Fig. 6.4b, c). Lys-63-linked 
ubiquitin was also detected. It is unclear how informative these sites are as the auto-
ubiquitylation activity of UHRF1 is possibly a result of the general E3 activity of UHRF1 
and modifications in this case are probably non-specific as is usually the case for poly-
auto-ubiquitylation and targeting proteins for proteasomal degradation. What it might 
inform us about, however, is what regions/areas of UHRF1 are available to be modified 
by the RING-domain. Relating this back to the XL-MS data may indicate solvent-
exposed regions and which domains are in close proximity with respect to the RING-
finger and UbcH5a. 
 
An important aspect of the E3 assay is that it is specific with respect to UHRF1 E3 
activity on histone H3 N-terminal tails as no ubiquitin modifications were found on other 
histones. Many E2-E3 pairs using the UbcH5 family members tend to non-specifically 
modify the target substrates so identifying biologically reported ubiquitylation sites in 
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addition to other potential target sites in an in vitro assay is important in trying to probe 
for mechanistic details of the reaction itself.  
 
 
 
6.5 A function for the N-terminal UBL-domain in UHRF1 E3 activity 
In parallel to investigating the binding of several UHRF1 fragments and mutants to 
modified chromatin (see Chapter 4), the E3-ubiquitin ligase activity of the mutants was 
tested using the assay described here. Preliminary UHRF1 auto-ubiquitylation 
experiments without chromatin substrates (Fig. 6.5a) revealed that UHRF1 without the 
C-terminal RING-finger was inactive (Fig. 6.5a, DRING/linker, DRING and 118-621). 
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Surprisingly, UHRF1 without the N-terminal UBL-domain were also inactive (Fig. 6.5a, 
DUBL). At very high exposure, minimal E3 activity could be detected by Western blot 
on UHRF1 for the DUBL fragment. The DUBL fragment similarly showed no activity in 
E3 assays using 12x187bp chromatin arrays (Fig. 6.5b).  
 
From the binding assays described in Chapter 4, deletion of the UBL-domain appeared 
to have little direct effect on the interaction between UHRF1 and nucleosome substrate 
but rather showed increased affinities, so the reduced detected activity cannot easily 
be explained by reduced binding to the substrate. Crosslinking/mass spectrometry 
(XL-MS) data (see Chapter 5) indicate that the UBL-domain within UHRF1 forms weak 
and transient contacts to other regions of UHRF1, including to the TTD, the PHD and 
SRA-domains, and the polybasic region (PBR) close to the RING-finger. It might be 
plausible that these contacts could indirectly affect chromatin binding (Chapter 4, Fig. 
4.5) in addition to the E3 activity of UHRF1. 
 
The UHRF1 PBR mutant (triple K>Q mutation; K644Q/K646Q/K648Q) was also tested 
in E3-ubiquitin ligase assays (Fig. 6.5c). The PBR has been implicated in binding to 
other biological molecules such as PI(5)P (Gelato et al, 2014) and USP7 (Zhang et al, 
2015) to regulate the binding of UHRF1 to chromatin and specific modifications such 
as H3K9me2/3. In this study, it is suggested that the PBR may play a role in relatively 
non-specific binding to nucleosomes and chromatin substrate (see Chapter 4). The 
reduced E3 activity of the DUBL fragment and the crosslinks observed between this 
domain and the PBR in the absence or presence of chromatin might indicate that the 
intra-molecular arrangement of UHRF1 is critical for histone ubiquitylation. The PBR 
mutant indeed showed reduced UHRF1 auto-ubiquitylation in addition to reduced H3 
ubiquitylation (Fig. 6.5c). However, activity is not completely lost. Reduced binding of 
the PBR mutant to nucleosomes (see Chapter 4), means it is difficult to conclude if this 
reduced E3 activity is due to a role of this basic region in the reaction mechanism or is 
just because of reduced binding to the substrate that in turn, leads to reduced 
stimulation of the ubiquitin transfer from E2~Ub to H3/UHRF1.  
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6.6 The effect of poly-auto-ubiquitylation on UHRF1 E3 activity 
A possible mechanism for the stimulation of E3 activity towards histone H3 is that 
processive poly-ubiquitylation of UHRF1, induced by longer chromatin arrays, may 
play a role in stimulating subsequent histone ubiquitylation activity. These polyubiquitin 
chains may help initiate ubiquitylation of the target substrate and this involvement of 
polyubiquitin chain formation activation of E3 ligases has been described (Mallery et 
al, 2002). To test this, a “no K” variant of ubiquitin with all seven lysine residues 
mutated to arginine residues to abrogate the possibility for polyubiquitin chain 
formation was used in the E3 assay (Fig. 6.6a). Ubiquitylation of the UHRF1 lysine 
residues reach saturation when compared with the wild-type ubiquitin variant indicating 
poly-mono-ubiquitylation with the no K-ubiquitin. Importantly, H3 ubiquitylation is still 
detected to the same extent as the wildtype protein. Therefore, polyubiquitin chain 
formation is not required for UHRF1 E3 activity on histone H3, but this does not rule 
out that specific mono-ubiquitylation or poly-mono-ubiquitylation is involved. It is 
interesting that H3 di-ubiquitylation is still detected in this assay using no K-ubiquitin, 
supporting the idea that it is the presence of multiple mono-ubiquitylated sites on the 
same histone H3 rather than the start of a polyubiquitin chain.  
 
6.7 The UBL-domain needs to be in-cis to stimulate UHRF1 E3 activity 
In Chapter 5 it was demonstrated that the UBL-domain makes contacts to other regions 
within UHRF1 but that these contacts seem to be weak as no stable binding of UHRF1 
to the UBL-domain could be observed (Chapter 5, Fig. 5.9a). Therefore, it could be 
that the transient interacting behaviour of the UBL-domain and other parts of UHRF1 
could stimulate the E3 activity of the RING-finger whilst not directly affecting the 
binding to chromatin. These interactions can potentially be in-trans (i.e. inter-molecular 
contacts between separate UHRF1 molecules) or in-cis (i.e. intra-molecular contacts 
within the same UHRF1 molecule). To test this, the wildtype, DUBL and H730A UHRF1 
variants were tested with or without a molar excess of His6-tagged UBL-domain in E3 
assays (Fig. 6.6b). However, the E3 activity of the DUBL fragment could not be rescued 
with the added separate UBL-domain whilst the E3 activity of the wildtype UHRF1 was 
not enhanced. This indicates that the UBL-domain needs to be appropriately 
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positioned in the context of full-length UHRF1 (i.e. intra-molecular) to have a 
stimulating role in its E3 activity.  
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To confirm that the UBL-domain needs to be attached to the rest of the protein to 
stimulate the E3 activity of UHRF1, a further complementation experiment was carried 
out in which equimolar mixtures of UHRF1 fragments were tested in E3 assays (Fig. 
6.6c). It might be possible that during a potential transient dimer formation a UBL-
domain from a neighbouring UHRF1 molecule can replace the missing UBL-domain of 
the DUBL fragment to stimulate its E3 activity. In this assay however, there was no 
rescue of the E3 activity of the DUBL fragment by a UBL-containing but RING-
catalytically inactive molecule of UHRF1 (Fig. 6.6c, lane 6 with a mixture of DUBL and 
H730A). Furthermore, wildtype UHRF1 could not do likewise as the level of H3 
ubiquitylation as analysed by Western blot was not increased for the mixture of 
wildtype and DUBL compared with the mixture of wildtype and H730A catalytically-
dead mutant (Fig. 6.6c, lanes 4 and 5). Therefore, the UBL-domain needs to be present 
in the context of full-length UHRF1 to stimulate its E3-ubiquitin ligase activity on 
chromatin.  
 
6.8 Binding of UHRF1 to UbcH5a is observed in the presence of 12x187bp arrays 
and the UBL-domain contributes to the binding 
It is clear from this study that the UBL-domain within UHRF1 is necessary to stimulate 
the E3-ubiquitin ligase activity towards chromatin. The mechanism for this is unclear, 
however. The XL-MS and binding data (Chapters 4 and 5) indicate that the UBL-
domain participates in transient interactions with other regions within UHRF1 that are 
likely to be weak contacts. It could be that the in the presence of an E2-conjugating 
enzyme, the UBL-domain can contact the E2 protein and stabilise the E2-E3 
interaction in the context of chromatin to stimulate ubiquitin transfer. These 
involvements of the UBL-domains and ubiquitin itself in activating E2 enzymes has 
been described (Hibbert et al, 2011; Wright et al, 2015). To test the binding of UHRF1 
(wildtype and other fragments) to the E2 enzyme (UbcH5a), a GST-tagged E2 protein 
was immobilised on glutathione beads (see Materials and Methods) and incubated with 
UHRF1 with or without chromatin (Fig. 6.7a). In the absence of chromatin, there is no 
specific interaction between UHRF1 and GST-UbcH5a (lanes 1 and 2, Fig. 6.7). The 
same is true for chromatin in the absence of UHRF1 (lanes 9 and 10, Fig. 6.7a). 
However, GST-UbcH5a can bind to both UHRF1 and chromatin (12x187bp array) 
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when both are present (lanes 11 and 12), suggesting the formation of a stable 
UbcH5a/UHRF1/chromatin substrate complex. The binding of wildtype and mutant 
UHRF1 to UbcH5a in the presence of chromatin was quantified using ImageJ for three 
independent experiments (see Materials and Methods) to investigate the relative 
binding of the truncated fragments of UHRF1 (Fig. 6.7b). Removal of the RING/linker 
region (lanes 15 and 16) reduced binding to approximately 16% compared to the 
wildtype whereas removal of the UBL-domain reduced binding to UbcH5a to ~50% of 
that of wildtype UHRF1 (lanes 13 and 14). Removal of both domains seemed to have 
an additive effect on the reduction of binding to UbcH5a (~5% wildtype, 118-621, lanes 
17 and 18). The RING-finger of E3-ubiquitin ligases binds to the E2~Ub to stimulate 
transfer of ubiquitin to the substrate so this steep reduction in binding is as predicted. 
The ~50% reduction in UHRF1-UbcH5a binding upon removal of the UBL-domain, 
suggests that the UBL-domain plays a role in binding to the E2 in conjunction with the 
RING-finger in the context of chromatin. However, the relatively small reduction in 
binding cannot explain the almost complete loss of E3 activity of UHRF1 in the absence 
of the UBL-domain. 
 
The binding of UHRF1 and chromatin to UbcH5a only when both are present could 
play a critical role in the E3 reaction mechanism. It is clear from this work that UHRF1 
E3 activity is stimulated on longer arrays of chromatin, despite UHRF1 being capable 
of binding mono-, di- and tetra-nucleosomes with similar affinity (see Chapter 4). It 
might be possible that it is the particular folding of 12x187bp arrays with multiple 
nucleosome core particles in close proximity that can stimulate RING-dependent E3 
activity of UHRF1 in the presence of the E2-conjugating enzyme. This conformation 
may then enhance the binding between the E2, E3 and substrate. To test this, GST-
binding assays similar to those described above were carried out with UHRF1 only or 
in the presence of mono-, di- and tetra-nucleosomes or with 12x187bp arrays (Fig. 
6.7b, c). Interestingly, UHRF1 in the presence of mono-nucleosomes (Fig. 6.7c, d), di- 
and tetra-nucleosomes (Fig. 6.7d) could not bind to UbcH5a, with UHRF1 binding only 
observed alongside the 12x187bp array. UHRF1 binding to UbcH5a in the absence of 
chromatin is hardly detectable. This information corroborates with the E3 assays (Fig. 
6.2) where UHRF1 ubiquitin ligase activity is stimulated in the presence of 12x187bp 
arrays but not with shorter lengths of chromatin. This suggests that there exists some 
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form of cooperativity in binding to the substrate by the E2-E3 pair and the formation of 
an active E2/E3/substrate complex, but only when a suitable chromatin substrate is 
present. Whilst this binding/E3 activity information correlates well, the precise 
mechanisms involved are likely to be more complex. The conformation of the 
12x187bp array could be a reason behind the stimulated activity enabling productive 
ubiquitin transfer but it could also be explained by a high local concentration of 
nucleosomes, resulting in enhanced binding by UHRF1/UbcH5a and increased H3 
ubiquitylation.  
 
6.9 Crosslinking/mass spectrometry of UHRF1 with UbcH5a in the context of 
chromatin 
To investigate how UHRF1, UbcH5a and chromatin are orientated with respect to each 
other in the E2/E3/substrate complex, crosslinking/mass spectrometry (XL-MS) 
experiments were carried out. The binding experiments (Fig. 6.7) suggest that the 
UBL-domain partially contributes to the binding of UHRF1 to UbcH5a in the presence 
of 12x187bp arrays but this cannot explain the sharp reduction in E3 activity. 
Therefore, it is likely that the UBL-domain has an allosteric effect on the ubiquitin 
transfer from E2~Ub to histone H3. Knowing the contact points between UHRF1, 
UbcH5a and histones in the E3 reaction may aid in investigating this. As no overall 
structures are available of the components in the context of this specific E3 reaction, 
knowing which regions of the proteins are in close proximity to each other might give 
some indication as to whether the increased activity is due to an altered interaction 
interface or an allosteric contribution of the substrate or other domains within UHRF1.  
 
UHRF1 was crosslinked with isotope-labelled BS3 (see Materials and Methods and 
Chapter 5) in the presence of UbcH5a +/- chromatin (12x187bp array, Fig. 6.8a, b). 
Although the interaction between UHRF1 and UbcH5a was quite weak, it would 
provide a good comparison to investigate how the presence of chromatin alters this 
interaction or conformation. Therefore, the XL-MS data of UHRF1 with chromatin 
would also provide another control. 
 
 135 
 
 
Information on the intra-molecular crosslinks in UHRF1 and crosslinks between 
UHRF1 and histones are described in much more detail in Chapter 5. XL-MS data of 
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UHRF1 with UbcH5a (Fig. 6.8a) show that the intra-molecular crosslinks within UHRF1 
are unaffected, with contacts between the UBL-domain and other domains (TTD, PHD, 
SRA and PBR), between the TTD and the PBR and between the PHD-finger and the 
SRA-domain/PBR as in the wildtype UHRF1 protein. There is an inter-molecular 
crosslink detected between the SRA-domain of UHRF1 and the N-terminus of UbcH5a. 
In the presence of 12x187bp arrays (Fig. 6.8b), the intra-molecular contacts within 
UHRF1 are altered (see Chapter 5) with a loss of detectable crosslinks between the 
TTD and the PBR whilst other crosslinks remain relatively unaffected. Furthermore, 
inter-molecular contacts between UHRF1 and histone proteins in the context of 
12x187bp chromatin arrays resemble those of UHRF1 with chromatin in the absence 
of UbcH5a (see Chapter 5).  
 
The contacts within UHRF1 and between UHRF1 and chromatin therefore do not seem 
to be altered in the presence of E2-conjugating enzyme. However, there are additional 
contacts to UbcH5a from UHRF1 that are only detected in the context of 12x187bp 
arrays. The crosslink between the SRA-domain and the N-terminus of UbcH5a is still 
present with additional contacts detected between the C-terminus of UbcH5a and both 
the PBR and a region close to the UBL-domain of UHRF1. It is unclear if these are 
separate conformations or occur simultaneously due to the intra-molecular contacts 
within UHRF1. It does support, however, that the UBL-domain and the PBR play a 
critical role in the E3 reaction mechanism for UHRF1-mediated H3 ubiquitylation in the 
context of a suitable chromatin substrate. As mentioned above, this cannot be wholly 
explained by a binding role for the UBL-domain to interact with UbcH5a in the presence 
of 12x187bp arrays, but it is likely to also be an allosteric effect of these contacts to 
the E2-conjugating enzyme to enhance ubiquitin transfer to the target substrate. It is 
also possible that the contacts within the E2-E3-chromatin complex described here 
influence the target specificity for ubiquitylation by correctly positioning the E2~Ub for 
transfer to the H3 N-terminal tail. Further structural and biophysical experiments would 
need to be done to discern how these domains influence the E3 activity of UHRF1. 
Preliminary electron microscopy (EM) work using the 12x187bp arrays (Fig. 6.8c) was 
carried out to check the conformation of the arrays and their amenability for possible 
downstream structural applications (see Chapter 7). The arrays are approximately the 
expected size, and the nucleosome makeup is apparent, whilst not forming many 
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aggregates or unfolding. A suggestion for the enhanced UbcH5a-binding and 
increased E3 activity of UHRF1 on arrays might be the close-packing and a high local 
concentration of nucleosome core particles. This close-packing is evident here but 
more work needs to be done in this area. 
 
6.10 A possible role for the hydrophobic patch on the UBL-domain of UHRF1 
Ubiquitin and other ubiquitin-like molecules have multiple surfaces that are potentially 
involved in catalysis or in the formation and structure of longer chains of polyubiquitin. 
A region commonly involved in stimulating ubiquitylation of target substrates is the 
hydrophobic surface, the so-called “hydrophobic patch”, of ubiquitin. Isoleucine-44 is 
present within the hydrophobic surface and is commonly mutated to alanine to 
investigate the function of this region on ubiquitylation events (Komander & Rape, 
2012). A BLAST search and sequence alignment of the UBL-domain indicates that a 
phenylalanine (Phe-46), a highly hydrophobic amino acid, is present at the 
corresponding position in UHRF1. Since this residue is in a hydrophobic patch, it might 
have similar functions. To test this, the Phe-46 was mutated to alanine and the 
corresponding UHRF1 F46A mutant was tested in binding and E3 assays (Fig. 6.9). 
Binding to mono-nucleosomes was unaffected when compared to wild-type UHRF1 
and DUBL mutant (Fig. 6.9b). To check for binding to the 12x187bp chromatin array 
used as a substrate for the E3 assays, a chromatin binding EMSA was set up and it 
was verified that binding to the longer array is not affected by removing the UBL-
domain or by the F46A mutation (Fig 6.9c). However, the E3-ubiquitn ligase activity of 
the F46A mutant was reduced to a similar level as that seen in the DUBL mutant (Fig. 
6.9a). This reduction in activity is also accompanied by a reduced binding to UbcH5a 
in the context of 12x187bp chromatin arrays in GST-binding assays when compared 
with wild-type UHRF1 (Fig. 6.9d). This reduction to about 50% of that of wildtype is 
again similar to that seen with the DUBL mutant. This suggests that the hydrophobic 
surface of the UBL-domain is critical for the E3-ubiquitin ligase activity of UHRF1. It 
might be possible that this hydrophobic patch can contact the E2 enzyme (perhaps via 
the “backside” binding already discussed in the introduction) that stimulates transfer of 
ubiquitin from the E2~Ub to the substrate. However, this needs to be investigated with 
more direct structural evidence.  
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Whilst this identifies a potential functional role for the hydrophobic surface of the UBL-
domain of UHRF1, it does not fully explain the mechanism behind the stimulating effect 
of the UBL-domain on UHRF1 E3 activity in the context of chromatin. From XL-MS 
data, the UBL-domain is involved in dynamic intra-molecular contacts within UHRF1 
whilst also being partially involved in the binding to UbcH5a and possibly to 
allosterically enhance ubiquitylation of histone H3. To investigate how the F46A 
mutation affects some of these characteristics of the UBL-domain of UHRF1, XL-MS 
experiments were carried out. The F46A mutant in isolation still shows crosslinks 
between the UBL-domain and other regions within UHRF1 similar to the wildtype 
protein, indicating that the intra-molecular contacts within the full-length protein are 
relatively unaffected (Fig. 6.10a). Binding of the F46A UHRF1 mutant to chromatin was 
largely observed to be unaffected relative to the wildtype protein (Fig. 6.9b, c) but XL-
MS data of the F46A mutant with chromatin does see altered crosslinks between 
UHRF1 and histones (Fig. 6.10b). No crosslinks are observed between histone H3 and 
the PHD-finger although contacts are detected between H3 and the PBR. Crosslinks 
within histones seem unaffected, however. The crosslinking pattern for F46A with 
12x187bp arrays in the context of UbcH5a (Fig. 6.10d) indicates that F46A UHRF1-
chromatin contacts are altered with H2B and H3 forming crosslinks to the SRA/PBR 
region. There are no crosslinks between F46A UHRF1 and UbcH5a. Similar results 
are observed using the DUBL mutant UHRF1 with UbcH5a and 12x187bp arrays (Fig. 
6.10e). Furthermore, no crosslinks were detected between UHRF1 F46A mutant and 
UbcH5a in the absence of chromatin (Fig. 6.10c). The UHRF1 F46A mutant therefore 
seems to form altered contacts to chromatin using the XL-MS approach, despite no 
detectable difference in binding, whilst also not forming contacts to UbcH5a. The 
hydrophobic surface in the UBL-domain of UHRF1 is therefore likely to be important 
for allosterically activating ubiquitin transfer to H3/UHRF1 by making contacts with the 
E2-conjugating enzyme and chromatin in the formation of the E2/E3/substrate 
complex. 
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6.11 Discussion 
The function of the C-terminal RING-finger E3-ubiquitin ligase activity in UHRF1 has 
only recently been elucidated. UHRF1-mediated histone H3 ubiquitylation at Lys-18 or 
Lys-23 is reported to recruit DNMT1 to newly replicated DNA via a ubiquitin-interacting 
motif (UIM) within the RFTS-domain of DNMT1 (Nishiyama et al, 2013; Qin et al, 2015). 
Further work has implicated the de-ubiquitylase (DUB), USP7, in this mechanism and 
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as it has been reported to be bound to DNMT1 upon recruitment to newly replicated 
DNA to remove the H3-Ub mark, enabling processive maintenance methylation 
(Yamaguchi et al, 2017). The mechanism by which UHRF1 enzymatically places this 
mark on newly replicated chromatin, however, is unknown. A recent study (Harrison et 
al, 2016) found that the E3 activity of UHRF1 was stimulated upon the addition of hemi-
methylated oligonucleotides with activity not detected on mono-nucleosomes or 
histone H3 peptides otherwise. Whether this is the situation in a physiological context 
is unclear, but these findings point towards a stimulation of the E3 activity by allosteric 
mechanisms through the chromatin substrate. 
 
In this study, it was found that UHRF1 E3 activity is stimulated in the presence of longer 
arrays of chromatin (Fig. 6.2). Similar to previous studies, E3 activity on histone H3 
was not detected on mono-nucleosomes (either reconstituted or purified from 
mammalian cells, data not shown). It is unclear as to why activity is increased on a 
longer stretch of chromatin. A possibility is that there is a higher local concentration of 
nucleosome core particles with more histone H3 substrate in close proximity for 
ubiquitin transfer. Electron micrographs (Fig. 6.8c) of the 12x187bp chromatin array 
substrate indicate that the nucleosome cores are packed quite closely, which may not 
be the case for the shorter chromatin substrates used in this study. The high relative 
local concentration of nucleosomes in conjunction with the close packing of chromatin 
may play a role in this increased activity due to molecular trapping mechanisms. 
Binding assays with GST-tagged UbcH5a indicate that UHRF1 is able to bind the E2 
enzyme in the presence of longer chromatin arrays but barely any detectable binding 
was observed for UHRF1 in isolation or with mono-/di-/tetra-nucleosome substrate. It 
is possible that the close packing of chromatin and thus high local concentration of 
nucleosomes enhances the formation of an active UHRF1/UbcH5a/chromatin complex 
and facilitates ubiquitin transfer to nearby H3 substrate with several nucleosomes 
nearby. This could be an artefact of the in vitro chromatin formation. However, super-
resolution microscopy images of nuclei show relatively stochastic formation of strings 
of nucleosomes and transcriptionally active nucleosome-free regions adjacent to more 
compact nucleosome clusters that resemble the in vitro reconstituted chromatin (Wang 
et al, 2014c). Furthermore, heterochromatin regions within the genome tend to be 
much more compact and nucleosome dense. Perhaps UHRF1 binding to hemi-
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methylated CpG sites with H3K9me2/3 marks within heterochromatic regions makes it 
more likely to be localised to compact chromatin regions and therefore stimulating its 
E3 activity in the desired location soon after DNA replication.  
 
The assays described in this study were carried out mostly on unmodified chromatin, 
so without pre-existing H3K9me2/3 marks or DNA CpG hemi-methylation. The mass 
spectrometry experiment (Fig. 6.4, Exp 2) with H3K9me3 and/or DNA CpG methylated 
chromatin arrays indicated no clear differences in the level of ubiquitylated peptides 
between samples, with the exception that the H3K9me3 mark prevented ubiquitylation 
at this residue. Hemi-methylated long chromatin arrays were not made in this study 
due to the technical difficulties in making long hemi-methylated, repetitive DNA 
stretches such as the 12x187bp array. Therefore, no conclusions can be made from 
this work as to whether pre-existing chromatin modifications affect the E3 activity of 
UHRF1. Whether hemi-methylated DNA present in a nucleosomal array, rather than 
adding hemi-methylated DNA oligonucleotides as used in other studies (Harrison et al, 
2016), stimulates the E3 activity further would be interesting to investigate. Judging 
from the nucleosome binding studies, it is likely, however, that the hemi-methylated 
nature of the substrate is more relevant for increased binding of UHRF1 to chromatin 
(see Chapter 4). It might therefore be difficult to distinguish whether the increased 
activity on chromatin results from an allosteric increase in ubiquitylation activity or a 
greater likelihood of UHRF1 being present and bound to the substrate.  
 
The mass spectrometry data from previous studies in addition to this one indicate 
activity on the H3 N-terminal tail, predominantly on Lys-18 and Lys-23. UHRF1 binds 
to the N-terminal tail of histone H3 via the TTD/PHD-finger region with increased 
specificity to H3K9me2/3 marks. In the study by Harrison et al., UHRF1 was still able 
to modify H3 N-terminal peptides in the presence of hemi-methylated DNA. It is unclear 
whether UHRF1 modifies the equivalent H3 N-terminal tail that it is bound to or if it can 
ubiquitylate the sister histone H3 (i.e. within the same nucleosome core) or a H3 on a 
neighbouring nucleosome. The latter hypothesis might fit with the discussion above as 
to the increased E3 activity due to an increased local concentration of nucleosomes 
on 12x187bp arrays, perhaps enabling histone H3 ubiquitylation on the same and/or 
neighbouring nucleosome core particles. Whilst UHRF1 can bind to one nucleosome 
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core via its PHD-finger and PBR, it is perhaps plausible that it is able to modify a H3-
tail in the immediate vicinity, rather than the same H3-tail that it has bound. This might 
be difficult to investigate using the current in vitro setup. Structural information of 
UHRF1 bound to the 12x187bp arrays used in these E3 assays with UbcH5a would 
help as the proximity of the RING-finger of UHRF1 to neighbouring H3 tails could be 
observed, perhaps even in relatively low-resolution images. Another possibility is using 
heavy-/light-labelled histone H3 and “barcoded” nucleosomes in a mass spectrometry 
experiment to test whether neighbouring histone H3 tails are modified. 
 
The mechanisms for the transfer of ubiquitin from E2~Ub to the target substrate have 
recently been proposed to involve other domains or proteins in RING E3 protein 
complexes and non-donor ubiquitin moieties to ensure efficient ubiquitylation to occur. 
Furthermore, particularly with respect to histone ubiquitylation (e.g. H2AK119 for 
PRC1 ubiquitylation and H2A K13-15 for RNF168), the nucleosome substrate appears 
to play a crucial role in the reaction mechanism and the specificity for the modification 
site (McGinty et al, 2014; Mattiroli et al, 2014). The contribution of the chromatin 
substrate for UHRF1-mediated H3 ubiquitylation has been discussed above but other 
domains within UHRF1 are likely to play a role in its E3 activity. In a previous study 
(Harrison et al, 2016), hemi-methylated DNA was found to allosterically activate the E3 
activity on histone substrate, implying that the SRA-domain nearby contributes to the 
RING activity.  
 
In the current study, the removal of the N-terminal UBL-domain and a mutation at Phe-
46 in the hydrophobic patch of the UBL-domain (Fig. 6.11) drastically reduced the E3 
activity of UHRF1. The UBL-domain is well conserved in UHRF-family proteins but its 
function has so far not been reported on. The UBL-domain does not directly contribute 
to chromatin binding (Fig. 6.9). In XL-MS experiments, the UBL-domain seems to be 
very flexible as crosslinks are detected from itself to several other regions within 
UHRF1 such as the TTD, PHD-finger and the SRA/PBR. These contacts are likely to 
be weak and transient. Upon the addition of nucleosome substrate, the UBL-domain 
still forms crosslinks to the other regions within UHRF1 and also to histones that might 
imply that its conformation is still quite dynamic. Upon the addition of the E2-
conjugating enzyme, UbcH5a, to UHRF1 and chromatin arrays an additional crosslink 
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is detected between the N-terminal region of UHRF1 near the UBL-domain to the C-
terminus of UbcH5a. This suggests that in the context of 12x187bp arrays, the UBL-
domain of UHRF1 does form contacts to the E2-conjugating enzyme. Using GST-
UbcH5a binding assays, these contacts may partially contribute to the interaction 
between UHRF1 and UbcH5a in conjunction with the RING-finger (Fig. 6.7). However, 
the reduction in binding (~50% of wildtype) does not explain the almost complete loss 
of E3 activity and suggests that these contacts allosterically stimulate the transfer of 
ubiquitin from E2~Ub to histone H3 substrate. 
 
 
 
Other examples of UBL-domains regulating the E3-ubiquitin ligase activity include 
Parkin (Chaugule et al, 2011) and in the PRC1-ubiquitylation module factor, BMI1 
(Gray et al, 2016). In the case of Parkin, the UBL-domain is thought to auto-inhibit E3 
activity by binding to the RING1-domain of Parkin. Ser65-phosphorylation of the UBL-
domain by PINK1 releases this auto-inhibition to activate Parkin E3 activity. The UBL-
domain of UHRF1 has not reported to be post-translationally modified and this study 
implicates it in stimulating E3 activity rather than having an auto-inhibitory role. In the 
case of BMI1, a central domain was predicted to form a ubiquitin-like fold and this 
domain is proposed to form oligomers via other accessory subunits to stimulate E3 
activity of the PRC1 ubiquitylation module (Isono et al, 2013; Gray et al, 2016). The 
UBL-domain within UHRF1 has not been reported to form oligomers and according to 
our experiments UHRF1 in solution forms monomers. Experiments carried out in this 
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study (Fig. 6.6b, c) suggest that the UBL-domain needs to be attached to the rest of 
UHRF1 to stimulate the E3 activity in the context of chromatin. The presence of excess 
free UBL-domain or of neighbouring UBL-containing UHRF1 protein did not seem to 
rescue the E3 activity of a DUBL UHRF1 mutant. This argues against any stimulation 
of E3 activity by inter-molecular contacts between UHRF1 molecules on chromatin, 
either by the UBL-domain or otherwise, and argues for an intra-molecular stimulatory 
function of the UBL towards the RING E3 ligase activity of UHRF1. 
 
Recent work looking at ubiquitylation mechanisms has identified a hydrophobic patch 
on ubiquitin that can bind to the “backside” of the corresponding E2 enzyme to 
stimulate transfer of the donor ubiquitin from E2~Ub to the substrate (Buetow et al, 
2015). From this work, the contacts made between the UBL-domain in the context of 
full-length UHRF1 and UbcH5a may occur via a hydrophobic patch to stimulate 
ubiquitin transfer to histone H3, but only in the presence of longer chromatin arrays. A 
point mutant at Phe-46, the corresponding position to Ile-44 in ubiquitin where the 
hydrophobic patch is present, to Ala behaves similarly to the DUBL mutant UHRF1 with 
reduced E3 activity whilst not affecting binding to chromatin (Fig. 6.9). This point 
mutant also bound to GST-UbcH5a at similar reduced levels as the DUBL truncated 
mutant, so further suggesting that the hydrophobic patch in the UBL-domain in UHRF1 
is responsible for stimulating the E3 activity in the presence of chromatin. XL-MS with 
the DUBL and F46A UHRF1 mutants with or without UbcH5a and chromatin indicate 
that the intra-molecular contacts within UHRF1 are relatively unaffected but contacts 
to the E2 enzyme are lost implying that the interaction with the E2 is weakened (Fig. 
6.10). Crosslinks between these UHRF1 mutants to histones in the context of 
chromatin are altered compared with the wildtype, perhaps implying that although 
binding affinities are not directly affected by removing or mutating the UBL-domain, 
subtle differences in the way UHRF1 contacts the chromatin occur (see Chapter 4, Fig. 
4.5). More work looking at the structure of this interaction in the context of the active 
E3 reaction would be required to confirm this but evidence from the biochemistry and 
mass spectrometry methods described in this study hint at an allosteric mechanism for 
UHRF1-mediated histone H3 ubiquitylation. The in vitro findings for the contribution of 
the UBL-domain to the E3-ubiquitin ligase activity are currently being tested in a cell 
culture system. Knockdown of endogenous UHRF1 using siRNA and complementation 
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with wildtype or mutant UHRF1 constructs is being carried out. The DNA CpG 
methylation at specific genomic loci can then be scored for. 
 
Further to the histone H3 ubiquitylation described in this study, UHRF1 auto-
ubiquitylation was also observed. UHRF1 has been reported to be cell cycle regulated 
at the protein level (Ma et al, 2012). A CDK-dependent phosphorylation at S652 
interrupts the interaction between UHRF1 and USP7, which leads to a build-up of 
polyubiquitin chains on UHRF1 resulting in its proteasomal degradation. The E3-
ubiquitin ligase responsible for this poly-ubiquitylation has not been specifically 
identified so it could be possible that UHRF1 auto-ubiquitylation is responsible for this 
degradation step. One study looked at UHRF1 in the context of DNA repair where 
phosphorylation at S108 enhanced its interaction with an SCF E3-ubiquitin ligase 
resulting in degradation of UHRF1 in response to DNA damage (Chen et al, 2013b). 
However, during normal DNA replication events, it is not clear if the same mechanism 
is responsible.  
 
In this study, the UHRF1 poly-auto-ubiquitylation was used as a metric for the level of 
activity of the RING-finger in conjunction with H3 ubiquitylation. In the presence of 
chromatin arrays, the auto-ubiquitylation of UHRF1 is increased as well as H3-Ub 
formation. Therefore, the presence of longer and possibly more compact chromatin 
arrays tends to increase the general RING E3 activity. Whether this is relevant for 
targeting UHRF1 for proteasomal degradation is unknown. It might be possible that 
UHRF1 binding to a suitable chromatin substrate after the passing of the replication 
fork forces it into a conformation that activates its E3 activity for H3-Ub and subsequent 
DNMT1 recruitment in addition to its own degradation, whilst still being regulated by 
USP7 and S652 phosphorylation. Thus, USP7 could enable dynamic and transient H3-
ubiquitylation at the replication fork and prevent UHRF1 degradation at the same time. 
There is some basal E3 activity of UHRF1 in the absence of chromatin. The substantial 
increase in activity in the presence of chromatin could be another mechanism for 
regulating UHRF1 at the protein level in addition to limiting the activation of UHRF1 E3 
activity to closely-packed chromatin, providing a fail-safe mechanism in order not to 
activate it in the wrong place for its function in DNMT1 recruitment. The sites of poly-
auto-ubiquitylation of UHRF1, whilst being quite non-specific, might be informative for 
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indicating what regions of UHRF1 are close to the E2/E3 enzymatic centre. Indeed, 
the sites centre around the UBL-domain, the linker between the PHD-finger and the 
SRA-domain in addition to the PBR, the same regions that also crosslink together to 
other regions of UHRF1. This corroborates the idea that these sites are physically in 
close contact, exposed to the enzymatic site and available to be modified. It also 
suggests that there is flexibility within UHRF1 that enables these sites to be available 
for RING-mediated ubiquitylation.  
 
The XL-MS experiments with UHRF1, UbcH5a and chromatin detected an additional 
crosslink between the PBR in UHRF1 and UbcH5a in the presence of chromatin 
compared to experiments without. Importantly the TTDN-PBR contact is lost, 
suggesting an opening up of UHRF1 upon chromatin binding and a positioning of the 
PBR close to the E2 and the H3 N-terminus. The PBR in UHRF1 was observed to have 
additional nucleosome binding contributions (see Chapter 4) as its removal or mutation 
of lysine residues to glutamine residues reduced the binding affinity for nucleosomes, 
independent of any histone modifications. Perhaps, as expected, given the reduced 
binding to the substrate, the E3-ubiquitin ligase activity of the PBR mutant in UHRF1 
was reduced with decreased UHRF1 auto-ubiquitylation and reduced H3-Ub 
formation. The additional crosslink from the XL-MS experiments and this reduced E3 
activity could be related to an important contribution of this basic region to the reaction 
mechanism. It has been reported in Bre1-Rad6 in yeast that an interaction between a 
basic region of the E2-E3 minimally active fusion protein and the acidic patch formed 
by H2A and H2B is important for activity on nucleosome substrate (Gallego et al, 
2016). This was found by a XL-MS and biochemical approach. A similar observation 
was found for the PRC1 ubiquitylation module (RING1A/B and BMI1 with UbcH5c) that 
used an arginine finger in RING1A/B in addition to UbcH5c contacts with the 
nucleosomal DNA and histones to specify the target site for ubiquitylation (McGinty et 
al, 2014). Therefore, the varying domains within ubiquitylation modules are likely to 
play a key role in the activity and specificity of the ubiquitin transfer. Whether the PBR 
in UHRF1 in conjunction with the UBL-domain plays a similar role in positioning the 
substrate or stimulating the E2 is unclear. As already discussed, the PBR has been 
implicated in interactions with several distinct biological molecules such as 
phosphoinositides, other proteins and nucleic acids that regulate UHRF1 function. It is 
 148 
likely that competitive binding, post-translational modifications and 
allosteric/conformational changes dictate the chromatin-binding and E3 activity of 
UHRF1 depending on the cellular state. 
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Chapter 7 
7. Towards a structure of UHRF1 bound to modified nucleosomes 
There is as yet no structure of the full-length UHRF1 with or without physiologically-
relevant nucleosome substrate. The structural information that has so far been 
elucidated has been with individual domains of UHRF1 such as the TTD and/or PHD 
domains with H3 N-terminal peptides (Rajakumara et al, 2011; Rothbart et al, 2012; 
Arita et al, 2012) or the SRA-domain with short DNA oligonucleotides (Arita et al, 2008; 
Hashimoto et al, 2008). This has elucidated the specific molecular details of how the 
individual domains within UHRF1 bind and specifically recognise histone and DNA 
modifications. For instance, the SRA-domain specifically interacts with hemi-
methylated CpG DNA by an unusual base-flipping mechanism on naked DNA. The 
TTD-PHD domains have been reported to act cooperatively in binding to H3 N-terminal 
tails (Rothbart et al, 2013). The PHD-finger can bind to the very N-terminal region with 
unmodified H3R2 and H3K4 (Hu et al, 2011; Lallous et al, 2011) whilst the TTD can 
contact the H3K9me2/3 mark via an aromatic cage in the N-terminal Tudor domain 
(TTDN). In addition to these published studies, the crystal structures of the N-terminal 
UBL-domain (PDB: 2FAZ) and the C-terminal RING-finger (PDB: 3FL2) have also 
been solved and deposited in the Protein Data Bank (PDB) and look as expected for 
a ubiquitin-like fold and RING-domain, respectively. Despite the individual domains 
being well studied and known, how the full-length protein is folded and arranged has 
so far not been elucidated. Crystallisation trials have been carried out but even with 
the shorter TTD>SRA fragment (118-621) attempted during this study, crystals could 
not be obtained (data not shown). Recent work by other groups has investigated how 
the domains within UHRF1 make contacts to each other and it was proposed that the 
protein exists in an equilibrium between an open and a closed state depending on the 
local biological context. It is likely, therefore, UHRF1 exhibits conformational flexibility 
and that this dynamic equilibrium abrogates the formation of crystals required for x-ray 
crystallography.  
 
For this study, it was attempted to form a complex of UHRF1 bound to nucleosomes 
with the goal to image the complex by electron microscopy (EM). Previous work has 
successfully used this technique for modified nucleosome-bound structures (Wilson et 
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al, 2016), therefore preliminary work using negative-stain EM was carried out. These 
initial tests were intended to see if a stable complex could be formed between UHRF1 
and mono-nucleosomes and also if this complex was amenable for EM-based 
techniques (negative-stain and later on possibly cryo-EM). The idea behind this 
approach was that binding to nucleosomes might fix the otherwise flexible UHRF1 
protein in one conformation and thereby enable the determination of its structure. 
 
7.1 Size-exclusion chromatography (SEC) formation of UHRF1-nucleosome 
complexes 
Using nucleosome pull-downs and EMSAs enabled detection of UHRF1 binding to 
nucleosomes with different chromatin modifications on immobilised nucleosomes and 
in solution (see Chapter 4). The first step towards elucidating some structural 
information was to try and form a stable complex of UHRF1 with a nucleosome core 
particle (Fig. 7.1). An analytical-size SEC column was used (Superose 6 3.2/300, GE 
Healthcare). UHRF1 (full-length or the short fragment) was incubated at a 2:1 molar 
ratio to nucleosome core particles containing individual chromatin modifications 
(H3K9me3 and/or hemi-methylated DNA). The migration behaviour of both UHRF1 
variants and nucleosome core particles shifted when in combination to a higher 
molecular weight with some unbound UHRF1 also being present (Fig. 7.1a, b). The 
stoichiometry was judged to be approximately 1:1 for UHRF1 bound to a mono-
nucleosomes, although using SEC with multiple angle light scattering (SEC-MALS) 
would give a more precise idea of the stoichiometry. The shift to a higher molecular 
weight and approximate stoichiometry seemed to be identical for UHRF1 bound to 
nucleosomes with the different chromatin modifications (H3K9me3 and/or hemi-
methylated CpG DNA). 
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The fractions from the SEC preparation for UHRF1-nucleosome complexes were 
analysed by both denaturing SDS-PAGE and native PAGE. The species present 
(UHRF1 and histones) could be observed by the former but the native gel 
electrophoresis gave potentially interesting results (Fig. 7.1b, bottom panel). Several 
distinct bands could be observed by Coomassie Brilliant Blue staining of the native 
PAGE gel in addition to the free nucleosome that is also present in the sample. A 
similar banding pattern could be detected in the nucleosome EMSA assays when 
staining with ethidium bromide (see Chapter 4, Fig. 4.5). This might indicate that 
several different conformations exist for UHRF1-bound nucleosomes or some 
structural heterogeneity within the complex that SEC could not resolve. Alternatively, 
since a symmetrical peak is observed by SEC this could also be an artefact of the gel-
based analysis. 
 
7.2 Sample quality assessment by negative-stain EM 
The formation of a stable complex between UHRF1 and mono-nucleosomes may 
make it amenable for structural analysis, possibly using electron microscopy (EM) 
techniques. The complex itself looks reasonably homogeneous by SEC with a single, 
symmetrical UV absorbance peak formed but it was not known whether the complex 
would remain stable upon heavy metal staining or loading onto carbon-coated copper 
EM grids during the negative-stain EM procedure. Following purification of a full-length 
UHRF1-nucleosome complex by SEC (Fig. 7.1b, left), individual fractions (C3 + C4) 
were crosslinked with small amounts of glutaraldehyde (see Materials and Methods) 
before diluting the sample with the added cross-linker, and loading it onto grids (Fig. 
7.2b). The sample was stained with uranyl acetate as a heavy-metal stain for negative-
stain EM. Complexes could be visualised and appeared larger than an equivalent 
sample only containing mono-nucleosomes (Fig. 7.2a) and slightly elongated. There 
was no observed aggregation and the sizes of the particles were as expected of 
nucleosome-bound complexes. Image analysis and 2D class averaging was carried 
out by Rafael Ayala (Xiaodong Zhang’s group, Imperial College London). Fourteen 
classes could be identified for the UHRF1-nucleosome complex with one of the classes 
potentially being an unbound nucleosome based on the approximate size (indicated 
by an arrowhead, class 6, Fig. 7.2b). SEC was chosen as the method for EM sample 
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preparation as the complexes could be directly loaded onto the copper grids without 
delay, effectively reducing the time for the complex to dissociate. Furthermore, 
complex formation by SEC can also be detected using in-line UV absorbance at 280 
nm (and 260 nm for DNA) for EM sample preparation.  
 
The EM work was carried out as an initial quality control for the sample to try and 
elucidate more detailed structural details of UHRF1 bound to nucleosomes but was not 
pursued further at the time. However, future efforts in this direction are being planned 
and carried out at present. 
 
 
 
7.3 Discussion 
The structures of individual domains of UHRF1 in isolation or with histone peptides or 
short DNA oligonucleotides have already been elucidated. However, the structure of 
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the full-length protein or how the full-length protein binds to physiological nucleosome 
substrates is not yet known. In this study, preliminary EM work using negative-stained 
grids on relatively low-power microscopes was carried out to indicate that UHRF1 and 
mono-nucleosomes form stable complexes in solution that can be imaged by EM.  
 
It might be possible in future to take this towards a structural project with a pipeline for 
complex production and the use of cryo-EM that might result in better resolution 
images. However, even low-resolution data might be useful in the case of UHRF1 as 
modelling with currently known structures of individual domains and energy profiles will 
enable an overall configuration to be discerned. Furthermore, XL-MS data described 
in this study (see Chapter 5) may provide some restraint data that will aid in deciphering 
the structural architecture in subsequent EM studies. As already mentioned, there is 
potential structural heterogeneity within the UHRF1/nucleosome complex but these 
different conformers might be resolved using particle picking. In this preliminary work, 
it was possible to identify a class of unbound nucleosomes so different conformations 
could be separated using the different class averages. Furthermore, once a pipeline 
has been set up for cryo-EM, it would be interesting to investigate how UHRF1 
recognises H3K9me2/3 and/or hemi-methylated CpG in the context of nucleosomes.  
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8. Conclusions 
The work described here attempt to elucidate the molecular characteristics of the 
replication factor UHRF1 in its chromatin binding and E3-ubiquitin ligase activity, and 
how this might be related to its intra-molecular conformation.  
 
Using reconstituted nucleosome and chromatin substrates, it was possible to 
recapitulate previous findings that UHRF1 binding is enhanced by a single hemi-
methylated CpG site in the linker DNA of a nucleosome core particle. Furthermore, 
there was little detectable increase in binding to H3K9me2/3 marks similar to previous 
findings for recombinant UHRF1 on histone peptides. A novel finding was that the basic 
linker between the SRA-domain and the RING-finger (the polybasic region or PBR) 
seemed to contribute to nucleosome binding as its presence increased UHRF1 binding 
to nucleosome substrate regardless of chromatin modifications present. During the 
course of this study, several publications identified this basic region within UHRF1 to 
regulate its binding to chromatin via other factors such as PI(5)P and USP7. This 
regulation was thought to involve intra-molecular contacts between this region and 
other domains within UHRF1 so an in-solution crosslinking/mass spectrometry 
approach was used to relate this with the chromatin binding characteristics of UHRF1. 
These contacts were verified within the full-length UHRF1 in addition to several likely 
transient contacts between the N-terminal UBL-domain and other solvent-exposed 
regions. Interestingly, contacts between the PBR and the Tandem Tudor domain were 
reduced in the presence of chromatin substrate whilst crosslinks between UHRF1 and 
histone proteins imply that the PHD-finger and SRA/PBR region make important 
contacts to histones within nucleosome core particles. This indicates that UHRF1 
switches from a “closed” into an “open” conformation upon chromatin binding as 
previously proposed (Gelato et al, 2014; Fang et al, 2016). 
 
The principle known function of UHRF1 is to specifically recruit DNMT1 to newly 
synthesised DNA for maintaining the CpG methylation status following DNA replication 
and recent studies have identified that UHRF1-mediated H3 ubiquitylation is critical for 
this. We find that UHRF1 E3 activity is stimulated on longer arrays of chromatin 
independent of pre-existing chromatin modifications and UHRF1 predominantly 
ubiquitylates histone H3 K18 and K23 as found previously. The specificity of 
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ubiquitylation may be related to how the UHRF1-UbcH5a complex is positioned on the 
chromatin substrate and XL-MS experiments do indicate altered contacts between 
UHRF1 and UbcH5a +/- chromatin that suggest an “induced-fit” model for the enzyme 
mechanism. These contacts involve the PBR and the UBL-domain of UHRF1. How this 
determines the enzyme specificity is unclear without more structural data, but it is clear 
that removal of the UBL-domain does substantially reduce UHRF1 E3 activity. 
Therefore, whilst the UBL-domain does not seem to directly contribute to chromatin 
binding of UHRF1 per se, it does seem to stimulate the RING-dependent E3-ubiquitin 
ligase activity by making contacts that serve to either recruit the E2 or allosterically 
activate transfer of ubiquitin from UbcH5a~Ub to H3. The data supports a contribution 
to both.  
 
Using this in vitro data, it is possible to update the model (Fig. 8.1) for UHRF1 binding 
and E3 activity at newly replicated chromatin that is required to recruit DNMT1 to 
replication forks. The ability for UHRF1 to preferentially bind hemi-methylated DNA can 
target it to newly formed chromatin with a small preference for the heterochromatin 
mark, H3K9me2/3. As the naïve chromatin assumes higher order structures, the E3-
ubiquitin ligase activity of UHRF1 is stimulated to ubiquitylate histone H3 with the UBL-
domain contacting the relevant E2, resulting in the recruitment of DNMT1 via a 
ubiquitin-interacting motif (UIM) for maintenance methylation. The H3K9me2/3 and 
hemi-methylated CpGs could also allosterically activate UHRF1 E3 activity. Processive 
maintenance methylation is promoted by continuous recycling of the ubiquitin mark by 
USP7 that can interact with both DNMT1 and UHRF1. This cooperativity keeps 
everything at newly replicated sites and makes sure that hemi-methylated CpG and 
H3-Ub marks are transient and fully methylated CpGs are faithfully restored. The role 
of the PBR in UHRF1 could be multi-faceted, potentially depending on PTMs in this 
region or on competing binding factors such as USP7 that might regulate its chromatin 
binding. However, it might be speculated, based on other histone E3-ubiquitin ligases 
and this work, that chromatin contacts via the PHD-finger and the PBR might correctly 
position UHRF1 and the E2 on the nucleosome and thereby specify the site for H3 
ubiquitylation in the context of a suitable chromatin substrate.  
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Appendices 
 
Appendix 1 Tables of crosslinked domains from XL-MS experiments. The major 
crosslinked domains from the indicated figures are listed with examples of specific 
crosslinked residues shown in brackets. 
 
Table associated with Fig. 5.8. Crosslinked domains within UHRF1 that are present 
in the relevant UHRF1 fragments 
 
Protein 1 Domain/linker 1 Protein 2 Domain/linker 2 
UHRF1 UBL (24) UHRF1 PBR (641, 648) 
UHRF1 UBL (11, 24) UHRF1 TTD (172, 196, 
198) 
UHRF1 UBL (24) UHRF1 PHD-SRA linker 
(302, 320, 290, 
404) 
UHRF1 UBL (24) UHRF1 SRA (524, 550) 
UHRF1 TTD (198) UHRF1 PHD (320, 386) 
UHRF1 TTD (198) UHRF1 PHD-SRA linker 
(404) 
UHRF1 TTD (198) UHRF1 SRA (544, 567) 
UHRF1 TTD (196) UHRF1 PBR (622, 641) 
UHRF1 PHD (302) UHRF1 PHD-SRA linker 
(390, 404) 
UHRF1 PHD (302) UHRF1 SRA (505, 550) 
UHRF1 PHD (302) UHRF1 PBR (641, 648) 
UHRF1 SRA (544) UHRF1 PHD-SRA linker 
(390, 404) 
UHRF1 SRA (544) UHRF1 PBR (641) 
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Table associated with Fig. 5.9. Crosslinked domains within UHRF1 and between 
UHRF1 and histone proteins in the context of mono-nucleosomes and 12x187bp 
chromatin arrays. 
 
Protein 1 Domain/linker 1 Protein 2 Domain/linker 2 
UHRF1 UBL (24) UHRF1 PBR (641) 
UHRF1 UBL (50) UHRF1 TTD (196) 
UHRF1 UBL (24, 50) UHRF1 PHD-SRA linker 
(302, 390) 
UHRF1 UBL (11, 24) UHRF1 SRA (505, 524, 
550, 567) 
UHRF1 PHD (320) UHRF1 PHD-SRA linker 
(390) 
UHRF1 PHD (302) UHRF1 SRA (505) 
UHRF1 PHD (320) UHRF1 PBR (622) 
UHRF1 SRA (544) UHRF1 PHD-SRA linker 
(390, 404) 
UHRF1 SRA (567) UHRF1 PBR (664) 
UHRF1 UBL (30) Histone H3.1 N-terminus (4, 9, 
14, 18) 
UHRF1 PHD (302, 320) Histone H3.1 N-terminus (4, 9, 
14, 18) 
UHRF1 SRA (544, 567) Histone H3.1 N-terminus (4, 9, 
14, 18) 
UHRF1 PBR (641) Histone H3.1 N-terminus (4, 9, 
14, 18) 
UHRF1 UBL (N-term) Histone H4 N-terminus (8, 12) 
UHRF1 PHD (302, 381) Histone H4 N-terminus (8, 12) 
UHRF1 SRA (524, 550) Histone H4 N-terminus (8, 12) 
UHRF1 PBR (644, 662, 
664) 
Histone H4 N-terminus (8, 12, 
16) 
UHRF1 PHD-SRA linker 
(390) 
Histone H2B N-terminus (12) 
UHRF1 PBR (641) Histone H2B N-terminus (27) 
UHRF1 SRA/PBR (505, 
547, 679) 
Histone H2A C-terminus (119, 
127, 129) 
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Table associated with Fig. 5.10. Crosslinked domains within and between UHRF1 
and USP7. 
 
Protein 1 Domain/linker 1 Protein 2 Domain/linker 2 
UHRF1 UBL (24) UHRF1 PBR (641, 648) 
UHRF1 UBL (11, 24) UHRF1 TTD (172, 196, 
198) 
UHRF1 UBL (24) UHRF1 PHD-SRA linker 
(302, 320) 
UHRF1 UBL (24) UHRF1 SRA (524, 550) 
UHRF1 TTD (198) UHRF1 PHD (320) 
UHRF1 TTD (198) UHRF1 PHD-SRA linker 
(404) 
UHRF1 TTD (198) UHRF1 SRA (544) 
UHRF1 TTD (196) UHRF1 PBR (641) 
UHRF1 PHD (302 UHRF1 PHD-SRA linker 
(404) 
UHRF1 PHD (302) UHRF1 SRA (550) 
UHRF1 PHD (302) UHRF1 PBR (641, 648) 
UHRF1 SRA (544) UHRF1 PHD-SRA linker 
(404) 
UHRF1 SRA (544) UHRF1 PBR (641) 
USP7 Catalytic (484) USP7 UBL3/4/5 (929) 
USP7 Catalytic (367) USP7 C-terminus 
UHRF1 UBL (N-term) USP7 Catalytic domain 
(372) 
UHRF1 UBL (24) USP7 UBL3/4 (869, 914, 
959) 
UHRF1 PHD (320) USP7 UBL1 (640) 
UHRF1 SRA/PBR (567, 
622) 
USP7 UBL3/4 (914, 
959) 
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Table associated with Fig. 6.8. Crosslinked domains within UHRF1 and between 
UHRF1 and UbcH5a with and without chromatin. Crosslinks highlighted in red only 
occur in the absence of chromatin whereas the crosslink highlighted in green occurs 
both with and without chromatin. 
 
Protein 1 Domain/linker 1 Protein 2 Domain/linker 2 
UHRF1 UBL (24) UHRF1 SRA (505, 567) 
UHRF1 UBL (N-term) UHRF1 PBR (627) 
UHRF1 UBL (24) UHRF1 TTD (172, 196) 
UHRF1 UBL (24, 50) UHRF1 PHD-SRA linker 
(390) 
UHRF1 UBL (24) UHRF1 SRA (567) 
UHRF1 TTD (198) UHRF1 PHD-SRA linker 
(404) 
UHRF1 TTD (198) UHRF1 SRA (495) 
UHRF1 TTD (196) UHRF1 PBR (627) 
UHRF1 PHD (302) UHRF1 PHD-SRA linker 
(390) 
UHRF1 PHD (383) UHRF1 SRA (505, 567) 
UHRF1 PHD (381) UHRF1 PBR (648) 
UHRF1 SRA (544) UHRF1 PHD-SRA linker 
(404) 
UHRF1 SRA (567) UHRF1 PBR (664) 
UHRF1 UBL (84) Histone H3.1 N-terminus (4, 9, 
14, 18) 
UHRF1 PHD (302, 320) Histone H3.1 N-terminus (4, 9, 
14, 18) 
UHRF1 SRA (505, 567, 
574) 
Histone H3.1 N-terminus (4, 9, 
14, 18) 
UHRF1 PBR (641) Histone H3.1 N-terminus (4, 9, 
14, 18) 
UHRF1 UBL (N-term) Histone H4 N-terminus 
UHRF1 PHD (320, 383) Histone H4 N-terminus (8, 16) 
UHRF1 SRA (505, 550, 
567) 
Histone H4 N-terminus (8, 12) 
UHRF1 PBR (622) Histone H4 N-terminus (12) 
UHRF1 PBR (641, 679) Histone H2B N-terminus (24, 
27) 
UHRF1 SRA (334, 495) Histone H2A C-terminus (118, 
129) 
UHRF1 UBL (84) UbcH5a C-terminus (144) 
UHRF1 SRA (550) UbcH5a N-terminus (8) 
UHRF1 PBR (648) UbcH5a C-terminus (133) 
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Appendix 2 Example mass spectra of ubiquitylated peptides identified on 
histone H3 and UHRF1. The peptide-based evidence using the b- (blue) and y- (red) 
ions to determine the modified sites in UHRF1-mediated ubiquitylation assays. The 
output is for each of the three experiments from MaxQuant (see Materials and 
Methods). 
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